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ABSTRACT
The Immunological and Neurochemical Toxicity of Benzene
and Its Interaction with Toluene in Mice
by
Gin-Chang Hsieh , Doctor of Philosophy
Utah State University, !988
Major Professor : Dr . R. D. R. Parker
Department:

Biology/ Toxicology Program

Benzene and toluene are known groundwater contaminants . Male CD-I
mice were continuously exposed to 0, 31 , !66 , and 790 mg/ L benzene and
0, 17 , 80, and 405 mg/ L toluene, respectively, in drinking water for
four weeks. Benzene caused a reduction of leukocytes, lymphocytes and
erythrocytes, and resulted in a macrocytic anemia.
to both B- and T-cell

mitogens,

Lymphocyte response

mixed lymphocyte response to

alloantigens, and the ability of cytotoxic lymphocytes to lyse tumor
cells were enhanced at the lowest dose of benzene and depres sed in the
higher dosage animals. Benzene at doses of 166 and 790

mg/L decreased

the number of sheep red blood cell (SRBC) -s pecific plaque-forming cells,
the level of serum anti-SRBC antibody, and the activity of interleukin-2
( IL -2).
Benzene treatment increased endogenous concentrations of the brain
biogenic amines norepinephrine (NE), dopamine (DA) and serotonin (5-HT),
and concomitantly, elevated the levels of their respective major
metabolites vanillymandel ic acid (VMA), 3,4-dihydroxyphenyl acetic acid
(DOPAC) and homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (SHIM), in several brain regions .

In most cases, the changes were dose-

xi
related; in several instances, maximum effects occurred at the 166 mg/ L
benzene dose .
Toluene did not adversely affect the hematological

parameters.

Depres sion of immune function was evident at the highest dose (405
mg/L), except for mitogeneses. Increased neurochemical concentrations
caused by toluene

displayed a dose-dependent bi phasic manner which

began at a dose of 17 mg/L, peaked at 80 mg/L, and decreased at 405
mg/ L. Toluene treatment had more selective effects on NE , 5-HT , VMA and
5-HIAA, than DA, DOPAC and HVA.
Both compounds, by increasing concentrations of the hypothalamic NE
and its major metabolite VMA, stimulated the hypothalamic -pituitary adrenocortical

axis activity,

resulting

in

an elevated

plasma

adrenocorticotropic hormone and serum corticosterone which had an
additive adverse effect on IL-2 synthesis.
Toluene, 325 mg/ L, completely inhibited benzene - induced cytopenia
and immunosuppression when it was coadministered with benzene (166
mg/ L) . The low dose of toluene (80 mg/L ) did not antagonize benzene
immunotoxicity. Mice given the combined exposures exhibited

raised

levels of regional neurochemicals when compared to the untreated
controls. Increased levels of monoamine metabolites in several brain
regions were

greater in the combined treatments of benzene and toluene

than when either chemical was used alone. The results of the interaction
studies support the known metabolic interaction mechanisms of benzene
and toluene.
(226 pages)

CHAPTER I
INTRODUCTION

Benzene,
occurrence .

the simplest aromatic
Its solubility and

hydrocarbon,

volatile

nature

is ubiquitous

in

indicate possible

environmental mobility . This chemical has a long history of extensive
use in industry.

At present it is produced primarily by petrochemical

industries and is used as a starting material for the manufacture of
many chemica 1s .

Benzene is a1so emp 1oyed as a essent i a1 canst ituent in

motor fuel (Fishbein, 1984; Brief et al., 1980). It has been identified
in ambient water
1985)

at

(U.S . Environmental Protection Agency, 1980a ; Cotruvo,

concentrations up to 10 mg/ L (U.S . National

Toxicology

Program, 1981).
Due to the high 1 ipophil ic nature of benzene which causes it to
accumulate in lipid rich tissue, particularly the bone marrow and brain
(Snyder et al.,

1981a; Rickert et al.,

production of biologically reactive

1979), and because of the

intermediates

through

metabolic

biotransformations (Snyder et al., 1987; Irons, 1985 ; Sawahata et al.,
1985; Bolcsak and Nerland,
potential

health hazard .

1983),

benzene is considered to be a

Like most organic solvents, benzene is a

central nervous system depressant at high concentrations

(Brief et al .,

1980). Accumulation of this chemical in the nervous system may lead to
impairment of the neuronal function. It has been shown that the major
toxic effect of benzene for human beings or laboratory animals is
primarily disturbance of the hematopoietic system, an effect unique to
benzene and which can affect every

subsequent cell 1 ine resulting in a

variety of blood dyscrasias (Fishbein, 1984).

The mechanism of benzene-

induced hematopoietoxic effects has not been well elucidated , however,
most

researchers believe oxidative benzene metabolites

rather

than

benzene itself, are required to mediate these hematopoietic effects
(Sawahata et al., 1985; Irons, 1985; Bolcsak and Nerland, 1983 ; Greenlee
et al., 1981b).

A number of recent studies on benzene carcinogenesis

and mutagenesis have been reviewed by Dean (1985) who also suggests that
benzene could be regarded as a classical initiator or a promotor to
explain its leukaemogenesis.
Toluene is also considered a major aromatic chemical
environmental and occupational significance

(Fishbein,

1985).

with
It is

produced in enormous quantities mainly from petroleum or petrochemical
processes, and is employed as a solvent

(for which it is increasingly

used as a "safe" replacement for benzene)

and as a starting compound

for other chemicals and a component in gasoline (U . S. Environmental
Protection Agency, 1980b) .

The neurotoxic property of this chemical

represents its main health hazard

(Benignus, 1981a,b). It has been

detected in concentrations up to 6.4 mg/L in finished water
and Youngren, 1986).

(Tardiff

Furthermore, it should be noted that commercial

toluene contains varying

amounts of benzene

and

it

is

frequently

employed in industry with benzene (U.S . National Academy of Sciences,
1982). Toluene, in sufficient amounts, appears to have the potential to
sig nificantly alter the metabolism and resulting bioactivity of certain
other chemica 1s, thereby

possessing a potentia 1 for alteration of the

toxicity of numerous chemical

agents

(Hayden et al.,

1977).

For

example, it has been documented that toluene is a competitive inhibitor
of the biotransformation,

and

antagonizes

myelotoxic and

genotoxic

effects of benzene (Ikeda et al., 1972; Andrews et al., 1977; Sato and

3

Nakajima, 1979; Tunek et al., 1981;

Gad-El-Karim et al., 1984; 1986) .

Although there is a large amount of information available detailing
the effects of benzene on the hematopoietic system,

studies concerning

the immunotoxic evaluations of this chemical are scant .

Also, little

information is available regarding the effects of toluene exposure on
immune systems.

Meanwhile , despite several published studies about the

positive effects of benzene and toluene on behavior changes, research
con ducted on the neurotox ic potential e.g., alterations in brain
neurochemicals}, is still limited.

Therefore the objective of this

study was to investigate basic immunotoxic and neurotoxic mechanisms by
utilizing

various

immunological

and

neuro-endocrinobiochemical

parameters to better understand the mode of toxic action s of these two
chemicals and their interactions in experimental

animals .

Because

benzene and toluene are known contaminants of groundwater, which is a
primary source of drinking water for approximately half the population
of the United States

(U.S. Office of Technology Assessment, 1984},

oral administration via drinking water in animals wa s employed.
Consequently, the information gathered may contribute to support of the
development of groundwater quality standards and protection efforts.
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CHAPTER II
LITERATURE REVIEW

IMMUNE SYSTEM AS A TARGET ORGAN FOR TOXICITY
The immune system is comprised of

complex but well-defined

network of specialized cells that interact to mount a response following
recognition of foreign materials termed antigens.

The potential

responses of the system range from the production of antibody or cellmediated reactions to the induction and modulation of allergic and
inflammatory responses (Sick et al., 19S5).

The response to antigens

and the mechanisms of many cellular interactions
control.

The use of the immune system as a

is

under genetic

target organ for detecting

toxicity of drugs, chemicals or environmental toxicants recently has
received considerable attention (Sick , 19S2; Dean et al. , 19S5a). It ha s
many se nsitive parameters whose alterations, as a result of experimental
procedures, are easily determined

(Dean et al., 1982; 1986 ; Thomas et

al. , 1985) .
Introduction of a chemical into a host may elicit a variety of
reactions.

Many chemicals, or their metabolites, may be recognized as

antigens.

This response may be directed at the native molecule or

metabolite or may result from the chemical group binding to host protein
creating new antigenic determinants . Foreign chemicals may enhance or
suppress immune competence.

Enhancement of immune potential may lead to

increased host resistance, or to autoimmunity.

Decreased immune

function may lead to the lack of an appropriate response.

It is

possible for these interactions to occur at the same time in various
combinations.

Lastly, a chemical may have no effect

on the immune

5

system at doses that produce toxicity in other organ systems.
In order to be able detect slight modifications in immune
responsiveness, sensitive assay systems

(Dean et al.,

al., !985a; Sharma and Zeeman, 1980)

must be employed and require

better standardization so little

1986; Thomas et

variation in data occurs . Table Il - l

summarizes a compre hensive panel of in vivo and in vitro assays used to
measure host resistance and immunity, and the end points measured. A
number of industrial and environmental chemicals have been shown to
affect the immune response in human beings and animals
1985a; Sharma, 1981; Faith et al ., 1980).

(Dean et al . ,

Risk assessment scientists

have begun to recognize that immunological

information gained from

cel lular and molecular approaches for the safety assessment of a drug or
chemical should facilitate improved human risk assessment .
NEUROBIOCHEMICAL APPROACHES TO TOXICOLOGY
As technology has become more refined in recent years,

useful

biochemical methods are available to understand the mechanisms involved
in normal and altered nervous system function
1986) .

(Narahashi, 1984; Bondy,

It is through the determination of s uch mechanisms that

neurochemistry can best contribute to the overall assessment of
neurotoxicity .

Neurotoxic agents can affect the nervous system in a

number of diverse ways (Bondy, 1985; Norton, 1986; Cooper et al ., 1986;
Mitchell,

1982).

Some agents act directly on the nervous system,

whereas others disturb non-neuronal processes which affect the nervous
sys tem indirectly.

In most instances, biochemical systems are

affected

through genera 1 or specific mechanisms.

A neurotoxin can disturb the

blood-brain

energy

barrier;

interfere

with

metabolism

or

the

6

TABLE II -1
IMMUNE FUNCTION ASSAYS FOLLOWING CHEMICAL OR DRUG EXPOSURE*
Endpoint measured

parameter
Immunopathology
Hematology

Complete blood count, WBC
differentia 1s

Weights

Body, spleen, thymus, kidney,
ad rena 1

Histology

Spleen, thymus, bone marrow,
lymphonode, adrenal

Cellularity

Spleen, bone marrow, B-cell
progenitor, pluripotent stem
cell, granulocyte/macrophage
progenitor, cell surface marker
profile (% T, B, macrophage;
T-cell subsets)

Inunune correlate
Overall immune
system

Mitogenesis
LPS
PHA, Con A

Incorporation of radiolabled
nucleic acid precursors into
DNA of dividing lymphocytes

PWM

B-cells
T-cells
B- and T-cells

Mixed lymphocyte
response

Incorporation of radiolabled
nucleic acid precursors into
DNA of dividing responder cells

CMI

lymphokines

Quantitated by incorporation
of radiolabled nucleic acid
precursors into DNA of dividing
lymphokine-dependent cells

CMI

Cytotoxic cells

en
K

% cytotoxicity of 5lcr-labeled

target cells (determined Natural or innate
Cr-release assay)
111111unity

tu~[,

by
NK

CMI

"

TABLE 11-1 (CONT.)
IMMUNE FUNCTION ASSAYS FOLLOWING CHEMICAL OR DRUG EXPOSURE
Parameter

Endpoint measured

Immune correlate

Specific serum antibody level
or quant it at ion of anti body
plaque forming cells (PFC)/106
spleen cells 4 days after
antigen immunization

AMI, macrophage

Radiometric assay with T celldependent antigen

CMI

BIGFJO
melanoma

Measurement of lung tumor cell
growth 21 days post-challenge
b.y quant it at ion of uptake of
[ 25 I] i ododeoxyuri dine

CM I , macrophage
NK

PYB6

lethal tumor frequency 100
exposure days post-challenge

CHI,
NK

Antibody response
T-dependent
antigen ( SRBC)
T-independent
antigen (LPS)
Delayed hypersensitivity response
Host resistance

sacroma

macrophage

Listeria
monocytogenes

Cumulative% mortality 14 days CMI, macrophage
post-challenge, mean survival
time

Streptococcus
zooepidemicus

Cumulative% mortality 14 days
post-challenge, mean survival
time

AMI, macrophage
polymorphonuclear
1eukocyte, nonspecific immunity

Influenza
A2/Taiwanj64

Cumulative %mortality 14 days
post-challenge, mean survival
time

CMI, AMI,
interferon,
macrophage, nonspecific immunity

Cumulative %mortality 21 days
post-change, mean survival time

CMI, AMI,
macrophage,
interferon, NK

Host resistance
Herpes
simplex virus/
type I and 2
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TABLE II -1 (CONT.)
IMMUNE FUNCTION ASSAYS FOLLOWING CHEMICAL OR DRUG EXPOSURE
Parameter

Endpoint measured

Macrophage**
function

CMI, AMI,
non -specific
immunity

Peritonea 1
macrophage

Cellularity quantitation

Phagocytosis
ability

%phagocytosis of Slcr-labeled
chicken or sheep erythrocytes

Cytolysis of
tumor cell

Slcr-release assay

Cytostasis

Inhibition of MBL-2 murine
leukemia cell growth (measured
by uptake of radiolebeled ONA
precursors)

Bactericidal
activity

~tio of the viable bacterial
( S-labeled Klebsiella
pneumoniae) counts

Ectoenzyme
levels

Quant it at ion

Granulocyte
function test

Immune correlate

Nitroblue terazolium (NBT) dye

Non-specific
immunity

* Abbreviations used in this table: AMI, antibody-mediated immunity; CMI,

cell-mediated immunity; Con A, concanavalin A; CTL, cytotoxic Tlymphocyte; K, killer cell; LPS, lipopolysaccharide; NK, natural killer
cell; PHA, phytohemagglutinin; PWM, pokeweed mitogen ; SRBC, sheep red
blood cell; WBC , white blood cell

**soth resident and activated peritoneal macrophages
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biosynthetic pathways of neuronal macromolecules; alter axoplasmic flow
or cellular permeability; affect neurotransmitter synthesis, storage,
release, and uptake; or interfere with neurosecretory processes (Bondy,
19B5; Mail man and Dehaven, 19B4) .

Such changes can occur in l oca 1i zed

brain regions, in specific cell types, or in subcellular organelles.
Most of the studies have focused mainly on the levels of monoaminergi c
neurotransmitters, namely, catecholamines (dopamine and norepinephrine)
and indoleamine (5-hydroxytryptamine) .

Functional significance of

monoamine alterations has now been well documented
19B5).

(Rogawski and Baker,

A number of neurological and psychiatric syndromes are caused by

an excess or deficiency of these specific neurotransmitters
Smith, 1985; Poirier and Bedard, 19B4).

(Willis and

However, assays of steady state

levels of neurotransmitters are difficult to interpret particularly when
they are measured in whole brain homogenates or in large brain region s.
Therefore monoamine

metabolite levels would be a reflection of

monoaminergic neuronal

activity and yield more useful

information

(Commissiong, 1985; Bondy, 1986) . A number of environmental chemicals,
either of natural origin or products of industrial processes,
shown to cause a variety of effects on neurochemical

have been

transmitters

(D ' Donoghue, 19B5; Sharma et al ., 19B6; Coulombe and Sharma, 1985;
19B6).
The hypothalamus is an area where around 40,000 nerve fibers
mediate between central nervous system and the rest of the body, by way
of release factors, trophic hormones, and endocrine hormones. In view of
the incompleteness of the blood-brain barrier, it is more exposed to
systemically circulating materials such as neurotoxins (Bondy, 1985).
Thus, the function a1 changes in this rather small area can have major
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reverberations.

Classically,

stress responses

(as determined by

increased circulating corticosteroid hormone levels) were thought to be
mediated and regulated entirely by the hypothalamic-pituitaryadrenocortical (HPA) axis through the following cascade
Rei sine, 1984; Besedovsky et al., 1985).

(Axelrod and

The central or peripheral

nervous system recognizes "stressors" (e.g. infections, chemical
intoxications, trauma, pain, psychologic stress) and leads to increase
of hypothalamic noradrenergic neural activity, which in turn increases
the secretion of corticotropin - releasing factor
hypophyseal portal circulation.

(CRF)

into the

As a consequence of the actions of CRF

at the corticotrope in the anterior pituitary,

adrenocorticotropic

hormone (ACTH) is relea sed into the systemic circulation.

ACTH acts on

the adrenal cortex to stimulate the synthesis and secretion of
corticosteroids.

Corticosteroids, the end products of HPA axis, are

well known to impair various aspects of immunocompetence (Besedovsky et
al. ,

1985; Cupps et al.,

1985)

and · have been shown

to

inhibit

interleukin-2 (IL-2) as well as interleukin-1 (IL-l) production (Gill is
et al., 1979a,b; Snyder and Unanue, 1982; Goodwin et al., 1986).
ENV IRONMENTAL ASPECTS OF BENZENE
Chemical and Physical Properties
Benzene (C 6H6 ), an aromatic hydrocarbon with a molecular weight of
78.1, is a volatile, colorless, clear, highly flammable liquid
hydrocarbon. Pure
point of 5.5°C.

benzene has a boiling point of 80 .!°C and a melting
Benzene has a density less than that of water (0.879 at

20°C) and is soluble in water at concentrations which have been shown to
be toxic to aquatic organisms.

Benzene is also readily soluble in
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natural fats and fat-soluble substances.

It may accumulate in 1iving

organisms and appears to accumulate in ani rna 1 tissues that exhibit a
high lipid content or that represent major metabolic sites such as liver
and brain.

The fairly volatile nature (high vapor pressure of 74 . 6 mm

Hg at 20°C) and a relatively high solubility (1,780 mg/L at 25°C)
indicate that benzene could be washed out of the atmosphere with
rainfall and then be evaporated back into the atmosphere, causing a
continuous recycling between the two media.

It is miscible with

acetone, alcohol, carbon disulfide, carbon tetrachloride, chloroform,
ether,

gl ac i a1 acetic acid and oi 1s.

Benzene undergoes the typi ca 1

reactions of aromatic hydrocarbons including: chlorination, nitration,
oxidation, and sulfonation (U . S. Environmental Protection Agency, 1980a;
Maltoni, 1983; Fishbein, 1984).

Benzene is also expected to be

photooxidized in air and otherwise biodegraded in the environment (Korte
and Klein, 1982) .
Occurrence and Usage
Benzene has been produced industrially from coal tar distillation
since 1849, and from petroleum by catalytic reforming of light naphthas
from which it is isolated by distillation or solvent extraction since
1941.

At present the major source of benzene is petroleum.

It is one

of the 1argest produced compounds and has been detected at various
concentrations in the atmosphere and ambient water. Benzene is reported
to occur in fruits, fish , vegetables, nuts, dairy products, beverages,
eggs, cooked chicken and heat-treated or canned beef. Benzene has also
been identified in cigarette smoke at levels of 150-204 mg/m 3 . Its
major use in the past was in blends with gasoline. Although this use has
been reduced in the United States, benzene is still largely employed in
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many countries for the production of commercial gasoline .

The benzene

content i n gaso 1i ne varies from country to country and its range is
es timated to be from I to 15% .

Presently , benzene is largely employed

as a chemical intermediate for the production of many important
industrial

compounds,

such

as

ethyl benzene,

styrene,

phenol,

cyclohexane, maleic anhydride, aniline, dichlorobenzenes, etc . In the
past, benzene was used as a solvent for paints and rubber .

It has also

been used in medicine, in the treatment of hemoblastosis (leukemia s,
po 1ycythemi a and ma 1 ignant lymphomas) , and in the veterinary fie 1d for
disinfestat i ng wounds (Brief et al ., 19BO; U.S. Environmental Protection
Agency, 1980a; Fishbein , 1984) .
Populations at Risk and Allowed Levels
The following population groups may be exposed to benzene:

workers

engaged in i ts production; workers in chemical industries using benzene
as an i ntermediate ; workers in indu strie s producing material containing
benzene ; workers utilizing or handling compounds containing benzene ;
people liv i ng in

industrialized town s near factories

employing benzene, or compounds containing it;

producing or

the general

overall

population since benzene is contained in gasoline and can also be found
as a contaminant in drinking water.

The 1eve 1s of benzene a11 owed in

workplaces vary from country to country .

Until I 978, in the United

States the Occupational Safety and Health Administration (OSHA) standard
for benzene prescribed an 8-hour time -weighted average (TWA) of 10 ppm
with an acceptable ceiling concentration of 25 ppm in air.

In addition,

this standard allowed excursions above the ceiling to a maximum peak
concentration not exceeding 50 ppm, provided that such exposure occurred
for no more than 10 minutes in any 8-hour work period .

In 1978, OSHA
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stated that :

"1 ppm TWA, with 5 ppm ceiling limit for 15 minutes during

the 8-hour day , is the level which most adequately assures,

to the

extent feasible, the protection of workers exposed to benzene." However ,
that rule was annulled by the U.S. Supreme Court (Maltoni, 1983; Brief
et al., 1980; Holmberg and Lundberg, 1985; Fishbein, 1984).
For the maximum protection of human health from the potential
carcinogenic effects of exposure to benzene through ingestion of
contaminated water and contaminated aquatic organisms, the ambient water
concentrations should be zero, based on the non-threshold assumption for
this chemical.
time .

However, zero level may not be attainable at the present

Therefore , if the incrementa 1 increa se of cancer risk over a

lifetime is estimated at 10 -5, 10 -6, and 10 - 7 (one
cancer in populations of 100,000,

additional case of

1,000,000, and 10,000,000},

the

corresponding recommended criteria are 6. 6 ).Jg/ L, 0. 66 ).Jg/ L, and 0. 066
).Jg/ L, respectively .

If these estimates are made for con sumption of

aquatic organi sms only , exc luding consumption of water , the levels are
400 .ug/ L, 40 . 0 .ug/ L, and 4. 0 .ug/ L, respectively

(U . S. Environmental

Protection Agency, 1986a).
Route s of Exposure
The respiratory route is believed to be the major source of human
exposure to benzene.

Benzene diffuses rapidly through the lungs and is

quickly absorbed into the blood , with the rate of absorption being
greatest at the beginning of exposure.

Inhalation of benzene vapors may

be supp 1emented by percutaneous absorption, although benzene is poorly
absorbed through i ntack skin.
benzene exposure is
(Fishbein, 1984) .

In the genera 1 population , much of the

from gasoline vapors

and

automotive emissions

The dermal route is only a minor source of human
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exposure since skin contact is infrequent

(Franz, 1983) . Exposure to

benzene through oral ingestion is also cons ide red to be a problem for
the general population (Lee et al., 1983 ; U.S. Environmental Protection
Agency, 1980a) . It has been reported that chromosomal damage is higher
with ora 11 y administered benzene than ot her ex posure routes in mice
(Gad-El-Karim et al., 1986).
BENZENE METABOLISM
Metabolism and Toxicity of Benzene
Benzene metabolism is required for its toxicity (Snyder et al.,
1983).

Exposure to benzene has long been associated with toxicity to

blood and bone marrow,

including lymphocytopenia,

pancytopenia,

thrombocytopenia, and aplastic anemia (Brief et al., 1980; Goldstein,
1983).
1985 ;

Benzene is also a carcinogen and mutagen (Aksoy, 1985; Oean,
Ereson et al.,

19B5) .

It

is associated with an

increased

incidence of acute myelogenous leukemia and some of its variants in
humans (Infante and White, 1985; Rinsky et al., 1987),

an increased

incidence of several solid tumors (Maltoni et al . , 1985; Oean, 1985),
and possibly leukemia/lymphoma
Cronkite et al . , 1984).
benzene

possesses

in

rodents

(Snyder et

al . ,

1980;

Several studies are also in agreement that

embryotoxic/teratogenic

pote ntial

in experimental

animals (Green et al., 1978; Kuna and Kapp, 1981; Ungvary and Tatrai,
1985).
The metabolic fate

of benzene has

toxicologist throug hout this

century.

interested biochemists
A variety of studies

and
have

established that benzene itself is not the toxic species but requires
metabolism to reactive intermediates (Snyder, 1g84; Irons, 1985),

15
through complex bioactivation mechanisms (Pellack-Walker et al. , 1985) .
In vivo metabolic studies following benzene exposure have identified

phenol as the primary metabolite of benzene with hydroquinone, catechol ,

trans,trans -muconic

acid

secondary metabolites

and

1,2,4-trihydroxybenzene

as

significant

(Snyder et al, 1981; Gad-El-Karim et al., 1985b).

The semiquinone radicals and/or p-benzoquinone derived from hydroquinone
and/ or catechol are generally considered to be the toxic

metabolites

(Tunek et al., 1980). Recently, it has been shown that trans,transmucondialdehyde, an open-ring product of catechol, is a possible toxic
reactive intermediate (Witz et al.,

1985;

Latriano et al.,

1986).

Ethanol potentiates benzene toxicity in vivo by accelerating the
hydroxylation of benzene

and

the

conversion of phenol

into

toxic

metabolites, thus, increasing benzene hematotoxicity (Nakajima et al.,
1985).

The major sites of benzene met abo 1 ism are 1 i ver and bone

marrow.

Benzene is converted by the 1 iver to (a) metabol ite(s) whi ch

travel(s) to the bone marrow and exert s its toxic effects.
Metabolism of Benzene in Liver
In the 1 i ver ,

the major s ite of benzene met abo 1ism, benzene is

converted via a cytochrome P-450-mediated pathway (Gonasun et al ., 1973)
to benzene oxide .

The majority of benzene oxide formed spontaneously

rearranges to yield phenol (Tunek et al., 1978), with a small portion of
the oxide undergoing hydrolysis (catalyzed by epoxide hydrolase)
benzene-1,2-trans-dihydrodiol.

The dihydrodiol can be further converted

to catecho 1 by cytoso 1 i c dehydrogenase (Jeri na et a1 . , 196B) .
believed to be the major metabolic pathway from
(Tomaszewski et al., 1975) .

to

This is

benzene to catechol

Phenol can be further hydroxylated by the

cytochrome P-450-dependent monoxygenase system to hydroquinone and
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catechol, the former being the major product

(Tunek et al.,

1980 ;

Sawahata and Neal, 1983) . Different isozymes of cytochrome P- 450 may be
involved in the formations of hydroqui none and catechol ( Sawahata and
Neal , 1983) .
Metabolism of Benzene in Bone Marrow
The bone marrow is the target organ of benzene.
concentration of cytochrome

P-450 measured

in

However, since the

bone marrow

is

low

compared with that measured in liver or lung (Andrews et al., 1979;
Sawahata et al., 1985), it possesses a limited capacity to metabolize
benzene (Andrews et al.,

1977 ; 1979; Rickert et al .,

1979) .

This

suggests that the metabolism of benzene by bone marrow cannot account
for the concentration of metabolites reported in this ti ss ue in vivo .
Andrews et al . ( 1979) also found the metabolism of benzene by bone
marrow microsomes required NADPH and was inhibited by carbon monoxide .
Phenol, hydroquinone, and catechol are more toxic to bone marrow
cultures than benzene .

After benzene exposure, phenol concentrations

within the bone marrow rise and decrease relatively quickly, whereas
hydroquinone and catechol concentrations, although moderately low
initially, rise with time and persist in relatively high concentrations
(Rickert et al ., 1979; Greenlee et al ., 1981a,b).

The retention of

phenol, hydroquinone and catechol in bone marrow could result from the
formation of these compounds in the liver and their subsequent uptake by
bone marrow cells.

The importance of hepatic metabolism of benzene in

production of benzene metabolites found in the bone marrow is supported
by the experiments performed by Sammett et al . (1979).

They found that

partial hepatectomy resulted not only in a reduction in amounts of
benzene metabolites excreted in urine,

but also

in a decrease in
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concentrations of benzene metabolites detected in bone marrow.
Microsomal Metabolism Q_f Benzene
Benzene induces the enzymes required for its metaboli sm.

Benzene

is converted to phenol by rat liver microsome (Gilmour et al . , 1986;
Sawahata and Neal, 1983). Small amounts of hydroquinone and catechol are
produced from both benzene and phenol in a reaction mediated by
cytochrome P-450 and stimulated by benzene pretreatment.

Two di sti net

forms of mixed-function oxidase activity in rat liver micro somes appear
to metabolize benzene (Post and Snyder , 1983) .
i ncreases enzyme activity without affecting
content

Benzene pretreatment

total

cytochrome

P-450

(Post and Snyder , 1983 ; Pathiratne et al . , 1986a) .

The

addition of methyl group s to the aromatic ring influences the inductive
pattern of benzene hydroxylase (Pathiratine et al . , 1986b). Gilmour et
al. (1986) also found that metabolism of benzene and phenol was
competitively inhibited by toluene , and benzene and phenol re ciprocally
i nhibited the metaboli sm of each other .

The rate of convers ion of

phenol to hydroquinone by mouse liver microsomes is signifi cantly higher
than the rate of metabolism of benzene (Lunte and Kissinger , 1983) .
The mechanism of the microsomal
oxidation of benzene has been studied with

cytochrome P- 450-dependent
rabbit liver microsomes and

reconstituted membrane vesicles containing cytochrome

P-450 LM2 by

Johansson and lnge lman-Sunberg ( 1983) , who concluded that the reaction
is media ted by free hydroxyl radi ca 1s generated from hydrogen peroxide
and superoxide anion in a modified Haber -Weiss reaction .

However, the

hydroxyl radicals do not contribute significantly to the metabolism of
benzene to phenol when the concentration of benzene is close to the Km
value for P-450 LM2.

At a benzene concentration below the Km values,
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the

free

radical-mediated

pathway of

phenol

formation

increasingly predominant {Gorsky and Coon, 1985).

becomes

Involvement of free

radicals in benzene metabolism is also suggested by Khan et al. {1984)
and Latriano et al. {1985).

The microsomal cytochrome P-450 conversion

of benzene to phenol via an arene oxide intermediate is demonstrably
followed by an NIH shift {Hinson et al., 1984; 1985).
{1985)

Hinson et al.

studied the role of the NIH shift in the formation of phenol

from the deuterated benzene derivative, 1,3,5-[ 2H3 ] benzene, and found
the expected products, 2, 3, 5- [2H 3 ] phenol and 2, 4- [2Hz] phenol, which
indicated that the shift had occurred.
Peroxidase-Dependent Metabolism
of Benzene Metabolites
The isolation of phenol, hydroquinone, and catechol in the bone
marrow following benzene exposure suggests the

possibility that the

critical metabolic events may involve an interaction of these phenolic
compounds during localized metabolism within the bone marrow
et al.,

1985 ; Eastmond et al.,

relatively

low

{Sawahata

1987b). Since bone marrow contains

concentrations

of

cytochrome

P- 450-dependent-

monooxygenases, the metabolism of hydroxylated benzene metabolites, i.e.
phenol, hydroquinone and catechol, in bone marrow by enzyme systems
other than the cytochrome P-450-mediated system has been reported.

Bone

marrow contains appreciable levels of myeloperoxidase for which phenol
is a known substrate and hydroquinone and catechol are probable
substrates {Eastmond et al., 1986) .

Myeloperoxidases are capable of

converting phenol to reactive protein-binding species {Eastmond et al .,
1986; 1987a,b) .

A secondary peroxidase-dependent metabolism of phenol,

hydroquinone, and catechol may be occurring within the bone marrow . This

19
mechanism may be respon sible for benzene - induced myelotoxi city .

It ha s

been suggested that phenol metabolized to hydroquinone and catechol , and
hydroquinone

oxidized

to

p-benzoquinone

is

mediated

by

the

myeloperoxidase -dependent pathway (Pellack -Walker et al . , 1985) .
Covalent Binding of Reactive
Benzene Metabolites
Several studies have indicated that benzene and certain benzene
met abo 1i tes are converted in nuc 1ei and mitochondria to bi o1ogi ca lly
reactive intermediates that covalently bind to macromolecule s and cause
DNA damage in the form of strand breaks and covalently bound adducts in
liver and bone barrow in vivo or in vitro (Lutz and Schlatter, 1977 ;
Irons et al.,

1980 ; Gill and Ahmed, 1981 ; Rushmore et al.,

1984;

Artellinoi et al., 1985; Kalf et al., 1985 ; Wallin et al. , 1985 ; Snyder
et al . , 1987) .

The level of DNA binding is highest in bone marrow .

Either benzene-induced aplastic anemia or leukemia might be related to
an interact i on of the bi o1ogi ca lly reactive intermediate s derived from
benzene with nuclei acids.

It has been shown that covalent binding wa s

greatly enhanced by H2o2 and horseradi sh peroxida se or myelopero xida se,
and prevented by ascorbate (Smart and Zannoni , 1984; 1985) . Peroxida se
appears to be res pons i b1e for the oxidation of pheno 1, as ascorbate
blocks the oxidation of phenol, and H2o2 is required for the activation
of phenol to covalently binding species. The myelotoxicity of benzene
may result from the high ratio of peroxidase activity to quinone
reductases, the enzymes which reduce quinone to hydroquinone or catechol
via a two-electron transfer,
Zannoni , 1984) .

activity in bone marrow

(Smart and

Lack of benzene toxicity in the liver , as compared to

the bone marrow, may thus result from the high quinone reductase
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(Wermuth et a l. , 1986) .

activity in the liver

DNA synthe sis i s

inhibited in mouse lymphoma cells after exposure to the be nzen e
metabolites, bd not to benzene (Pellack-Walker et al., 1985; Pellack Walker and Blumer, 1986). Benzoquinone is the most potent inhibitor,
followed

by hydroquinone ,

1,2,4-benzenetriol,

catechol,

and

phenol .

These findings suggest that inhibition of DNA synthesis correlate s with
the ease of oxidation to reactive metabol i te(s}.
DNA or RNA in vitro by benzene metabolites

Decreased synthe s i s of

is also observed in rat

liver and rabbit bone marrow mitochondria (Schwartz et al., 1985; Kalf
et al . , 1982},

mouse lymphocytes

and macrophages (Po st et al ., 1985;

1986}, and rabbit bone marrow nuclei (Po st et al. , 1984) .
marrow mitoplasts,

Rat bone

prepared by stripping the outer membrane of

mitochondria to avoid microsomal contamination , in vitro incubated with
benzene metabolites

show

concentration-dependent

inhibition

of

mitochondrial RNA synthesi s (Kalf et al. , 1985).
HEMATOTOXICITY AND BENZENE
Benzene - Induced Hematotoxicity
Benzene is a proven hematoxi n and is well
greatest toxicity on hematopoietic cells

known to exert its

both in the peripheral blood

and in the hematopoietic organs (Fishbein, 1984; Bolcsak and Nerland,
1983).

Repeated benzene exposure in humans and laboratory animals

results in the induction of pancytopenia, a condition characterized by
markedly decreased numbers of ci rcul at i ng erythrocytes , 1eukocytes and
thrombocytes .

The resultant aplastic anemia, i.e., pancytopenia

associated with fatty replacement of functional

bone marrow,

is a

potentially fatal disorder which in its severe form has greater than a
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fifty percent mortality rate (Green et al., 198la,b; U.S . Environmental
Protection Agency, 1980a; Brief et al., 1980).

In certain individuals,

continued exposure to berzene leads to both pancytopenia and bone marrow
hyperplasia, a condition that may indicate a preleukemic state
et al., 1977) .

(Snyder

It was suggested that chronic benzene poisoning is most

easily detected by using erythrocyte reduction

and

increased mean

corpuscular volumes (MCV) but other hematologic parameters increase the
diagnostic accuracy

(Haley, 1977). In mice Baarson et al.

reported that low-level

(1984)

repeated exposure to benzene (10 ppm) via

inhalation could markedly depress the number of erythrocytes.
A number of observations have demonstrated that lymphocytes are
particularly sensitive to benzene toxicity in animals
Rozen and Snyder, 1985 ;
Snyder et al.,

(Aoyama, 1986;

Dempster et al . , 1984; Baarson et al., 1984;

1982; Green et al.,

1981a),

or in humans who are

inadvertently exposed to this chemical in the workplace (Moszczynsky and
Lisiewicz, 1984;
inhalation showed
lymphocytes

Brief et al ., 1980).

Mice exposed to benzene via

significant depressions in the numbers of

a-

(s-IgM+ cells) in blood, bone marrow and spleen, and in the

numbers of T-lymphocytes (Thy1,2+ cells) in blood, thymus and spleen
(Aoyama , 1986; Rozen and Snyder, 1985). In addition, benzene has been
shown to increase the permeability of lymphocyte lysosomal membranes and
to release lysosomal enzyme into the cytoplasm, resulting in decrease of
lymphocytes (Moszczynski and Lisiewicz, 1984).
The mechanism for benzene-induced hematopoietoxic effects has been
studied for many years. Studies have shown that oxidative benzene
metabolites, rather than benzene itself, are required to mediate these
hematopoietic effects of benzene (Sawahata et al ., 1985; Irons, 1985;
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Bolcsak and Nerland,

1983; Snyder et al.,

1981c; Greenlee et al.,

1981 a, b). The increases in 1eukocyte a1ka 1 i ne phosphatase activity were
reported both in humans

occupation~lly

exposed to benzene (Moszczynski,

1980; Yin et al., 1982) and in experimental animals
Yin et al ., 1982).

(Li et al., 1986;

The validity of the increase in activity of alkaline

phosphatase in leukocytes as an early
leukopenia has been

demonstrated (Li

indicator of benzene-induced
et al.,

1986). Hematopoietic

toxicity of benzene would arise from the toxic damage to one or more of
the components of the hematopoietic system: stem cells, trans it ce 11 s
(progenitor cells in various degrees of differentiation), and the bone
marrow stromal microenvironment (Kalf et al., 1987).
Effect of Benzene on Stem Cell
Several studies have shown that benzene causes reductions in the
numbers of pluripotent stem cells (CFU-S) in mice following

exposure to

benzene (Uyeki et al., 1977; Green et al., 1981b; Snyder et al . , 198lb;
Tunek et al., 1981; 1982) , whereas other workers have reported no change
(Frash et al., 1976).

This discrepancy has been explained, in part, by

a toxic effect of benzene on the transit cells, which signals stem-cell
proliferation and different iation, and thus depletes the stem-cell pool
(Snyder et al ., 1977;

Gill et al., 1980; Cronkite et al., 1982) .

Effect of Benzene on Progenitor Cell
Benzene affects committed progenitor cells by a decrease in the
numbers of differentiating erythroid and myeloid progenitors i n benzeneexposed rats, without an effect on the number of progenitor cells or
mature cells in the bone marrow

(Irons et al. , 1979) .

Studies on the

effects of benzene on the kinetics of 59 Fe uptake into maturing mouse
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erythrocytes indicated that the pronormoblast was the progenitor most
sensitive to benzene, whereas stem cells and nondi vi ding ret i cu l ocytes
were not affected (Lee et al., 1974).

The

m~tabolites

phenol, catechol,

and hydroquinone have also been reported to reduce 59Fe incorporation
into developing erythrocytes . The erythropoietic toxicity of benzene and
phenol is completely alleviated by the mixed-function oxidase inhibitor,
but not of hydroquinone or catechol

(Bolcsak

and Nerland,

1983).

Trans,trans-mucondialdehyde, a six-carbon alpha, beta-diene aldehyde and
an open-ring metabolite of benzene, is a potent bone marrow toxin in CDI mice in a manner similar to benzene (Witz et al., 1985; Latriano et
al., 1986).

Other studies have shown that the number of erythroid (CFU-

E) and granulocyte/macrophage (CFU-GM) progenitor cells was depressed in
benzene-exposed mice (Tunek et al., 1981;
and

Snyder, 1986).

Baarson et al., 1984; Keller

A reduction of lymphocyte progenitor cells was also

observed in the spleen and bone marrow of hydroquinone or catecholtreated animals (Wierda and Irons, 1982; King et al . , 1986) .
Effect of Benzene on Marrow Stromal Cells
Bone marrow stromal

cells

act

as

an

essential

component

for

hemopoiesis by forming a supporting matrix for developing precursor
cells and releasing soluble factors

involved

in the regulation of

hemopoiesis (Lichtman, 1981; Tavassoli and Friedenstein, 1983; Allen and
Dexter, 1984).

Stromal cells produce colony-stimulating factors (CSF),

growth factors, which induce myelopoietic cell proliferation, and
maturation.

Ext race ll ul ar matrix components produced by bone marrow

stromal cells may also regulate myelopoiesis.
indicated that administration of benzene, phenol,

Several studies have
or hydroquinone to

animals altered cellular characteristics of the bone marrow stromal
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cells and inhibited the ab ility of stromal cells to support hemopoiesis
in culture (Harigaya et al., 1981;
Wierda ,

1985;

1987).

Garnett et al. , 1983; Gaido and

Gaido and Wierda (1984)

showed that phenol,

hydroquinone, and p-benzoquinone were most effective in decreasing the
ability

of

stromal

cells

to

s upport

the

colony

formation

granulocyte/ macrophage progenitor cells (CFU -GM) in a coculture sys tem ,
whereas catechol only inhibited stromal cells at high concentrations .
Benzene administration in vivo induced elevated prostaglandin E2
(PGE 2 ) in bone marrow samples (Gaido and Wierda, 1987).

These authors

suggested that increases in PGE 2 may be involved in myelosuppression by
benzene.

Prostaglandin E2 can act as a negative regulator of

hemopoiesis. In vivo

administration of PGE 2 can block the ability of

myelopoietic cells to respond to colony-stimulating factor (CSF)
(Gentile and Pel us, 1987; Tavassol i and Friedenstein, 1983) and can
inhibit CSF production by peritoneal macrophages and bone marrow stromal
cells (Kriegler et al., 1984).

Thus, bone marrow stromal cells, by

producing both an inducer, CSF, and an inhibit or, PGE 2 , can act to
regulate myelopoiesis via a feedback control system (Kurland and Moore,
1977; Oayer et al ., 1985).
Phenol and hydroquinone also alter prostaglandin production
(Pol sky-Cynkin et al., 1976;

Hemler and Lands, 1980;

1984; Gaido and Wierda , 1987) .

Gollmer et al.,

One possible mechanism may be via

cooxidation with prostaglandin synthetase (Hirafuji and Ogura, 1985).
Through cooxidation, phenol and hydroquinone can be activated to more
reactive

intermediates,

such

as

semiquinone,

which

bind

macromolecules and inhibit cellular enzymes (Tunek et al ., 1982).

to
The

tendency of thes e agents to cooxidize with prostaglandin synthetase and

25

alter PGE 2 synthesis may contribute to benzene hematoxicity (Gollmer et
al., 1984) . However, benzene toxicity to stromal cells is not due
solely to increased prostaglandin synthetase activity (Gaido anc Wierda,
1987).
Benzene and Leukemia
There is no longer any real doubt that benzene is considered to be
a leukemogenic agent in man (Aksoy, 1985) . The evidence is derived from
a number of different approaches including different

types of

epidemiological studies and a series of case reports beginning more than
50 years ago (Aksoy, 1985; Infante and White, 1985; Rinsky et al . ,
1987) .

These observations were corroborated recently by carcinogenesis

bioassays in mice and rats (Snyder et al., 1980; Maltoni et al., 1983;
1985; Cronkite et al., 1984; 1985) .
The type of leukemia most commonly associated with chronic benzene
exposure is acute myelogenous leukemia and its variants, including acute
myelomonocytic leukemia,

acute erythroleukemia and acute myelocytic

leukemia (Goldstein, 1983; Aksoy, 1985) .

Acute myelogenous leukemia is

the adult form of acute leukemia, and is a rapidly fatal disease . The
other major acute form of leukemia, acute lymphocytic leukemia, has been
reported to be associated with benzene exposure. There are several
reports (Goldstein, 1983) describing the frequency of occurrence of
chronic myelogenous leukemia or even chronic lymphoid leukemia following
benzene exposure. Other hematological disorders possibly associated with
benzene exposure include Hodgkin's disease, lymphoma, myeloid metaplasia
or myeloma.

leukemia associated with benzene exposure frequently

develops following a peri od of bone marrow depression, i . e., benzeneinduced pancytopenia has been followed through a preleukemic phase into
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the development of acute myelogenous leukemia

{Vigliani, 1976) .

IMMUNOTOXICITY OF BENZENE AND ITS METABOLITES
Immunotoxicity of Benzene
The sensitivity of lymphocytes to benzene indicates an immunotoxic
potential for this compound since lymphocytes play a principal role in
alterations of the immune function.

Evidence has been presented in

several reports that the short-term administration of benzene by
inhalation or intraperitoneal injection to experimental animals results
in abnormalities
suppression

in

of

immune-associated

parameters

including a

mitogenic response of B-and T-lymphocyte proliferations

{Rozen and Snyder, 1985;

Rozen et a l. , 1984;

Wi erda et a1 . , 1981),

an

impairment in humor a1 anti body response as measured by p1aque- fermi ng
cells to sheep erythrocytes {Aoyama, 1986; Wierda et al., 1981), and an
increased susceptibility to pathogenic microorganisms, such as Listeria

monocytogenes {Rosenthal and Snyder, 1985) and Klebsie11a pneumoniae
{Aranyi et al., 1986).

Pandya et al. {1986) also showed that serum

hemaglutinating SRBC antibody titers and interferon levels were reduced
in rats exposed to benzene via
Recently, it has been

intraperitoneal administration .
demonstrated that exposure to

100 ppm

benzene {5 days/week x 4 weeks) via inhalation in mice depressed the
mixed lymphocyte culture {MLC) responses and also reduced the cytolytic
abilities of cytotoxic T lymphocytes, and ruled out the possibilities
that depressions in immune function are due to an induction of
suppressor cell activity {Rosenthal and Snyder, 1987).

As MLC

responsiveness is generally thought to represent the in it i a1 phases in
the induction of cytotoxic T ce 11 s {CTL), the

benzene-induced 1oss of
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CTL lytic ability to tumor cells might be explained by an impaired
ability of T cells to recognize foreign tissue or tumor-associated
antigens during T-helper-cell -mediated induction of CTL cells.

More

importantly, short-term exposure of mice to benzene concentrations at
the industrial standard -exposure level (10 ppm) significantly depresses
mitogen - induced lymphoproliferation of

both B- and T-lymphocytes (Rozen

et al., 19B4).
Immunotoxicity of Benzene Metabolites

In vitro.

Benzene metabolites have been shown to produce a variety

of alterations in immune function in vitro.

The ability of phenol,

hydroquinone, and catechol to suppress lymphocyte growth and function in

vitro

correlates with their capacity to undergo oxidation and with

their concentration in the bone marrow or lymphoid organs (Irons et al.,
19B1; Pfeifer and Irons,
oxidation

product,

differentiation

1981; 1982; 1983).

p -benzo quinone ,

inhibit

Hydroquinone and

its

proliferation

and

in lectin -st imulated lymphocytes

in

culture at

concentrations that are not cytotoxic, while phenol or catechol suppress
lymphocyte growth or function only at concentrations that result in cell
death.

Suppression of lymphocyte bla stogenesis by hydroquinone is

postulated to be mediated by the interaction of p-benzoquinone with
sulfhydryl ( SH) groups on tubuli n (Irons et al . , 1981; 1984 ; Pfeifer and
Irons, 1983).

Tubulin has previously been shown to possess highly

nucleophilic SH groups that are required for guanosine triphosphate
(GTP)
1974).

binding during the process of microtubule assembly (Mann et al .,
This binding interferes with microtubular integrity, which is

required not only for cell division via spindle formation but also for
regulation of surface receptor movement and normal signal transduction
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at the cell membrane.
Benzene metabolites are also immunotoxic i n vivo .

In vivo.

et al.

Post

(1985) demonstrated that exposure to p-benzoquinone in mice

completely inhibits the proliferation and production of the T-cell
lymphokine,

interleukin-2, by concanavalin A (Con A) - stimulated T-

lymphocytes.

Proliferation and maturation of lymphocyte cells are

regulated by this polypeptide lymphokine (Dinarello and Mier, 1986) .
Hydroquinone and catechol have been shown to reduce the frequency of
spleen and bone marrow progenitor B-lymphocyte and inhibit polyclonal
plaque-forming cells (Wierda and Irons, 1982) .
NEUROTOXICITY OF BENZENE
Effect of Benzene on Neurobehavior
Organic solvents have long been associated with neurophysiological
and psycho 1og i ca 1 disorders (Grasso et a1 . , 1984; Savo 1a i nen, 1977) .
The critical

acute effects associated with inhalation of high

concentrations of benzene, namely, depression of central nervous system
function and narcosis, most likely ensues directly from benzene itself
rather than from its metabolites (Dempster et al., 1984; Brief et al. ,
1980; Haley, 1977). Exposure of human beings to lower concentrations
(250-500 ppm) of benzene has been reported to cause the following
clinical symptoms: vertigo,
and nausea

drowsiness, giddiness, euphoria, headache,

(Brief et al., 1980; Haley, 1977). Chronic industrial

exposure to benzene also cause neurological abnormalities (Baslo and
Aksoy, 1982) .

The behavioral endpoints including locomotor activity,

appetitive indices and hind-limb grip strength were also demonstrated to
be altered by benzene in experimental animals (Dempster et al., 1984).
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In another study,

i nha 1at ion of 300 or 900 ppm benzene in creased t he

occurrence of eating and grooming, and reduced the number of mi ce that
were sleeping or resting (Evans et al. , 1981) .
Effect of Benzene on Neurochemicals
Despite numerous positive investigations on neurobehavior effects,
few published data are available on the neurochemical
benzene .

Recently,

effects of

Paradowsk i et al . (1985) showed that a four week

prolonged subcutaneous administration of benzene to rats increases the
contents of norepinephrine (NE) and dopamine (DA) in brain or other
i nterna 1 organs
condition s,

such as sp 1een , 1i ver and kidney .

increases of the indoleamine serotonin

metabolite, 5- hydroxyindole acetic acid (5 -HIAA) were

Under the same
(5-HT)

and

its

also observed in

brain tissues, particularly in the striatum (Paradowski et al . , 1984).
The mechani sm for the benzene - induced changes in levels of monoamines
and their metabolites is not yet known .

It appears that the effects of

benzene on the major enzyme systems in the monoaminergi c biosynthetic
pathway have never been clearly shown.

Intraperitoneal admini stration

of benzene to mice increased striatal levels of tryptamine, 5-HT, and 5HIAA , and produced an induction aromatic-L-amina acid decarboxylas e
(AADC) but ruled out the possibility of inhibition of monoamine oxidase
(MAO) (Juorio and Yu, 1985a) . Benzene also produced marked increases in
mouse and rat striatal

concentrations of beta-phenylethylamine, p-

tyramine and, to a lesser extent , m-tyramine (Juorio and Yu , 1985b).
ENVIRONMENTAL AND TOXICOLOGICAL ASPECTS OF TOLUENE
Chemica 1 and Phys i ca 1 Properties
Toluene (C 6HsCH 3), also referred to as toluol, methyl benzene, and
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phenylmethane, is a colorless liquid with both volatile and flammable
properties. It has a molecular weight of 92 . 13,

boiling point of

110.63°C , freezing point of 94 .9°C, specific gravity of 0.867 at 20°C,
and a vapor pressure of 30 mm Hg at 26°C. This chemical is only slightly
so 1ubl e in water, 535 mg/L in fresh water and 379 mg/L in sea water
(U.S. Environmental

Protection Agency,

1980b).

It is miscible with

alcohol, chloroform, ether, acetone, glacial acetic acid, carbon
disulfide, and other organic solvents . Toluene is soluble in natural
fats and fat-soluble substances, and accumulates readily in animal
tissues that exhibit a high lipid content or represent major metabolic
sites such as liver and brain . The nucleus of toluene, like that of
benzene, undergoes substitution reactions. Substitution occurs a1most
exc 1us i ve 1y in the orthro and para pas it ions and occurs faster with
toluene than benzene. The presence of a methyl group offers additional
possibilities for reaction;

the most important

is dealkylation to

benzene (U.S. National Academy of Sciences, 1982).
Occurrence and Usage
Toluene is produced primarily from catalytic reformating processes
in refineries and from petroleum-derived pyrolysis gasoline as a byproduct of olefin manufacture during the cracking of hydrocarbons (96%).
Small amounts (4%) of toluene are also produced in coal-derived coke
oven light oil and as a by-product in the manufacture of styrene (Merian
and Zander, 1g82). Toluene is extensively employed in a wide spectrum of
applications. Approximately 70% of toluene is converted to benzene,
another 15% is used as a starting agent for other chemica 1s (e .g. ,
benzoic acid, nitrotoluene, toluene dii socyanates, as well
pharmaceuticals, food additives, plastics, etc.),

as dyes ,

and the remainder
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(15%) is used as a solvent (which

is increasingly being used as a

"safe" replacement for benzene) for consumer products and as an
esse~tial

abused by

gasoline component . Additionally,
"glue sniffers".

Hence,

toluene has been widely

there is a broad potential

for

exposure both for industrial workers and the general public ( Fishbein,
1985). It has been detected at various concentrations in the atmosphere
and ambient water . There is a paucity of data ava i 1ab 1e on 1eve 1s of
toluene in food (Fishbein, 1985).
Population at Risk and Allowed Levels
It is known that workers and segments of the general public are
exposed to to 1uene from chemica 1 manufacturing processes, coke ovens,
petroleum refineries, solvent operations , the storage and distribution
of gasoline , urban automobile emission, urban gasoline service stations,
the use of se lf -service gasoline, and from consumer product s containing
toluene as well as from drinking water contaminated with this compound
(Fishbein, 1985) .
The occupational exposure limits for toluene vary from country to
country. In the United States, the National Institute for Occupational
Safety and Health ( 1973) has recommended a workplace 1 imit of 100 ppm
(8 - hr TWA) with a ceiling of 200 ppm (750 mg/m 3 ) for a 10 -minute
sampling period. Occupational exposure levels are generally lower than
this standard, although short exposures to higher vapor concentrations
occur (Fishbein, 1g85).
Toluene is also a major organic chemical contaminant in drinking
water . For the protection of human health from the toxic propert ies of
toluene following ingestion of contaminated water and aquatic organisms,
the ambient water criterion is set at 14.3 mg/L (U.S. Environmental
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Protection Agency, 1986a). This permissible concentration is basically
extrapolated from a general toxicity evaluation of an oral do se study in
rats (Wolf et al . , 1956), which at the time was thought to be well below
any toxicity -based criterion. A level up to 6.4 mg/ L has been detected
in drinking water {Tardiff and Youngren , 1986) .
Routes of Exposure
Toluene may enter the human body by inhalation of vapor ,
percutaneous absorption of liquid, ingestion, and eye contact . Most
actua 1 exposures have occurred in re 1at ion to its use as a so1vent ,
vapor inhalation being the mode of entry of major concern. Skin contact
with toluene is of far less significance (U . S. National Academy of
Sciences, 1982). Exposure to toluene through oral
considered

to

be a problem for

the general

ingestion is

population

(U.S .

Environmental Protection Agency, 1980b). After toluene is absorbed , it
i s rapidly di stributed to the higher vascular tissues includ i ng the
brain and eventually accumulates in adipose tissue (Savolainen , 1978).
Metabolism of Toluene
In vivo studies have shown that toluene exposure is as sociated with

the induction of microsomal cytochrome P-450 dependent enzymes and
conjugation enzymes (Pyykko, 1980; Toftgard et al., 1982; Pathiratne et
al., 1986b). The time-course of effects of toluene on several microsomal
monooxygenases in the liver or some non-hepatic tissues of rat s exposed
to toluene have been reported (Pyykko, 1983).
An important pathway of toluene metabolism proceeds

initially

through the oxidation of its methyl group by microsomal monooxygenase to
benzyl a1coho 1 in the endop 1asmi c ret i cul urn of the 1i ver. In turn, the
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benzyl alcohol is oxidized to benzaldehyde and, subsequently, to benzoic
acid by alcohol dehydrogenase . The benzoic acid is then conjugated with
glycine to form so-called hippuric acid which is excreted via urine in
man and animals, (Ikeda et al., 1972; U.S. National Academy of Science s,
1982; Toftgard et al ., 1982). Conjugation of benzoic acid with
glucuronic acid to produce benzoyl glucuronide apparently occurs when
the glycine conj ugation reaction

is saturated after heavy toluene

absorption (Fishbein, 1985).
Toluene

is

also

metabolized

via

(a)

chemically

reactive

intermediate(s) . The formation of o-cresol and p-cresol from aromatic
oxidation of the absorbed toluene is mediated by cytochrome P-450
enzymes in the liver. These metabolites are synthesized through an arene
oxide intermediate which is a reactive metabolite and is responsible for
the binding of toluene to biomacromolecules (Bakke and Scheline, 1970;
Pathiratne et al., 1986b). In the formation of p-cresol , a part of the
hydrogen in the para position migrates to the meta

position . Superoxide

anions are a1so formed during the formation of secondary met abo 1ites,
such as semiquinones and quinones, from the oxidation of cresol
(Pathiratne et al . , 1986b) ; covalent binding of toluene to biological
macromolecules involves more than one reactive metabolite.
Toxicity of Toluene
Exposure to toluene is reported to produce a variety of pathologic
states

in

humans

or

experimental

animals,

including

cardiac

sensitization, kidney and liver damage, and various neurological
disorders

(Benignus, 1981a,b; Hayden et al . , 1977).

The neurotoxic

properties of toluene represent the main health hazards

(Fishbein,

1985). Although there is general agreement that toluene does not have
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the hematotoxic properties of benzene, alterations of lymphocyt e
f unctions ,

host

resistance

to

infectious microorganism s,

and

clastogenic activity by toluene were reported (Mohtashamipur et al .,
1985; 1987 ; Suleiman, 1987; Schmid et al ., 1985 ; Dean, 1985 ; Aranyi et
al ., 1985; Fishbein, 1985). Toluene was also found to be embryotoxic in
rats, mice, and rabbits (Courtney et al., 1986; Ungvary and Tatrai,
1985; Nawrot and Stap 1es, 1979) .
Toluene appears to have a pronounced effect on behavior; schedule controlled behaviors have been reported to produce inverted U- shaped
concentration effect curves on response rates , i.e . initially i ncreasing
r ate s and at higher levels decreasing rates of response (Dyer et al.,
1984;

Benignus,

1981b) .

Several

studies

have

indicated

that

concentrations of various brain biogenic monoamines are affected by
acute or subchroni c administration injection to rats .

Increa ses

in

steady -s tate levels of NE , DA, and 5-HT have been reported in whole brain homogenates or discrete brain areas of rats who continuously
inhaled 100 , 300 , or 1,000 ppm toluene for 8 hr (Rea et al ., 1984).
Subchronic repeated expo sure of rats to toluene vapor al so increased
concentrations

of catecholamines

and

their

turnover

rates

in

hypothalamus or median eminence (Anders son et al . , 1980 ; 1983) . After a
single ip administration of 200 mg toluene/kg body weight to rats, Arito
et al . (1984) reported an increase in the regional concentrations of NE,
5-HT and their respective metabolites, 3- methoxy-4-hydro xyphenyl
ethyleneglycol (MHPG) and 5-HIAA; alterations in DA and its metabolites
3-4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were
not detected . In their follow up study, however, 14 consecutive days of
i p injection of to 1uene in rats increased NE and MHPG on 1y

(Ari to et
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al ., 1985). Pronounced increases in the concentrations of serum
corticosterone, growth hormone , follicle stimulating hormone , and
prolactin were increased in rats under the

~nfluence

of toluene exposure

via inhalation (Andersson et al., 1980; 1983) .
Evaluations of the myelotoxicity of toluene in laboratory animal s
have generally indicated that the chemical is nontoxic. Wolf e t al.
(1956) conducted a long-term toxicity study in which toluene was given
orally to rats and indicated there we re no adverse effects on the cell
counts of circulating blood and bone marrow. Andrews et al. (1977) noted
that benzene inhibited the incorporation of 59 Fe into erythrocytes of
mice but that toluene did not. A marked decrease in leukocyte counts
were reported in dogs exposed to 200 - 700 ppm toluene, but these changes
were found to be temporary (Hobara et al ., 1984). After exposure to
toluene vapor at concentrations ranging from 2.5 to 500 ppm, mice
exhibited increased susceptibility to respiratory infection with
Streptococcus zooepidemicus and decreased pulmonary

bactericidal

activity to K1ebise71a pneumoniae (Aranyi et al., 1985). Several reports
have appeared in the literature which link exposure of toluene to
altered immunocompetence in animals and humans (U.S. National Toxicology
Program, 1987; U.S. Environmental Protection Agency, 1980b).
BENZENE -TOLUENE INTERACTION
One possible mode by which xenobiotics modify the toxicity of their
own and also that of other compounds is alteration of their metabolism
by induction of drug-metabolizing enzymes (Sipes and Gandolfi, 1986).
Toluene is frequently employed in industry with other chemicals (U.S .
National Academy of Sciences, 1982) . In sufficient amounts, it is known
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to possess the potential for significantly altering

metabolism and

resulting bioactivity of certain chemical agents (Hayden et al ., 1977 ;
Fishbein, 1985) .

Toluene exposure can stimulate the activity of many

microsomal monoxygenases and increase the concentration of cytochrome P450 (Pyykko , 1980 ;

Toftgard et al., 1982; Pathiratne et al., 1986a),

thereby enhancing metabolism of the second chemical.
exposure to

The time of

to 1uene re 1at i ve to the time of exposure to a second

chemical could be quite important (Sipes and Gandolfi, 1986) . Time course of effects of toluene on several microsomal enzymes in the liver
and some non-hepatic tissues of rats exposed to toluene has been
demonstrated (Pyykko, 1983).

Should concurrent exposure occur, toluene ,

which is readily hydroxyl ated by the microsomal monooxygenease system,
would be expected to inhibit the metabolism of other compounds which are
acted upon by this same enzyme system. This phenomenon would be expected
to result in a prolonged half-life of both toluene and the other
compound.

Inhibition of metabolism of a second compound may be

beneficial or detrimental , depending upon the toxicity of the
compound versus its

metabolite ( s). To 1uene a1so undergoes a1coho 1i c

oxidation and conjugation reactions subsequent
hydroxylation reaction.

parent

to the initial

Therefore, a substantial dose of toluene could

conceivably interfere with the metabolism of compounds that undergo
oxidation and glycine conjugation

(U.S.

National Academy of Sciences,

1982; Ungvary et al., 1983 ; Takahashi et al ., 1987) .
Several in vitro or in vivo

studies

indicate

that toluene is a

competitive inhibitor of the biotransformation of benzene and can
significantly influence the myelotoxic and genotoxic effects of benzene.
The conversion of benzene to phenols in rats, mice or in vitro has been
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reported to be suppressed when benzene was given in combination with
toluene

(Ikeda et al. , 1972; Andrews et al. , 1977; Sato and Nakajima,

1979; Gilmour et al., 1986) .

Andrews

et al .

(1977) coadministered

benzene and toluene to mice or rabbits and observed a marked reduction
in levels of benzene metabolites in bone marrow, coupled with a
compensatory increase in pulmonary excretion of unmetabol ized benzene .
It was also demonstrated using liver microsomes in vitro that toluene is
a competitive inhibitor of benzene metabolism.

When benzene and toluene

were administered in combination to rats intraperitoneally, their
disappearance rates from blood and the rates of uri nary excretion of
their metabolites were delayed compared with those observed when they
were given separately.

Their metabolic interaction was found to be

dose-dependent (Sato and Nakajima, 1979).
Toluene protects against benzene -i nduced depression of red cell
59 Fe uptake in bone marrow of mice (Andrews et al., 1977).

Toluene not

only alleviates the benzene - induced leukopenia but also the benzeneinduced increase in leukocyte alkaline phosphatase activity (Li et al.,
1986) .

Toluene significantly decreases the adverse effects of benzene

on granulopoietic stem cells
cellularity in mice

(CFU per tibia) and on tibial bone marrow

(Tunek et al., 1981; 1982).

When benzene-exposed

mice were simultaneously given an ip injection of toluene, the sister
chromatid exchange ( SCE) incidence was reduced by up to 90% compared
with animals exposed to benzene alone (Ti ce et a l., 1982). Gad -El-Kari m
et al. (1984; 1985a; 1986)

also found that toluene antagonized

benzene's myeloclastogenicity and metabolism when
chemicals were administered orally to CD- 1 mice .

mixtures of both
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CHAPTER III
ALTERATION OF HUMORAL AND CELLULAR IMMUNITY
BY BENZENE IN CD-1 MICE

INTRODUCTION
Concern for the safety of po 11 utants present in ground water i s
attracting attention, since ground water is a major source of dr inking
water supplies . The major concern is the possible subclinical effect s
after long -term exposure. The immune system

is being studied as a

target organ for detecting toxicity since its sensitive parameters are
eas ily evaluated (Bick et al ., 1985 ; Dean et al . , 1982) .

A number of

indu strial and environmental chemicals induce immunosuppression (Faith
et al . , 1980) . Benzene, a ubiquitou s environmental pollulant , exert s it s
greatest toxicity on hematopoietic cells, including erythroid, myeloid
and lymphoid lineages both in the peripheral

blood and in t he

hematopoi etic organs (F i shbe i n, 1984; Bolcsak and Nerland, 1983) .
Repeated benzene exposure in human and

laboratory animals

induces

various forms of cytopenia, aplastic anemia , 1eukaemi a and the
development of chromosomal abnormalities (Dean , 1985; Green et al .,
1981a; U. S. Environmental Protection Agency, 1980a; Brief et al . , 1980).
The mechanism for benzene-induced hematopoietoxic effects has not been
well elucidated , however, most researchers believe oxidative benzene
metabolites, rather than benzene itself , are required to mediate these
hematopoietic effects of benzene (Sawahata et al., 1985; Irons, 1985;
Bolcsak and Nerland , 1983 ; Greenlee et al . , 1981b).
Lymphocytes in animals are sensitive to benzene toxicity (Rozen and
Snyder, 1985; Dempster et al., 1984; Snyder et al . , 1982; Green et al.,
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1981a; Aoyama, 1986), as are those from humans who are inadvertently
exposed to this chemical (Moszczynsky and Lisiewicz, 1984; Brief et al .,
1980) .

Benzene-induced depressions in 1ymphocyte counts may impair

immunocompetence, since lymphocytes play a principal role in immune
function.

The short-term admi ni strati on of benzene by i nha 1at ion or

intraperitoneal
abnormalities of
suppression

injection

to

experimental

immune-associated

animals

parameters,

has

caused

including a

in mitogenic response of B-and T-lymphocyte proliferations

(Rozen and Snyder, 1985; Rozen et al., 1984; Wierda et al., 1981 ; Aoyama
1986), impaired humoral antibody response as measured by plaque-forming
cells to sheep erythrocytes (Wierda et al., 1981; Aoyama , 1986), and an
increased susceptibil ity to pathogenic microorganisms (Rosenthal and
Snyder, 1985; Aoyama, 1986) . Similarly, treatment with benzene
metabolites has also impaired immune responses (Pfeifer and Iron s, 1982;
Wierda and Irons , 1982) .
The inbred C-57BL mice used in

experiments described above may

harbor an endogeneous lymphoma virus (Kaplan , I967) ; activation of this
latent virus after benzene treatment may influence the toxicity of
benzene (Snyder et al., 1980; Longacre et al. , 1981) .
mice were used in this study.

The outbred CD-1

There are relatively few reports on

effects of benzene after oral ingestion.

Because some water supplies

may be contaminated with benzene (U.S. Environmental Protection Agency,
1980a), oral administration was employed via drinking water for a four week period .
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MATERIALS AND METHODS
Animals
Male, adult CD-I mice (Charles River Breeding Laboratory Inc.,
Wilmington, MA) were procured at 5 to 6 weeks of age (approximately

IB

g) and were acclimatized to the AAALAC-accredited animal care facility
for 1 week before use.

Mice were randomly assigned to control and

treatment groups and housed five per group in plastic cages with
hardwood-chip bedding.

They were maintained on 1aboratory rodent chow

and tap water ad libitum. Room conditions were maintained at an ambient
temperature

of 21 ± I°C and a relative humidity of 50 ± 10%.

The

light/dark cycle was maintained at 12 -hr intervals.
Exposure
Analytical reagent grade of benzene (99 . 99% purity, J.T . Baker
chemical Co. Phillipsburg , NJ), was dissolved in normal tap water to
make nominal concentrations of 40 , 200, and 1000 mg/ L.

Benzene has a

sol ubility of 1,7BO mg/L in water at 25°C (U . S. Environmental Protection
Agency, 19BOa).
continuously

The benzene-treated water was

administered to mice

for 2B days via drinking water; the control group received

untreated tap water.

To minimize decomposition and to maintain the

concentration of benzene, drinking water was provided in glass water
bottles, was shaken frequently during treatment and was changed every
three days.

Feed and water consumption

animals were weighed once a week.

was monitored continuously, and

Benzene concentrations in drinking

water were confirmed on different days by a gas chromatography (U .S.
Environmental Protection Agency, 19B6a).
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Gross Observations and Hematology
Twenty -eight days after the exposure to benzene, mice were killed
by decapitation, and gross patho 1ogi ca 1 ex ami nations were performed on
all mice. Major organs, i.e., 1iver, spleen, thymus and kidney were
removed, trimmed and weighed.
siliconized

test

tubes

Blood samples were collected in

coated

with

potassium

ethylene-

diaminetetraacetate . Leukocytes and erythrocytes were counted with an
automated electronic cell counter (Model ZBI, Coulter Electronics, Inc . ,
Hialeah , FL) .

Hematocrits were performed with microhaematocrit

equipment. Differential leukocyte counts were evaluated by Wright ' sGiemsa stained thin smears .
Isolation and Culture of Splenic Lymphocytes
After sacrifice, the spleen was aseptically removed from each
animal, rinsed in ice-cold sterile isotonic saline and single cell
suspen s ions were prepared and cultured according to Sharma and Gehring
(1979) .

Cells were suspended in RPM! 1640 media (Gibco Laboratories ,

Grand Island , NY) supplemented with 5% heat-inactivated fetal calf serum
(Hyclone Sterile Systems, Inc., Logan, UT) and
100

~L

100 units penic i llin and

streptomycin per mL. Cell counts were made by using the Coulter

counter .
Lymphocyte Proliferation to Mitoqens
Splenic lymphocytes were plated in triplicate cultures (5 x 105
cells/culture well) in 96-well flat -bottom microtiter plates (Microtest
II, Falcon Plastics, Oxnard , CA)

to assay their responses to £. coli

lipopolysaccharide (LPS; Sigma Chemical Co., St. Louis, MO), pokeweed
mitogen (PWM; Gibco Laboratories, Grand Island, NJ), Concanavalin A (Con
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A; Sigma Chemical Co . , St.

Louis, MO), or phytohemagglutinin (PHA;

Well come Reagents Ltd., Beckenham, England). Culture media with or
without mitogen was added; total well volum2 was adjusted to 0.15 mL.
The optimized concentrations of mitogens were 20
~g/mL,

and 6.0

~g/mL,

30

~g/mL,

2.5

for LPS, PWM, Con A and PHA, respectively . Cultures

~g/mL

were incubated at 37°C in a humidified atmosphere with 3.5-4%
4B hours and harvested after an additional 6-hr pulse with 0.5

co 2
~Ci

for
of

[methyl-3H]-thymidine (3H -TdR; New England Nuclear, Boston, MA) per
we 11 .

The ce 11 s were co 11 ected on a glass fiber filter using an

automated multiple sample cell harvester (Model M12, Biomedical Research
and Development Laboratory, Rockville , MD) . The amount of radioactivity
(dpm) incorporated was measured with a scintillation counter (Model
2660, Packard Instrument Co., Drowners Grove , IL).
Mixed Lymphocyte Culture iMb£1 Response
The proliferation of splenic lymphocytes (responders) from benzenetreated or control animals in response to challenge with allergenic YAC1 tumor cells (stimulators) was evaluated . The exponential growth phase
YAC-1 murine lymphoma cells (H-2a) of A/ Sn origin previously maintained
in culture medium (> 90% viability by trypan blue exclusion) at a
concentration of 2 x 10 7 cells/mL were treated with 50 ~g/mL mitomycin
C (Sigma) for I hr at 37°C, then washed three times immediately before
putting into culture.
microtiter plates.

Cultures were set up in triplicate in 96-well

Responder cells from the spleen of CO-l mice were

cocultured alone or with stimulator cells at a responder-stimulator
ratio of 2:1. The complete RPM! culture medium was supplemented with
5 x 10- 5 M 2-mercaptoethanol (2-ME) . The proliferative response was
assessed by [methyl- 3H]-thymidine incorporation during the last 24 hr of
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a 3-day culture.

The cultures were harvested and counted as described

for the mitogenesis assays above.
Cell-Mediated

Cytolysis~

Response

Cytotoxic activities of splenic cytotoxic T-lymphocyte {CTL) were
generated in vitro against YAC-1 tumor cells as described by Grabstein
(1980) with modifications.

The splenic lymphocytes (responder cells)

were incubated with mitomycin C-treated YAC-1 cells (stimulator cells)
in RPM! complete medium supplemented with 5 x Io- 5 M 2-ME for 5 days at
37°C in a 3. 5-4% co 2

atmosphere. The exponential growth phase YAC-1

cells were labeled with 0. 25 mCi of sodium chromate-51 (New England
Nuclear) by incubation at 37°C for 1 hr under gentle agitation and then
washed , counted, and resuspended at 2 x 10 5 cells/ml. A constant number
(2 x 104 in 0. 1 ml) of Slcr -labeled YAC-1 cells (target cells) were
added to each well of a plastic -well rnicrotiter plate followed by the
addition of aliquots of the incubated splenic cells (effector cells)
a total volume of 200 .ul.

in

The desired effector-to-target cell ratios

were 50:1 and 25 :1 which gave optimal lysis of target cells. Effector
and target mixtures were spun for 1 min at 1000 g, and then incubated
for another 4 hr at 37°C.

After incubation, cells were pe ll eted by

centrifugation for 10 min at 1000 g, and the supernatants were decanted
and counted in a gamma counter (Model 3320, Packard) The labeled target
cells in the presence of cornpl ete med i urn or 0. 5% steri 1i zed saponin
51 cr released ,
served as the spontaneous Slcr released and total
respectively.

The triplicate mean was used to calculate the percentage

of specific lysis of target cells as described earlier (Grabstein,
1980).
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Plague Forming Assay
Numbers of IgM p1aque - forming cells ( PFC) were determined by the
method of Jerne and Nordin (1963) as modified by Cunningham and Szenberg
(1968) .

Each mouse from control and test groups was

sensitized by ip

injection with 0. 25 mL of a 20% sheep red b1ood cell SRBC suspension 4
days before the end of the benzene exposure.
were prepared

(1

x 107

cells/mL)

Splenic cell suspensions

as described above.

A mixture

containing 45% splenic cells suspension, 45% of a 10% SRBC suspension,
and 10% guinea pig complement (Cappel Laboratories, Cochranville , PA)
was delivered to counting chambers, three replicates per animal.
Cultures were incubated at 37°C for 1 hr and PFC were calculated and
expressed as plaques/ 106

splenic cells or plaques/ total splenic cells .

Enzyme - Linked Immunosorbent Assay .li..U.SAl
Double sandwich enzyme-1 inked immunosorbent assay (ELISA) was used
to analyze

anti -SRBC (0\-SRBC) antibod ies (Voller et al ., 1979) .

Serum

samp 1es were collected from mice uti 1 i zed in the p1aque - formi ng ass ay .
Plates

(Gilford

polystyrene

EIA

cuvettes

Medical

Laboratories, Inc ., Oberlin, OH) were coated with 200

Instrument s
JJL sheep red

blood cell ghosts (prepared as descri bed by Hanahan and Ekholm, 1974)
containing 3.6

)Jg/mL protein

solubilized

sulfate, and kept at 4°C for 24 hr .
aliquots of sera

in

0.1% sodium dodecyl

After several rinses, 200 JJL

(dilution 1:150) were added to the plate wells and

incubated for 2 hr at 37°C,

and rinsed.

Subsequently,

250 ..uL

peroxidase -conjugated goat anti -mouse immunoglobulins (Hyclone Sterile
Systems, Inc., Logan, UT) diluted 1:2000 were pipeted to each well to
determine ~-SRBC antibody levels, and incubated another 3 hr at 37°C.
The enzyme reaction was

performed by

adding

the

phosphate-citrate
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solution containing 0. 4 mg/mL o-phenylenediamine

buffered substrate
(Sigma) and 0.4

JJL/mL H2o2 , prepared immediately before use .

The

results were expressed as change in absorbance (AOO) 15 min after the
addition of substrate solution .
used as a negative control .

Non - sensitized

mice pooled sera were

The optical density was determined by using

an automated spectrophotometer (Gilford, Model EIA 50, Oberlin, OH) ;
readings were made at 490 nm.
Statistical Analysis
The results are expressed as
Statistical significances for

the means ± their

differences between

corresponding normal water control data

were

standard errors.

benzene -exposed and

determined by a one -way

analysis of variance (ANOVA) design followed by multiple comparison
procedures of Fisher's least significant differences (LSD) test (Dowdy
and Wearden, 1983), when F ratios indicated significant difference .

A

level of p<O.OS was considered statistically significant .
RESULTS
The average concentration of benzene

in drinking water as

determined by gas chromatographic analysis on several days is indicated
in Table III-I.

There was a

10% loss of benzene on the first day , an

additional 10% loss per

day followed on the second and third day, when

the water was changed.

Based

on observed average intake of benzene-

treated water, the daily dose of benzene in each animal was estimated to
be 0, 8, 40, and 180 mg/kg, respectively.
Body and Organ Weights
Continuous exposure of adult, CD-1 male mice to various levels of

TABLE III-I
ORGAN AND BODY WEIGHTS OF MICE FOLLOWING 4 WEEKS OF BENZENE EXPOSUREa
Co ncentrat ion
in 1~a t e r, mg/L

Doses
mg/kg/day

Nom i na 1 Observedc

Body Weight (g)b
Day 0

Day 28

Organ weight(g/ 100 body weight)b
Spleen

Liver

Kidney

Thymus

0

0

Control

23 . 20 ± 0. 37 31.22 ± 0.62

0. 33 ± 0. 02

5.57 ± 0. 13

1. 55 ± 0.06

0.16 ± 0.02

40

31

8

22.68 ± 0. 33 29.94 ± 0.98

0.30 ± 0.01

5.46 ± 0.2 9 1.58 ± 0.08

0.12 ± 0. 01

200

166

40

23.74 ± 0.22 32 .98 ± 0.65

0.28 ± 0.01

5.86 ± 0.07

0. 12 ± 0. 01

1000

790

180

23.14 ± 0. 29 32.26 ± 0.86

0.26 ± 0. 01* 5. 98 ± 0.20

1.87 ± o.o5* 0.11 ± 0.01

c The observed overall ranges of benzene concentration were 28 to 36, 147 to 178 , and

734 to 855 mg/ L, in the

1.65 ±0.1 0

a Benzene was administered continuously via dr inki ng water
b Values are given as mean ± SE (n=5)

three treatment groups, respectively
Significan tly (p<0.05) different from control values
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benzene via drinking wate r over a 4-week period did not produce overt
clinical symptoms of toxicity .
water consumption.

Overall , there was no change in food and

No gross lesions were observed on any of the organs

of mice in all treatment groups.

There was no apparent alteration

body weight gain at termination of the study .

in

Although the two groups

receiving higher doses (40 and 180 mg/kg/day) had a slight increase in
growth rate, growth was not significantly different than the control s
(Table II1-l) .

The weights of selected organs are also pre sented in

Table 111-1. Weights of spleen, a secondary lymphatic tis sue , decreased
significantly in animals treated with benzene at the 180 mg/kg/ day do se.
Kidney weights correspondingly increased. Thymu s weight was reduced in
all treated groups but not significantly.
Hematological Parameters
The effects of benzene exposure on erythrocyte counts, hematocrit s,
mean corpu sc ular volume s (MCV) , leukocyte counts, and leukocyt e
differential counts

are pre sented in Table 111-2 . Numbers of

erythrocytes decreased sign i fi cantl y as dose increased.

Hematocri ts

were depressed significantly at the 40 and 180 mg/ kg/ day of benzene .
However, all of the MCV values of treated animals, when calculated from
the hematocrits and erythrocyte counts, exhibited a significant
increase.

There was a significant dose-related reduction in number of

total circulating white cells after oral
Lymphocyte

population

decreased

ingestion of benzene.

significantly

differentials were expressed on an absolute basis .

when

leukocyte

The number of

neutrophils and other differential white blood cells (monocytes,
eosinophils and basophils) were not altered greatly by the benzene
exposure.

TABLE III-2
EFFECTS OF BENZENE EXPOSURE ON SELECTED BLOOD PARAMETERS

Hematocrit

(%)

(fL)

7. 01 ± 0.65d

50.30 ± 0.58

74.01 ± 6. 03

Control
8
40
180

Leukocyte absolute differential s

Mcvb

Do sea
Erytgroc~tes
mg/ kg/ day (10 /mm )

5.96 ± 0.60

4.38 ± 0. 52

1.01 ± 0. 13 0. 45 ± 0. 08

4. 57 ± 0.28t 48.80 ± 0. 46 108 .30 ± 6. 49* 4.23 ± 0.07* 2.99 ± 0.07* 0.85 ± 0. 10 0.38 ± 0. 05
3. 68 ± 0.65 * 46.20 ± 0.46* 125.18 ± 15 .68* 4. 22 ± 0. 57 * 2.35 ± 0.30 * 1. 46 ± 0. 24 0. 40 ± 0. 09
3. 43 ± 0.39 * 45 . 00 ± 1.22 * 136 . 76 ± 12 . 57 * 2.87 ± 0.16 * 1.61 ± o. 1o* 1. 02 ± 0. 07 0. 25 ± 0. 09

a Benze ne wa s administered continuously to CD-1 mi ce via drinking water for 4 weeks
b Mean corpuscular volume
c In cluding monocytes, eosinophils and basoph i l s
d Value s are given as mean± SE (n• 5)
* Signifi cantly (p<0 .05) different from control values
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Mitogen-Induced Lymphocytic Proliferations
Following 4 weeks of benzene treatment, the proliferative res ponse
of either mitogen stimulated or nonstimulated splenic lymphocytes were
elevated in low dose group and depressed in higher dose groups (Table
III -3). At the optimal concentration of LPS (20 ug/ ml) , 3H-TdR uptake
increased significantly in the group receiving 8 mg/kgjday of benzene.
In contrast, the benzene - treated groups receiving 40 and 180 mg/kg/ day
manifested a significant suppression of 3H-TdR incorporation of
splenocytes upon LPS stimulation. Simil arly, there were significant
biphasic alterations of lymphoproliferation in T cell mitogen - treated
ce lls;

both the Con A and PHA - induced responses were enhanced in the

lowest treatment group and inhibited at the two highest levels.
or nonmitogen - stimulated responses increased

The PWM

significantly in the

animals treated with the lowest dose of benzene but were insignificantly
depressed in groups receiving higher amounts .

Total spleen cellularity

decreased significantly at the highest dose of benzene treatment .
MLC and CMC Responses
The results of MLC presented in Figure III-I demonstrated a doserelated biphasic response, i.e ., 3H-TdR uptake was inhibited at the
higher benzene doses but increased in lowest dose group.

The effect of

benzene exposure on CMC activity is shown in Table 111 -4.

Cytotoxicity

data was calculated as the % of total releasable counts, corrected for
spontaneous release of radiolabel. Total release ± SE of the 2 x 10 4
Slcr -1abe 1ed target ce 11 s was 3253 ± 324 cpm. Spontaneous re 1ease was
less than 7% of total releasable counts for all assays . The results of
Slcr-release assay revealed that benzene significantly impaired the
capacity of cytotoxic lymphocyte to lyse the alloantigenic cells (target

TABLE 111-3
EFFECTS OF BENZENE EXPOSURE ON SPLENIC LYMPHOCYTE PROLIFERATIVE RESPONSE TO MITOGENS
Spleen
Dose a
cellular}tyb
(x1o- )
mg/kg/d ay

Control

7.51 ± o.4od

8

7.91 ± 0.62

40

7. 50 ± 0.41

180

5.17 ± 0.64 *

Mitogenic responsesc
None

LPS

1.6B ± 0.31

102.04 ± 23.66

PWH

Con A

7.45 ± 1.90 154 .69 ± 49 . 33
6B . 02
*
3.55 ± O. B9* 261.23 ± 25.62 12.92 ± 2. 19* 384 .90 ± IOB .61* 285 .81
1.13±0 . 13
22.43 ± 3.48* 3.25 ± 0.71
29.30 ± 7.69 * 16 . 43
0.91 ± 0.19
25 . 44 ± s.2o* 3.65 ± 0. 72
14 .61 ± 2.66*
8.87

a Benzene was administered continuously to CD-1 mice via drinking water for 4 weeks
h Reco ve red number of splenocytes per spleen x1o- 7
c dpm/10- 3;10 6 splenic cells: response evaluated by incorporation of
splenocyte cultures for 6 hours pulsing
d Values are given as mean± SE (nz5).
Sig nificantly (p<0 .05) different from control values

PHA
± 1B.57
± 88.01*
± 3. 94*
± 1.83*
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*
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R:S=2:1
R ALONE
RESPONDERS(R)-TO-STIMULATORS(S) RATIO

Fig. I II - I.
Effect of benzene exposure on mixed 1ymphocyte culture
(MLC) response . Benzene was administered continuously to CD- I mice via
drinking water for 4 weeks . The bar (left to right), 0 , 'Zl,
88l ,
and
•
, indicate benzene doses at 0 (control) , 8 , 40 , and 180
mg/kg/ day , r espectively. Stars (*) denote significan t ly (p<O . OS)
different from control values . Responder cells were the syngeneic
splenic cells of CD-I mice and stimulator cells were the allogeneic YAC 1 cells . Several stimulator responder ratios were used, but data are
presented only from a ratio of 1:2 stimulators to responders which gave
maximal stimulation. The stimulator cells were treated with mitomycin -C
before addition to the culture.
MLC evaluated by incorporation of
[methyl -3H] - thymid i ne into day 3 MLC cultures for 6 hours pul si ng .
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TABLE I II -4
EFFECTS OF BENZENE EXPOSURE ON CYTOTOXIC
LYMPHOCYTE FUNCTIONS
% Cytotoxicity

Dose a
mg/kg/day

50: I b

25:1

Contro 1

15 . 72 ± 1.16c

15.98 ± 2.98

8

17.94 ± 1.61

23.32 ± 2.o5*

40

8. 77 ± 1.87*

180

5.82 ± 0.94*

11.09 ± 1.71
9.1 7 ± I. 53*

a Benzene was administered continuously to CD-I mice via drinking
water for 4 weeks
b Effector (day 5 MLC lymphocytes ) -to -target (Sicr labelled YAC - 1
cells) cell ratio
c Values are given as mean ± SE (n=S)

* Significantly (p<0.05) different from control value s
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cells) at 25:1 and 50 : 1 effector (E) - to - target (T) cell ratios after 4
weeks of oral i ngestion .

The lowes t dose (8 mg/ kg/day) of benzene al so

obviously enhanced the CTL responsiveness in 25 : 1 E:T ratio.
Antibody Production
The primary antibody response to SRBC was assessed four days later
after sensitization with SRBC; the SRBC-specific plaque-forming cells
( PFC) were

counted, and the

shown in Table III-5,
specific antibody

-SRBC anti body titer was determined. As

ability of treated animals to produce SRBC -

changed .

40 and 180 mg benzene/ kg/day
as

0(

The number of PFC in the animals receiving
was significantly reduced, when expressed

either specific activity ( PFC/106

sp 1een ce 11 s) or who 1e sp1een

basis. However, there were more PFC per 106
exposed to the lowest level of benzene.

sp 1eni c cells in anima 1s

The total number of recovered

splenocytes was significantly reduced in a dose-related manner .
titer of o<. -SRBC antibodies corresponded

The

to the numbers of PFC, but

si gnificant depression was only found at the highest concentration of
benzene (Table III-5).
DISCUSSION
The results demonstrate that oral administration of various dosages
of benzene via drinking water ad libitum to CD-1 mice markedly altered
the immune function.

The alteration of immunocompetence was gross 1y

evidenced by a decrease of thymic and splenic weights, which are useful
indicators of immune dysfunction ,
peripheral blood and spleen.

and

a loss

of lymphocytes

from

Benzene appeared to specifically affect

lymphocytes since numbers of neutrophils and other leukocytes did not
decrease significantly (Table III-2) .

Various studies have revealed

TABLE 111-5
EFFECTS OF 4 WEEKS OF BENZENE EXPOSURE ON THE ANTIBODY

RESPONSES

TO THYMIC-DEPENDENT ANTIGEN SHEEP ERYTHROCYTE (SRBC)a

Dose
mg/kg/day

Spleen
cellula7ity
(x1o- )

PFC/10 6
Splenic cells

Control

22 . 59 ± 3.02c

B

16.80 ± 1.59*

40

15 .36 ± 0.65*

643 ± 49*

180

12 . 70 ± 1.51*

229 ± 40*

PFC/total
sp 1een le 11 s
(x1o- )

ol-SRBC
titer

1,254 ± 171

295 . 72 ± 74.51

0. 44 ± 0.06

1, 576 ± 65*

268 .80 ± 36.10

0.57 ± 0. 11

99 . 76 ± 10 . 32 *
31.41 ± 9.52 *

0.31 ± 0.05
0. 21 ± 0.01.

a Mice were sensitized with SRBC 4 days before the end of the benzene exposure .
Splenic lymphocytes were analyzed for anti body forming ce 11 s (p 1aque -forming
cell, PFC) and sera were detected for antibody titer (o<.-SRBC)
b Benzene was administered cont i nuously via dr i nking water
c Values are gi ven as mean ± SE (n-5)
Significantly (p<0. 05) di ffe r en t from control values
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that lymphocytes are particularly sensitive to benzene toxicity via
i nha 1at ion (Rozen and Snyder, 1985; Dempster et a1., 1984; Snyder et
al., 1982; Green et al., 1981a) .

Benzene increases the permeability of

1ymphocyte 1ysosoma 1 membranes and re 1eases lysosoma 1 enzyme into the
cytoplasm,

resulting

in a decrease

(Moszczynsky and Lisiewicz, 1984).

in the number of lymphocytes

Mice exposed to 300 ppm benzene via

inhalation showed significant depressions in the numbers of
lymphocytes

a-

(s - IgM+ cells) in bone marrow and spleen and in the numbers

of T-lymphocytes (Thy 1,2+ cells)
Snyder, 1985).

in thymus and spleen (Rozen and

Similar effects on these two lymphocyte populations in

blood and spleen were also reported in mice after 7 or 14-day inhalation
exposure to 50 or 200 ppm benzene (Aoyama, 1986).

Occupational exposure

to benzene showed significant 1y decreased

T-1 ymphocyte counts

(Moszczynsky and Lisiewicz, 1984) .
In our studies,

mice

exposed to

benzene had significant fewer

peri phera 1 erythrocyte numbers and hematocrits.

The increase in mean

corpuscular volume (MCV) indicates that benzene ingestion induced a
macrocytic anemia.

In human beings chronic benzene poisoning is most

easily detected by RBC reduction and increased MCV, but an accurate
diagnostic also requires other hematologic parameters (Haley, 1977).
Baarson et al. (1984) reported that repeated exposure to low levels of
benzene (10 ppm) via inhalation in mice depressed

the in vitro colony-

fermi ng abi 1 i ty of one of the erythroid progenitor ce 11 s, the co 1anyforming unit-erythroid (CFU-E), the numbers of splenic nucleated red
cells and the numbers of circulating erythrocytes and lymphocytes .
Generally, the size of lymphatic organs associated with immunologic
function decreased.

The effect of benzene on immune parameters in the
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present study was often a biphasic response, enhanced at lowest dose (8
mg/ kg/ day)

and suppressed at the higher doses (40 and 180 mg/kg/ day) .

Several workers have reported the in vivo immunosuppressive E'ffect of
benzene (Aoyama, 1986; Rozen and Snyder, 1985; Pandya et al . , 1986).
However, differences in animal models, doses and duration of exposure,
and routes of admi ni strat ion make comparisons difficult (Longacre et
al., 1981).

Inhalation of benzene depressed host resistance to the

infectious agents,

Listeria monocytogenes and K7ebsie71a pneumoniae

(Rosenthal and Snyder , 1985; Aranyi

et al.,

1986). Mitogen-induced

lymphoproliferation was suppressed in mice treated ip with benzene
metabolites, i.e., hydroquinone and catechol (Wierda and Irons, 1982) .
The cell renewal rate as well as the rate of DNA, RNA, and protein
synthesis in cultured leukocytes and lymphoma ce 11 lines exposed to
benzene or its metabolites were inhibited (U . S. Environmental Protection
Agency, 1980a; Pellack-Walker et al., 1985; Post et al ., 1985; Schwartz
et al., 1985).

Hemopoiesis in vitro

in stromal cells pretreated with

low doses of oxidative metabolites of benzene, such as hydroquinone, was
enhanced (Gaido and Wierda, 1984).

Garnett et al. (1983)

also obtained

biphasic responses in vitro with CFUs (colony forming units-spleen) from
mice that inhaled benzene .

These results support the hypothesis that

benzene or its metabolites may promote as well as suppress the
hemopoietic system (Harigaya et al., 1981).
Recently, Post et al.

(1985) indicated that exposure of T-

lymphocytes to p-benzoquinone,

one of the metabolites of benzene,

inhibited the formation of lymphokine interleukin-2 (IL-2).
produced by T lymphocytes,

IL-2,

is an important regulatory cytokine in

lymphocyte proliferation since it is a growth factor for helper, and
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cytotoxic T lymphocytes (Dinarello and Mier, 1986).
The data from this study show that ingestion of benzene via
drinking water in CD-I mice noticeably affected all aspects of the
immune system, including cellular and humoral parameters.

Of particular

importance was the fact that the effects were evident at the lowest dose
of treatment and a no-effect level could not be established .

Further

studies involving lower levels of exposure are necessary to fully
ascertain the safety of this chemical in groundwater.
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CHAPTER IV
ALTERATION OF REGIONAL BRAIN MONOAMINE
NEUROTRANSMITTERS BY BENZENE IN CO-l MICE

INTRODUCTION
Benzene, the simplest aromatic hydrocarbon, is a ubiquitous
chemical. It occurs naturally in petroleum, trees, fruit, seeds, dairy
products, eggs and meat

(U . S. Environmental Protection Agency, 1980a).

This chemical is also among the most widely distributed of the
environmental pollutants.

It is produced by the petrochemical industry,

and is a basic starting material in the manufacture of many beneficial
products (Fishbein, 1984) .

Due to its lipophilic nature and to the

production of biologically reactive intermediates
biotransformation

through metabolic

(Irons, 1985; Bolcsak, and Nerland, !983; Greenlee et

al ., 1981a), benzene is considered to pose a significant

health hazard.

The major toxicity of benzene reported in humans and laboratory animals
has mainly focused on the dysfunction of the hematopoietic system
(Sawahata et al., 1985; Bolcsak and Nerland, 1983).
Organic solvents have been associated with neurophysiological and
psyc hological disorders (Grasso et al ., 1984; Savolainen, 1977) .
However, few studies have concerned the effects of benzene on the
nervous system, particularly with neurotransmitters. Acute effects
associated with inhalation of extremely high concentrations of benzene
(about 25,000 ppm), namely, depression of the central nervous system
(CNS) and narcosis, most likely are caused by benzene rather than its
metabol ite(s) (Dempster et al ., 1984; Brief et al., 1980; Haley, 1977).
Exposure of human beings to lower concentrations of benzene (250-500
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ppm) has reportedly caused vertigo, drowsiness, giddiness, euphoria,
headache ,

and nausea

(Brief et al .,

19BO;

Haley,

1977) . Chronic

indu strial exposure to benzene also causes neurological abnormalities
(Bas 1o and Aksoy, 19B2).
activity,

The behavi ora 1 endpoints inc 1udi ng 1ocomotor

appetitive indices, and hind-limb grip strength were

demonstrated to be altered by benzene in animals (Dempster et al.,
1984) . Recently, Paradowski et al.
administration

of

benzene

to

(1985)

rats

for

showed that subcutaneous
4 weeks

increased

the

concentrations of norepinephrine (NE) and dopamine (DA) in brain or
other internal organs.
the indoleamine

Under the same conditions, the concentrations of

serotonin (5 -HT) and its metabolite, 5-hydroxyindole

acetic acid (5 - HIAA), also increased in brain tissues (Paradowski et
al., 1984).
shown to

Intraperitoneal administration of benzene to mice has been

increase brain levels of 5- HT and 5-HIAA and produce an

induction of aromatic-L-amina acid decarboxylase, a major enzyme in the
synthesis of biogenic amines (Juorio and Yu, 1985a).
Since relatively little information is available concerning the
effects of benzene on the neurochemi ca 1 transmitters in anima 1 brain,
current studies were undertaken to evaluate the neurotoxicity of benzene
in mice.

The primary objective was to determine if subchronic

administration of benzene to CD-1 mice via drinking water altered the
concentrations of specific brain catecholamines, indoleamine, and their
metabolites in discrete brain regions. These selected neurotransmitters
are known to play an important role in physiology and behavior (Rogawski
and Baker, 1985; Poirier and Bedard, 1984; Willis and Smith, 1985).

The

results of this investigation would help to understand the potential
neurotoxic actions of this ubi qui to us en vi ronmenta 1 contaminant, which
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is also a major groundwater pollutant .
MATERIALS AND METHODS
An i mals
Male, adult CO-l mice (Charles River Breeding Laboratory Inc . ,
Wilmington, MA) were quarantined and allowed to acclimatize to the
animal care facility for one
21 - 24 g initial body weight).

week prior to experiment (approximately
Room conditions were kept at ambient

temperature ( 21 ± 1°C) with re 1at i ve humidity ranging between 40 and
60%, and the 1i ght/ dark eye 1e was rna i nta i ned at 12 -hour i nterva 1s.
Commercial rodent chow (Wayne Products , Chicago . Ill) and tap water were
given ad libitum . After acclimatization, the apparently healthy animals
were randomly assigned to control and treatment groups and hou sed (five
per cage) in plastic cages containing hardwood-chip bedding.
Exposure
Analyt i cal reagent grade benzene (99.9% purity , JT Baker Chemi cal
Co. , Phillipsburg, NJ) was dissolved in normal tap water to provide the
i ntended concentrations of 40, 200, and 1000 mg/ L. Benzene

has a

solubility of 1,7BO mg/L in water at 25°C (U.S . Environmental Protection
Agency, 1980a) . Treatments were achieved by supplying the indicated
concentrations of benzene in the drinking water to mice for 28 days;
controls received tap water with no benzene. Treated water solutions
were changed every three days to ensure freshness . Feed and water
consumptions were measured continuously, and animals were weighed
weekly.

Drinking water samples were collected daily for chemical

analysis after making the fresh benzene-water solution . Final benzene
concentration in water was confirmed with a gas chromatographic method
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described earlier (U.S. Environmental Protection Agency, 1986b).
Processing of Brain Tissues
Following four weeks of continuous exposure,
killed by decapitation, and their

the animals were

brains were rapidly removed, placed

on an ice-cooled glass plate and microdissected into the following
discrete regions according to the methods described by Glowinski and
Iversen

(1966):

hypothalamus,

medulla oblongata,

striatum, cerebral cortex and midbrain.

cerebellum,

The midbrain included the

hippocampus, thalamus and subthalamus (Coulombe and Sharma, 1986).
brain section was weighed to the

corpus

Each

nearest milligram and immediately

placed in tared vials containing various volumes (in relation to tissue
weight) of ice -cold 0.05 M perchloric acid (containing 0.1% cysteine to
prevent oxidation of monoamine neurotransmitters).

To overcome possible

diurnal alterations in regional brain neurochemicals, all animals were
sampled between 10:00 and 12:00 AM on the same day.

Brain tissues were

homogenized individually, and the mixtures were centrifuged at 10,000 g
(30 min at 4°C) .

The clear supernatant fractions were passed through

0. 2 ..um pore cellulose filter membrane by centrifugal filtration (MF-1
filters, Bioanalytical Systems Inc., W Lafayette, IN) at I ,000 g for 3
min at 4°C, then transferred to a 1.5 ml conical microcentrifuge tube.
These filtrates were frozen at -80°C until analyzed within a few weeks.
Assay of Monoamines and Their Metabolites
The concentrations of the major brain catecholamines norepinephrine
(NE), dopamine (DA), and their principal metabolites 3-methoxy-4hydroxymandelic

acid

(vanillymandelic

acid,

VMA),

3,4 -

dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA); the
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indoleamine serotonin (5-hydroxytryptamine, 5-HT) and its metabolite , 5hydroxyindoleacetic acid (5 - HIAA) in perchloric acid extracts of
indi vidual brain sections were determined by high performance 1iquid
chromatography (HPLC) with a multiple -electrode electrochemical detector
(Mayer and Shoup 1983).

The HPLC system (Bioanalytic Systems Inc., W

Lafayette, IN) included a Model LC 150 electrochemical analyzer,

Model

LC 3A amphoteric detector, Model LC 22A temperature controller, and a
Biophase ODS reverse phase column.

The mobile phase was prepared

according to methods described by Mayer and Shoup (1983) and was allowed
to equil i brate overnight at a flow rate of 1.4 mL/ min before sample
ana 1ys is.

The co 1umn temperature was maintained at 30°C .

Leve 1s of

brain monoamines or their metabolites were computed (using a 3390A
reporting intergrator, Hewlett - Packard, Avondale, PA) from chromatograms
derived from the responses of analytical amine standards (Sigma Chemical
Co. , St . Louis , MO) prepared by diluting amine in 0.05 M perchloric acid
conta i ning 0. 1% cysteine to produce concentrations of 10, 25 , 50, 100 ,
200, 500 ng/ mL.

Detector response provided

a linear correlation

coeffi ci ent for all standards(r2 > 0.98) . The retention time (min) of
VMA, NE, DOPAC , DA, 5-HIAA, HVA, and 5-HT is 2.84, 3.66, 5.85 , 6. 72,
9.67, 11 .41, and 16.68, respectively.
Statistical Analyses
The levels of monoamines determined from brain regions were
expressed as .ug/ g wet tissue weight .

The effects on each regional

neurochemi cal were analyzed by one -way analysis of variance (ANOVA),
followed Fisher ' s least s ignificant difference (LSD) test (Dowdy and
Wearden, 1983). Statistically significant differences were considered at
p<0.05 .
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RESULTS

Benzene concentration of drinking water mixtures was determined by
gas chromatography on different days during the test period.

Although

the concentrations of benzene in the drinking water decreased
approximately 27-30% over a 3-day period, the average

concentration was

31 mg/ l for the 40 mg/l nominal concentration (79% of the intended
concentration), 166 mg/ l (B3% of the intended concentration) for the 200
mg/l group, and 790 mg/l ( 79% of the intended concentration) for the
1000 mg/l group . Based on the observed water consumption during the
period of exposure, the daily estimated benzene doses corresponded to 0,
8, 40, 180 mg/ kg, respectively.
Benzene levels used in this study did not significantly alter body
weights, compared to the controls. Also, there were no apparent
treatment-related behavioral alterations in test animals .

Food and

water consumptions were not s i gni fi cant ly affected by benzene addition
to water in any of the groups.
Administration of benzene via drinking water induced significant
increases in monoamine neurotransmitters in several of the brain regions
studied.

In most cases, the changes were dose-related;

in several

instances maximum effects occurred at the benzene dose of 40 mg/kg/day,
and did not increase in the highest dose group (180 mg/kg/day). An
elevation in concentrations of NE

and its acid metabolite VMA was

observed in various brain regions after four weeks of benzene treatment
(Figure IV - I and IV-2, Table IV-I) .

Of particular interest, was a

significant increase in the concentration of NE in the hypothalamus, the
region containing the highest level of this monoamine,
higher dosed groups.

in the

two

The NE concentrations in this region increased by
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Fig. IV-!.
Concentrations of the various monoamines and their
metabolites in the hypothalamus of mice exposed to benzene in drinking
Stars (*) denote significantly different from
water for 4 weeks .
untreated control (p<0 . 05) .
Values are given as mean ± SE of five
animals per group . NE , norepinephrine; 5-HT , serotonin; DA, dopamine;
VMA, vanillymandelic acid ; 5-H IAA , 5-hydroxyindoleacetic acid; DOPAC ,
3,4-dihydroxyphenylacetic acid; and HVA, homovanillic acid .
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Fig. JV - 2 . Concentrations of norepinephrine in the various brain regions
of mice exposed to benzene in drinking water for 4 weeks . Stars(*)
denote significantly different from untreated control (p<0.05). Values
are given as mean± SE of five animals per gouup .

TABLE IV-1
EFFECTS OF BENZENE EXPOSURE ON REGIONAL CONCENTRATIONS OF BRAIN VANILLYMANDELIC ACID (VMA)
Concentrations ( pg/g wet tissue)a

Dosesb
(mg/kg/ day)
Medulla
oblongata

Cerebellum

Midbrain

Corpus
striatum

Cortex

Control

0 . 189 ± 0. 034

0.194 ± 0.010

0. 231 ± 0.031

0.204 ± 0.028

0.170 ± 0.017

8

0. 238 ± 0.009

0.241 ± 0. 016*

0.285 ± 0. 017

0.282 ± 0. 029*

0.287 ± 0. 030 *

40

0.240 ± 0. 005

0.234 ± 0.006*

0.248 ± 0. 015

0.291 ± o.ol3*

0.350 ± 0.040*

0. 242 ± 0.008

0.281 ± 0. 014*

0.266 ± 0.012

0.295 ± 0.019*

0.293 ± 0.006*

180

a Values are given as mean ± SE (n=5)
b Benzene was administered continuously via drinking water for 4 weeks
* Significantly (p < 0.05) different from control values
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40, 58 and 61 % in groups receiving 8, 40 and 180

mg/kg/day,

respectively. Similar effects on NE were produced by benzene in medulla
oblongata and cerebellum at various dose levels. As indicated in Table
IV -1,

VMA was induced concomitantly with increases of its parent

chemical, NE .

Significant elevation of VMA was observed in the corpus

striatum, cerebellum and cerebral cortex in all treatment groups.
Increases in concentrations of DA and its major metabolites , DOPAC
and HVA, in the various brain regions were also observed. Concentrations
of DA increased significantly in the hypothalamus of all benzene -treated
groups (Figure IV-1) . In the corpus striatum, the region richest in DA ,
the concentrations of this neurochemical

increased significantly in

animals receiving 8 and 40 mg/ kg/ day of benzene. Concomitantly, both DA
metabolites, DOPAC and HVA, also increased significantly in thi s brain
region (Figure IV-3). In other brain regions , the concentrations of
DOPAC , the first acid product

of the DA oxidative pathway , were

si gnificantly elevated only in midbrain (8 and 40 mg/kg/ day) (Table IV2).

Amounts of DA, DOPAC and HVA in cerebellum, a region containing

relatively low levels of these chemicals, were not determined .
Significant benzene-induced increases of 5-HT levels were seen in
hypothalamus, midbrain, cerebral

cortex, corpus striatum and medulla

oblongata (Figure IV-1 and JV-4) . No effect on 5-HT levels could be
detected in the cere be 11 urn, where the concentrations of this biogenic
amine are relatively low. Accompanying increases of 5-HT, there were
significant

increases of its main metabolite 5-HIAA in the midbrain

corpus striatum and cortex (Table IV-3).
generally accumulated to coordinate
(Figure JV -1).

The hypothalamic 5-HIAA levels

its precursor chemical,

5-HT
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15

CJ Control
fZl 8 mg/kg/day
~

•

40 mg/kg/day
180 mg/kg/day

*
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~
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DA
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HVA

Fig . IV-3 . Concentrations of dopamine and its major metabolites in the
corpus stria tum of mice exposed to benzene in drinking water for 4
weeks. Stars(*) denote significantly different from untreated control
(p<0.05) . Values are given as mean± SE of five animals per gouup . DA,
dopamine; DO PAC, 3, 4-di hydroxyphenyl acetic acid; and HVA, homovani ll i c
acid.

69
TABLE IV -2
EFFECTS OF BENZENE EXPOSURE ON REGIONAL CONCENTRATIONS OF BRAIN
DOPAMINE (DA), 3,4 -DIHYDROXYPHENYLACETIC ACID (DOPAC) ,
AND HOMOVANILLIC ACID (HVA)

Chemicals

DA

DO PAC

HVA

Dosesb
(mg/kg/day)

Concentrations ( ~9/9 wet tissue)a
Medulla
oblongata

Midbrain

Cortex

Control

0.037 ± 0.005

0.265 ± 0.068

0.958 ± 0. 142

8

0. 047 ± 0.006

0.494 ± 0.113

I. 349 ± 0. 178

40

0.046 ± 0.003

0.496 ± 0. 129

1.367 ± 0.086

180

0.043 ± 0.006

0. 330 ± 0.058

1.148 ± 0.105

Control

0.042 ± 0.006

0.118 ± 0.020

0.209 ± 0.018

8

0. 058 ± 0.008

0. 217 ± 0.025*

0.249 ± 0.018

40

0.054 ± 0.006

0. 215 ± 0.038*

0. 270 ± 0.033

180

0. 043 ± 0.006

0. 120 ± 0.012

0.195 ± 0.021

Contra l

0.042 ± 0.003

0. 138 ± 0.017

0.187 ± 0. 023

8

0. 047 ± 0.006

0. 179 ± 0.021

0. 226 ± 0.008

40

0.065 ± 0. 004

0. 218 ± 0.026

0. 246 ± 0.019

180

0.056 ± 0.007

0. 156 ± 0.019

0. 212 ± 0.008

a Values are given as mean ± SE (n=5)
b Benzene was administered continously via drinking water for 4 weeks
* Significantly (p < 0. 05) different from control

values
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CJ Control
!Zl 6 mg/ kg/day
IK8l 40 mg/ kg/ day
•
160 mg/ kg/day
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*
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Fig. IV-4. Concentrations of serotonin in the various brain regions of
mice exposed to benzene in drinking water for 4 weeks . Stars(*) denote
s ignificantly different from untreated contro l (p<O.OS} . Values are
given as mean ± SE of five animals per gouup .

TABLE IV-3
EFFECTS OF BENZENE ON REGIONAL CONCENTRATIONS OF BRAIN 5-HYDROXYINDOLEACETIC ACID (5 -HIAA)
Concentrations ( pg/g wet tissue)a

Dosesb
(mg/kgfday)

Control

Medulla
oblongata

Cerebellum

Midbrain

Corpus
striatum

Cortex

0.400 ± 0.017

0.172 ± 0.010

0. 552 ± 0.029

0.451 ± 0.057

0.225 ± 0.014
0.317 ± 0.016*

0.285 ± 0.010*

8

0.438 ± 0.035

0. 192 ± 0.020

0.636 ± 0.013

40

0. 494 ± 0.019

0.173 ± 0.007

0.741 ± 0.057*

0.598 ± 0.009 *
0. 683 ± 0.033 *

180

0. 452 ± 0.031

0.151 ± 0.007

0.638 ± 0.038

0.548 ± 0.024

a Value s are given as mean ± SE (n=5)
b Benzene was administered continuously via drinking water for 4 weeks
* Significantly (p< 0.05) different from control

value s

0.311 ± 0.028*
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DISCUSSION
This study monitored changes in selected regional brain monoamines
that occurred after

four weeks of benzene exposure in mice via drinking

water. Since the concentration of any neurotransmitter does not by
itself provide

an

appropriate

indication

of the

turnover of that

neurotransmitter to reflect monoaminergic neurophysiological
(Commissiong, 1985), its

metabolite(s)

were also assayed.

various regions of the brain is essential

activity
Assays in

to detect potential

perturbations of brain neurotransmitters because significant changes of
certain neurochemicals may be concealed in certain minute brain regions
and, therefore, remain undetected (Coulombe and Sharma, 1986). Due to
the rapid changes

in brain monoamine concentrations caused by the

enzymes for both synthesis and catabolism

(Faiman et al.,

1973), the

methods used to prepare brain tissues described earlier minimized the
risk of postmorten alterations .
The region a1 concentrations of brain monoamine neurotransmitters
and their metabolites obtained for the untreated control mice in this
study were

similar to those reported earlier for CD-I mice (Sharma et

al., 1986) . Ingestion of benzene at the doses studied
potentia 1 neurotoxic effects. Although
the various discrete

brain

enhanced

se 1ected neurotransmitters

regions were

significantly altered,

in
no

toxicological signs were observed during the period of treatment; the
growth rate, and consumptions of food and water were not influenced by
the benzene treatment. Similar treatment, however, caused macrocytic
anemia at all dose levels of benzene (Chapter Ill).
Benzene had the greatest effect on NE in the hypotha 1amus and
medulla oblongata; and on 5-HT in the hypothalamus, medulla oblongata
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and midbrain.

These increases were frequently associated with

corresponding increases in VMA and 5-HIAA, respectively, suggesting an
increased

turnover of biogenic amines.

Dopamine concentrations

elevated significantly only in the corpus striatum, a brain region
especially rich in this neurotransmitter,

and in the hypothalamus .

Elevated DOPAC and HVA levels were also observed in these brain regions.
These findings are compatible with results

reported by others

(Paradowski et al. , 1984; 1985; Juorio and Yu, 1985a,b).

However, since

their studies were performed on whole-brain homogenates or only in one
or two selected brain regions; our studies provide confirmation of their
observations . In rats, subcutaneous admi ni strat ions of benzene in doses
of 67.5 -540 mg/ kg/day for 4 weeks i nduced increases of
concentrations

(Paradowski

et

al .,

1985},

and

brain NE and DA
also

produced

accumulations of both 5-HT and 5-HIAA in the hypothalamus and striatum
(Paradowski et al ., 1984).
monoamines

The regional concentrations of the variou s

increased enough

to suggest

that

benzene-induced

perturbations in CNS monoaminergic biosynthetic pathways, as i s
confirmed by the accompany ing increases in the met abo 1i tes of these
monoamines .

Both synthesis and

catabolism of

these neurotransmitters

increased following benzene intake. Synthesis of NE, DA and 5-HT more
then compensated for their release and breakdown during the increased
neuronal activity. In other words, their syntheses could cope with
increased noradrenergic, dopaminergic and serotoninergic activities .
Despite rather nonspecific correlations, behavioral changes may
also indicate the involvement of monoamines.

Benzene-induced milk-

licking, tremors, and hind-limb weakness indicated that this chemical
possesses properties of neurobehavioral alterations in mice (Dempster et
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al .,

1984), which are often attr i buted to an imbalance in the

concentrations of catecholamines and indoleamine (Leibowitz 1986; Willis
and Smith,

1985) .

Furthermore,

the subjective clinical

indices of

neurobehavior in humans exposed to benzene (250-500 ppm), e.g., vertigo,
drowsiness,

euphoria,

giddiness,

headache,

(Brief et al., 1980) may be mediated by

and

nervous

irritability

alterations in regional brain

monoamine levels.
The mechanism for the benzene - induced changes in levels of
monoamines and their metabolites is not yet known .

The effects of

benzene on the major enzyme systems in the monoaminergic biosynthetic
pathway have never been clearly shown.

Benzene produced an induction of

aromatic - L- amino acid decarboxylase (AADC) but no effect on monoamine
oxidase

(MAO)

(Juorio and Yu,

!985a) .

However,

due to

its

high

enzymatic activity, the induction of AAOC may not result in significant
changes of endogenous monoamine levels (Cooper et al . , 1986) .
investigations are needed

to determine whether

benzene

Further

alters

the

kinetics of the rate-limiting enzymes, tyrosine hydroxylase and
tryptophan hydroxylase, in the catecholamines and indoleamine synthetic
pathways, respectively. Benzene may interact with more than a single
biological

site,

so data from nervous system molecular events,

pharmacokinetics, as well as in vivo neurobehavioral changes are
essential in the evaluation of the potential neurotoxic risk caused by
ora 1 ingestion of benzene.
Similar levels of benzene in drinking water caused alteration of
various immune responses in CD-I mice as described earlier (Chapter
I I I) .

Although benzene is a hemopoi etoxi c chemica 1 and can directly

suppress immune functions, the increases in brain

catecho 1ami nes will
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have an additive

adverse effect on the immune system via hypothalamus -

pituitary-adrenal (HPA) axis. Increased levels of catecholamines can
result in increased adrenal corticosteroid levels (Makara et al ., 1980)
which in turn are immunosuppressive (Claman,

1972). The pituitary-

adrenal status after benzene treatment is current ly being investigated
in our laboratory.
In summary, administratering benzene to CD-I mice for four weeks
via drinking water significant elevated levels of NE, DA, and 5-HT, and
their metabolites (VMA, DOPAC , HVA and 5-HIAA) in several brain regions
studied . More detailed study of these phenomena will

identify the

mechanisms (membrane-mediated, metabolic , or both) that perturb the
monoaminergic biosynthetic pathways.

It is not known whether the

neurotoxic effects of benzene are produced directly or indirectly (due
to some metabolite(s) of this chemical) .
effect level of benzene in drinking water.

The data do not predict a no -
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CHAPTER V
EVALUATION

OF

TOLUENE

EXPOSURE

ON

LEVELS

OF

REGIONAL BRAIN BIOGENIC MONOAMINES AND
THEIR METABOLITES IN CD-1 MICE

INTRODUCTION
Chemical contamination of

groundwater, which

is a primary source

of drinking water for approximately half the population of the United
States, has become a great matter of public concern (U.S. Office of
Technology Assessment , 1984).

Of major concern is the probable

subclinical, deleterious effects resulting from continuous long-term
exposure to low levels of chemicals. Toluene, a major aromatic chemical,
is produced in enormous quantities , and is extensively employed as a
starting

material

for other chemicals,

an

important component

in

gasoline, and a "safe" replacement for benzene in solvent applications
(Fishbein, 1985).

It has been detected in

concentrations up to 6. 4

mg/L in finished water (Tardiff and Youngren,

1986). The neurotoxic

properties of this chemica 1 represent an important health hazard
(Fishbein, 1985; Benignus, 198la).
Toluene appears to have a

pronounced effect on

behavior;

schedule-controlled behaviors have been reported to produce inverted Ushaped concentration-effect curves on response rates in experimenta 1
animals (Benignus, 1981b) . Abnormal electroencephalographic (EEG)
activity following toluene inhalation was found in humans (Grasso et
al., 1984), as well as in animals

(Naalsund, 1986; Dyer et al., 1984).

Rigorous neurochemi ca 1 studies are needed to better exp 1a in to 1uene' s
neurobehavioral

effects.

Several

studies

have

indicated

that
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concentrations of various brain biogeni c monoamines are affected by
acute or s ubchronic administrat i on of toluene via inhalation or
intraperitoneal

injection to r2ts . Most reports

showed that brain

norepinephrine (NE) increased while dopamine (DA) increased or remained
unaltered after toluene treatment (Rea et al., 1984; Andersson et al.,
1980; 1983; Arito et al., 1984; 1985) . Significant alterations in brain
concentrations of serotonin (5 -HT) were also reported (Rea et al., 1984;
Arito et al., 1984; 1985) .

None of those studies involved evaluation of

regional neurotransmitters after prolonged oral exposure to toluene .
In this experiment we studied

alterations i n concentrations of

region a1 brain biogenic ami nes (i.e ., catecho 1ami nes , indo 1eami ne) and
their major metabolites in CD-I mice continuously exposed to toluene via
drinking water for 4 weeks. The neurochemicals selected for analys is are
known to play an important role in physiology and behavior (Rogawski and
Baker , 1985 ; Poirier and Bedard , 1984) . The concentrations of
metabolites were studied since steady -s tate transmitter concentration s
a1one are of 1i mited va 1ue about how a to xi cant perturbs the centra 1
nervous system.
metabolic

Changes in metabolite concentrations

activity

of

neuronal

neurotransmitters (Commissiong, 1985).

pathways

related

indicate the
to

s pecific

Discrete brain areas were chosen

because examination of discrete brain regions demonstrate preferential
effects on specific pathways. Recently,
laboratory have indicated that

several studies in our

chemical-induced neurotox i city might be

re 1a ted to the alterations of certain neurochemi ca 1s in certain minute
brain regions (Coulombe and Sharma, 1985; 1986; Sharma et al., 1986) .
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MATERIALS AND METHODS
Animals
Adult male CD-1 mice (Charles River Breeding Laboratory
Wilmington, MA) were used in all studies.

Inc . ,

Mice were kept in an AAALAC-

accredited animal care facility with ambient temperature of 22 - 24°C, 40 60% relative humidity, and a 12 h light dark cycle and acclimated one
week prior to the beginning of the study .

Commercial rodent chow (Wayne

Products, Chicago, IL) and tap water were available ad libitum.
Chemical Treatment
To 1uene (chromatography grade, 99 . 7% purity, Burdick and Jackson
Labs. Inc ., Muskegon, MI) was dissolved in drinking water to provide
nominal

concentrations of 20 ,

100,

and 500 mg/L.

Toluene

solubility of 535 mg/L in fresh water at 25°C (U.S.
Protection Agency, 1980b).

has

a

Environmental

Exposures were conducted by continuou s 1y

supplying the indicated concentrations of toluene in the drinking water
for 28 days . Control animals

received tap water without toluene.

The

treated water solutions were changed every three days to ensure
freshness, and the volume of water ingested was recorded to estimate the
dose of toluene
continuously,
concentrations

intake .

and
in

Food consumption was

animals were weighed
drinking

water

were

weekly.

also

monitored

Actual

determined

by

toluene
a

gas

chromatographic method (U . S. Environmental Protection Agency, 198Gb) .
Processing of Brain Tissues
Following 4 weeks of continuous exposure, mice were decapitated and
their brains removed and immediately placed in an ice-cold glass petri
dish.

The brain was microdissected into six discrete

regions:
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hypothalamus, medulla oblongata, cerebellum, corpus striatum, cerebral
cortex and midbrain according to the procedures of Glowinski and Iversen
(1966).

The midbrain includes the hippocampus,

(Coulombe and Sharma, 1986).

thal~mus

and subthalamus

Each dissected brain region was promptly

weighed in tared vials containing several volumes (in relation to tissue
weight) of ice-cold 0.05 M perchloric acid with 0.1% cysteine then
frozen on dry ice. To overcome possible diurnal alterations in regional
brain neurochemicals, all animals were sampled between 10:00 and 12:00
AM on the same day. Tissue samples for chromatographic analysis were
prepared

as described in the methods section of Chapter IV.

Assay of Neurotransmitters
and Their Metabolites
The concentrations of biogenic amines and their metabolites in
various brain regions were assayed by high performance liquid
chromatography (HPLC) with a multiple -electrode electrochemical detector
(Mayer and Shoup, 1983) . The HPLC system consisted of a Model LC - 150
electrochemical analyzer, Model LC -3A amphoteric detector, Model LC -22A
temperature controller, and a Biophase ODS -reversed phase column

(Bio -

Analytic System Inc.). The mobile phase, containing sodium octyl sulfate
as ion -pair reagent, was prepared according to our modifications of the
methods described previously (Mayer and Shoup, 1983). A constant flow
rate of 1.4 ml/min was delivered, while the column temperature was
maintained at 30°C. The neurochemicals were oxidized by setting the
potential at +0.7 V and the controller at 10 nA full scale. Data were
recorded with a Hewlett- Packard (Avonda 1e, PA) 3390A integrator from
chromatograms derived from the responses of analytical standards (Sigma
Chemical Co., St.

Louis, MO).

Standards were prepared by diluting
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chemicals in 0. 05 M perchloric acid containing 0.1% cysteine to produce
concentrations of 10, 25 , 100, 200, 500 ng/ml. The detector responses
provided a linear correlation coefficient of > 0.98. Compounds assayed
incl uded the major catecholamines norepinephrine (NE), dopamine (DA),
and their principal metabolites, 3-methoxy-4-hydroxymandel i c acid
(vanillymandelic acid, VMA) , 3-4-dihydroxyphenylacetic acid (OOPAC) , and
homovanillic acid (HVA); indoleamine serotonin (5-hydroxytryptam ine, 5HT) and its metabolite , 5-hydroxyindoleacetic acid (5-HIAA).
Statistical Analysis
The concentrations of monoamines and their metabolites determined
fr om bra in regions were expres sed as

~g/ g

wet tissue. One-way analysis

of var i ance (ANOVA) and follow-up Fisher's least significant differences
(LSD)

test were used to analyze the data for differences between

toluene -exposure and corresponding normal water contra l . A l evel of
p<0.05 was considered statistically significa nt .
RESULTS
Gas chromatographic analyses revealed that concentrations of
toluene in drinking water mixtu res decreased approximately 25-35% over a
3-day period. The observed concentrations (overall average of the daily
analysis) for the nominal concentrations of 0, 20, 100 , and 500 mg/ L
were 0, 17 (±16%) , 80 (±12%), and 405 (±14%) mg/L, respectively. Based
on water consumption during the duration of exposure, the estimated
toluene intake doses corresponded to 0, 5, 22 , and 105 mg toluene/kg
body weight/ day.
At the doses used in this study, toluene did not adversely affect
growth, mortality, body weights, nor did it produce any other overt
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clinical

symptoms of toxicity in mice.

Food and water consumption

throughout the study did not suggest any significant differences between
treatment and control group .
The regional concentrations of brain biogenic amines (NE, DA, 5-HT)
and their major metabolites (VMA, DOPAC, HVA, 5-HIAA) in CD-1 mice are
shown in Figs. V-1 through V-3 and Tables V-1 through V-3.

Toluene

ingestion induced significant increases in concentration of these
neurochemicals in several of the brain regions studied. In most cases
where statistical differences are noticed, the increases exhibited a
biphasic response which began at a dose of 5 mg/kg/day, peaked at 22
mg/kg/day, then decreased at 105 mg/kg/day. In several instances,

the

effects were dose-related. Figure V-1 indicates the effects of toluene
on se 1ected neurochemi ca 1s in the hypotha 1amus.

The concentrations of

NE increased significantly by 51, 63, and 34% in groups dosed with 5,
22,

and

105 mg/kg/day,

accumulations
significant.

of

its

respectively ,
metabolite,

in this

VMA,

were

compartment.
not

The

statistically

Significant increases of DA and DOPAC levels were detected

in animals receiving toluene doses of 5 and 22 mg/kg/day, but their
metabolite, HVA,

was

not

influenced.

Toluene

(22 mg/kg/day)

also

significantly increased concentrations of both hypothalamic 5-HT and its
metabolite 5-HIAA.
Figure V-2 illustrates the concentrations of the major amines and
their metabolites in the corpus striatum following toluene treatment .
Increases of DA concentrations in the corpus striatum, a brain region
especially rich in this neurotransmitter, were dosed-related and
ex hi bi ted significant differences i n the two higher dosed anima 1 groups
as compared to those

in the untreated animals.

Toluene increased
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2.5

CJ Conlrol
•
5 mg/kg/day
EZI 22 mg/kg/day
~ 105 mg/kg/day

**

0 .5

NE

VMA

5-HIAA

DA

DO PAC

HVA

Fig. V-1. Concentrations of various biogenic monoamines and their
metabolites in the hypothalamus of mice exposed to toluene in drinking
water for 4 weeks . Stars (*) denote significant differences from control
values at p<0.05. Values are given as mean ± SE of five animals per
group. NE, norepinephrine; 5-HT, serotonin; VMA, vanillymandel ic acid;
5- HIAA, 5-hydroxyindoleacetic acid; DA, dopamine; DOPAC, 3,4dihydroxyphenylacetic acid; and HVA, homovanillic acid.
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*
D
•

Control
5 mg/kg/day
~ 22 mg/kg/day
D 105 mg/kg/day

10

*

DA

DO PAC

HVA

...

...

*

...

Fig . V-2. Effects of toluene treatment on concentration s of var iou s
biogenic monoamines and their metabol i tes in the corpus stria t um . St ars
(*) denote significant differences from control values at p<0.05 . Valu es
are given as mean± SE of five animal s per group . NE , norepin ephr i ne; 5HT, serotonin ; VMA, vanillymandelic acid ; 5-HIAA, 5-hydroxyindol eacet ic
acid; DA, dopamine; DOPAC, 3,4-dihydroxyphenylacetic acid ; and HVA ,
homovanillic acid .
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striatal HVA at the highest dose level only .

No effects on NE were

observed i n this brain region, but VMA concentrations were signif ic antly
induced in animals dosed with 22 and 105 mg/kg/ day. The two higher do se
levels of toluene significantly elevated the hypothalamic 5- HT
concentrations, while concentrations of 5-HIAA in this

region were

significantly higher only in the 105 mg/kg/day dosed animals.
Concentrations of biogenic amines and their major metabolite in the
brain regions of cerebellum, midbrain and cerebral cortex are given in
Table V- 1 through V-3.

The results shown in Table V-1 indicate that

s i gni fi cant increases of NE were found in the midbrain in all to 1uene
treatment groups . The concentrations of VMA were correspondingly
increased in this brain region and showed statistical difference from
untreated control values in the two higher dosed groups .

Toluene also

caused a significant increase of VMA in cerebral cortex at the highest
dose .

The amounts of DA and its metabolites DOPAC and HVA , were not

obviously affected in these three brain areas (Table V- 2) . Although HVA
increased occasionally in the cerebellum, the concentrations of this
chemical are relatively low in this region .

There were significant

increases of 5-HT in midbrain in all three toluene dosed groups and in
cerebral cortex in the 22 mg/kg/day dosed mice (Table V-3).
The effects of toluene ingestion on neurotransmitters and their
metabolites in the medulla

oblongata are

presented

in Figure V-3.

Significant toluene-induced increases of NE and VMA were found at the 22
mg/kg/day dose only .

Relatively high concentrations of 5-HT and 5-HIAA

were noticed in this brain area.

There were significant increases of 5-

HT in the two higher toluene dosed animals and 5-HIAA in

the

22

mg/kg/day dosed group. Dopamine and HVA in this brain region were not
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TABLE V-1
EFFECTS OF TOLUENE EXPOSURE ON NE AND VHA CONCENTRATIONS
IN CEREBELLUM , MIDBRAIN , AND CEREBRAL CORTEX

Chemicals

Concentrationb

Dosea
(mg/kg/day)
Cerebellum

Midbrain

Cerebral Cortex

0.330 ± 0.041

0. 575 ± O. Oll

0.359 ± 0.020

5

0.335 ± 0.015

0.409 ± 0.029

22

0.416 ± 0.023

0.660 ± 0.031 *
0.671 ± 0.026 *

105

0.377 ± 0. 018

0. 691 ± 0.019*

0.429 ± 0.021

Control
NE

Control
VMA

0.460 ± 0.026

0.253 ± 0.015

0.305 ± 0.024

0. 253 ± 0.017

5

0. 286 ± 0.009

0.320 ± 0.007

0.265 ± 0.006

22

0.272 ± 0.020

0.250 ± 0.013

105

0.244 ± 0.008

0.356 ± 0.015 *
0. 377 ± O.Oll *

0. 347 ± 0. 006 * '

a Toluene was administered continuously vi a drinking water for 4 weeks
b ~g neurochemical/g wet tissue, Mean ± SE (n=5)
* Signi ficantly different from untreated control at p<0.05
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TABLE V-2
EFFECTS OF TOLUENE EXPOSURE ON DA, DOPAC, AND HVA CONCENTRATIONS
IN CEREBELLUM, MIDBRAIN, AND CEREBRAL CORTEX

Chemic als

DA

DO PAC

HVA

Concentrationb

Dosea
(mg/kg/day)
Cerebellum

Midbrain

Control

0.040 ± 0. 004

0.270 ± 0.026

1.197 ± 0.093

5

0. 044 ± 0. 006

0. 488 ± 0.093

1.121 ± 0.130

22

0.041 ± 0.007

0.310 ± 0.040

1.243 ± 0. 159

105

0.046 ± 0. 005

0. 393 ± 0.061

1.134±0 .084

Control

0.027 ± 0.003

0.141 ± 0. 010

0 . 185 ± 0. 008

5

0.1 55 ± 0.017

Cerebral Cortex

0.022 ± 0.002

0.192 ± 0.049

22

0. 030 ± 0.005

0.1 26 ± 0.016

0.189 ± 0. 013

105

0.029 ± 0. 003

0. 124 ± 0.011

0.179 ± 0.013

Control

0. 008 ± 0.008

0.126 ± 0. 021

0.180 ± 0.019

5

0.009 ± 0.009

0. 161 ± 0.030

0. 142 ± 0.012

22

o.043 ± o.oo5*

0. 119 ± 0. 009

0.180 ± 0.023

105

0.020 ± 0.009

0.132 ± 0.008

0.170 ± 0.0 17

a Toluene was administered continuously via drinking water for 4 weeks
b ~9 neurochemical/g wet tissue , Mean ± SE (n=5)

* Sig nificantly different from untreated control at p<0 .05
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TABLE V-3
EFFECTS OF TOLUENE EXPOSURE ON 5-HT AND 5-HIAA CONCENTRATIONS
IN CEREBELLUM, MIDBRAIN , AND CEREBRAL CORTEX

Chemicals

5-HT

5-HIAA

Concentrationb

Dose a
(mg/kg/day)
Cerebellum

Midbrain

Cerebral cortex

Control

0. 222 ± 0.054

0.763 ± 0.017

0.527 ± 0.013

5

0.191 ± 0.028

1.020 ± 0.046*

0.655 ± 0.007

22

0.274 ± 0.027

1.102 ± 0.072*

0. 788 ± 0.049*

105

0.194 ± 0. 027

0.982 ± 0.018*

0.654 ± 0.006

Control

0.091 ± 0.022

0.370 ± 0. 005

0.170 ± 0.007

5

0. 084 ± 0.012

0.417 ± 0.023

0. 194 ± 0.013

22

0.105 ± 0.016

0. 417 ± 0. 063

0. 232 ± 0.026

105

0.060 ± 0. 005

0.322 ± 0.009

0. 179 ± 0.007

a Toluene was administered continuously via drink i ng water for 4 weeks
b ~g neurochemical/g wet tissue, Mean ± SE (n=5)
* Significantly different from untreated control at p<0 . 05
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CJ Conlrol
•
5 mg/kg/day
EZI 22 mg/kg/day
~ 105 mg/kg/day

5-HIAA

DA

DO PAC
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Fig. V-3. Effects of toluene treatment on concentrat i ons of various
biogenic monoamines and thei r metabolites in the medulla oblonga t a .
Stars (*) denote significant differences from control values at p<0. 05.
Values are given as mean ± SE of five animals per group . NE ,
norepinephrine; 5-HT, serotonin ; VMA , vanillymandelic acid ; 5- HIAA , 5hydroxyindoleacetic acid; OA, dopam i ne ; DOPAC , 3,4-dihydroxyphenylacet i c
acid ; and HVA, homovanillic acid .

89
affected by toluene treatment . A significant increase in DOPAC
concentration was observed in the 22 mg/kgjday dosed group.
DISCUSSION
This study eva 1uated the potentia 1 of to 1uene to induce monoamine
transmitter-related neurotoxicity in mice after 4 weeks of exposure via
drinking water.

The highest dose was lower than the solubility of

toluene in fresh water at 25°C, which is 535 mg/L (U.S. Environmental
Protection Agency, 1980b). The lowest dose was slightly higher than the
EPA maximum permissible concentration of 14 . 3 mg/L for ambient water
(U.S. Environmental Protection Agency, 1986a), which was mainly based on
a general toxicity evaluation of an oral dosing study in rats (Wolf et
a l . , 1956).
The concentrations of neurochemicals gained in the control group in
this study we re similar to those reported earlier for CD-1 mice (Sharma
et al . , 1986). In addition, since diurnal

variations and postmortem

changes in neurochemical concentrations were avoided, values generally
varied little within groups.
The findings indicate that ingestion of ambient water containing
toluene at the EPA permissible concentration may have neurotoxic
effects. Significant increases in regional concentrations of various
neurochemi ca 1s in several brain regi ens caused by toluene ingestion
waul d be sufficient to suggest toluene-induced perturbat i ens in
monoaminergic biosynthetic pathways.

The corresponding

their metabolites su pport the validity of these findings.

increases

in

Noradrenergic

neurons and serotonergi c neurons appeared to be high 1y vul nerab 1e to
toluene while dopaminergic neurons were rather resistant. Toluene
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dramatically affected NE concentrations in the hypothalamus, medulla
oblongata, midbrain and corpus striatum, and 5-HT concentrations in the
hypothalamus, medulla oblongata, midbrain, cerebral cortex and corpus
striatum. Increased concentrations of NE and 5-HT along with their
respective metabolites (VMA and 5-HIAA) in these regions suggest that
syntheses of NE and 5-HT more than compensate for their releases and
breakdown during increased neuronal activities.

The significant

increase in concentrations of DA and its metabolites in the hypothalamus
may be a secondary effect si nee they are not major neurochemi ca 1s in
this brain compartment. Although toluene treatment significantly
increased DA concentrations in the corpus striatum, only slight
increases of its metabolites DOPAC and HVA were observed.
to these two brain areas, no apparent effects

In addition

on DA or its metabolites

were found in any of the other brain regions.
Increases in

steady-state

levels of

NE, DA and

5-HT

have been

reported in whole-brain homogenates or discrete brain areas of rats who
continuously inhaled 100, 300, or 1000 ppm toluene for 8 hr (Rea et al . ,
1984). Subchronic repeated exposure of rats to toluene vapor also
increased concentrations of catecholamines and their turnover rates in
hypothalamus or median eminence (Andersson et al., 1980; 1983). After a
single ip administration of 200 mg toluene/kg body weight to rats, Arito
et al.

(1984) reported a significant increase in the regional

concentrations of NE, 5-HT and their respective metabolites, 3-methoxy4-hydroxyphenylethyleneglycol (MHPG) and 5-HIAA, however, alterations in
DA and its metabolites DOPAC and HVA were not detected. In their followup study, however, 14 consecutive days of ip injection of toluene in
rats significantly increased NE and MHPG only (Arito et al., 1985).
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Pronounced increases in the concentrations of serum cortico sterone ,
growth hormone (GH), follicle - stimulating hormone (FSH) and prolactin
(PRL) were found in rats under the influence of toluene exposure via
inhalation (Andersson et al., 1980; 1983) . Hypothalamic monoaminergic
mechanisms are known to have an important role in the secretion of these
types of adenohypophyseal hormones.
Results in the present study also support the possible involvement
of

monoamine

metabolism

in

the

available

behavioral

and

neurophysiological reports of toluene - induced bell-shaped concentration effect curves , i.e . , initially increasing rates and at higher level s
decreasing rates of response (Dyer et al.,

1984; Benignus, 1981b).

Alterations in the brain concentrations of neurotransmitters and their
metabolites have been correlated

with abnormal

behavioral and

physiological functions (Rogawski and Baker, 1985; Will is and Smith,
1985; Poirier and Bedard, !984) .
The mechanisms of these changes in concentrations of biogenic
amines and their metabolites are not yet known .

Changes in the amount s

of neurotransmitters in neurons may result from the destruction of
cellular elements in which transmitters reside, or from perturbation s
that profoundly alter neuronal

activity or metabolism .

Uptake of

toluene in the central nervous system is highest in the cerebrum, and is
rapidly eliminated from brain tissue in rats (Savolainen, 1978).
Subacute treatment of rats with toluene via inhalation was reported to
reduce affinities in striatal DA receptors (02 type) and cortical 5-HT
receptors at a high concentration (3 , 000 ppm) (Celani et al., 1983), and
the number of 5-HT binding sites in hippocampus and pons plus medulla
oblongata at a concentration of 7,000 ppm toluene (Yamawaki et al.
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1982) . A down regulation activity at the DA and 5-HT synapses , resulting
in a ma j or metabolic effort of the presynaptic monoamine nerve cell to
maintain normal monoamine rgic transmission , was suggested by the se
workers . In contrast, one st udy demonstrated that no neurostructural
changes in the rat brain were found following subchronic inhalation of
less than 1,500 ppm toluene (Lewis and Holdsworth, 1982). The absence of
neurostructural changes together with the reported increases in response
rates of neurobehavioural and electrophysiological effects following
exposure to low toluene

concentrations mentioned above suggest that

toluene -i nduced neurotoxicity may result from elevated concentrations of
significant neurotransmitters.
The toluene-induced increase in brain biogenic monoamine metabolism
may have an additive adverse effect via the hypothalamo-pituitary adrenal (HPA) axis. The role of HPA status after toluene treatment is
currently being investigated . It is important to note that significant
changes in concentrations of neurochemical s in several specific brain
regions occurred at the dose near the current U.S .
Protection Agency criterion level

(i.e .,

Environmental

14 . 3 mg/L) for toluene in

water . Further investigations to re -evaluate the safety limits of low level toluene exposure via drinking water seem warranted.
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CHAPTER VI
IMMUNOTOXICOLOGICAL EVALUATION OF SUBCHRONIC
TOLUENE EXPOSURE IN CD-1 MICE

INTRODUCTION
The initial

studies of this series of subclinical

effects of

groundwater contaminants focused on benzene (Chapter Ill, VI) .
another major aromatic

Toluene ,

hydrocarbon of environmental significance, is

produced in enormous quantities

and is widely used in a broad spectrum

of applications as a solvent, an important component in gasol i ne , and an
intermediate in the synthesis of a multitude of organic chemicals
(Fishbein, 1985).

It has been detected in finished water supplies in

concentrations up to 6.4 mg/L (Tardiff and Youngren, 1986) .

Potential

for exposure to to 1uene exists for both industria 1 workers and the
general public.
Toluene exposure is reported to produce a variety of pathologic
states in humans beings or experimental

animals,

including cardiac

se nsitization, kidney and liver damage, and various neurological
disorders (Benignus, 1981a,b; Hayden et al ., 1977). We demonstrated that
toluene ingestion causes perturbation of regional brain monoamine
met abo 1 isms in

the centra 1 nervous system of mice (Chapter V) . In

addition, toluene was found to be embryotoxic in rats, mice, and rabbits
(Courtney et al., 1986; Ungvary and Tatrai, 1985; Nawrot and Staples,
1979).

Alterations in lymphocyte fu nctions, protei n kinase C activity

and cl astogen i c effects a1so have been noted (Mohtashami pur et al.,
1987; Roghani et al., 1g87; Suleiman, 1987; Dean, 1985; Fishbein, 1985;
Schmid et al . , 1985).

Both in vivo and in vitro studies have indicated
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that toluene, via oxidation of the aromatic ring, is activated to give
reactive intermediates

that bind covalently to biomolecules (Pathiratne

et al., 1986b).
Despite the many toxicologic studies of toluene in experimental
animals,

only few published

studies have examined

its

immunotoxic

potential (Fishbein, 1985; U.S. Environmental Protection Agency, 1980b).
Recently, Aranyi et al. (1985) reported a significant suppression in
host defense mechanisms against microorganism infections in mice that
inhaled toluene at concentrations ranging from 2.5 to 500 ppm.
of its

Because

benzene-like structure and lipophilic nature, and its common

occurrence in groundwater,

a primary source of drinking water for

approximately half the population of the United States, it is important
to fully understand the immunotoxicity of toluene. Toxicity on the
immune system may be relevant to determine significance to human health
following chronic low-level exposure to toluene.
This study was designed to evaluate the general

toxicity,

hematological response, interleukin-2, and both humoral and cellmediated immunity in mice exposed to various concentrations of toluene
vi a ora 1 ingestion for 28 days.

The 1owest concentration of to 1uene

employed approached the EPA maximum permissible level (14.3 mg/L) for
drinking water (U.S. Environmental Protection Agency, 1986a).
MATERIALS AND METHODS
Animals
Six-week-old male CO-l mice were obtained

from Charles

River

Breeding Laboratory Inc. (Wilmington, MA) and quarantined 1 week prior
to being used. Mice were housed in groups of five per cage in a room
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maintained at a constant temperature (22 - 24°C) and humidity (40 - 60%)
with a 12-h light/dark cycle before and during the experiment .
Commercial rodent chow (Wayne Products, Chicago,

IL) and water were

available ad libitum.
Exposure Regimens
To 1uene ( chromatoqua 1i ty grade, 99.7 % purity Burdick and Jackson
Labs. Inc . , Muskegon, MI) was dissolved in normal
concentrations of 20, 100, and 500 mg/L.

tap water in

Toluene has a solubility of

535 mg/L in fresh water at 25°C (U.S. Environmental Protection Agency,
1980b) .

Exposures were conducted by administering the toluene solutions

to mice continuously for 28 days via drinking water; control animals
received tap water without toluene .
changed at least every 3 days .

Drinking water was prepared and
Food and water consumption were

monitored continuously, and animals were weighed once a week.
was

sampled

daily

to

confirm

toluene

The water

concentrations

by

gas

chromatography (U . S. Environmental Protection Agency, 1986b).
Gross Observations and Hematology
Body, spleen, thymus, liver and kidney weights of animals were
determined immediately upon sacrifice at the end of 28 days continuous
exposure .

Gross pathological examinations were performed on all mice .

Total erythrocytes and leukocytes of blood samples were counted with a
Coulter counter. Differential leukocyte counts were evaluated by
Wright ' s stained smears.

The single splenocyte suspensions were

prepared aseptically as described by Sharma and Gehring (1979).

Unless

stated otherwise, all splenocyte manipulations were performed in
complete RPM! tissue culture medium containing RPM! 1640 medium
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supp 1emented with 5% heat-inactivated feta 1 ca 1f serum, 100 units/mL
penicillin and 100

~g/mL

streptomycin.

Mitogen -Stimulated Lymphocyte Proliferation
Splenocyte lymphoproliferative
determined with optimal

responses

to mitogens

concentrations of the T-cell

phytohemagglutinin (PHA , 6.0

~g/mL;

were

mitogens

Wellcome Reagents Ltd. , Beckenham,

England), and concanavalin A (Con A, 2.5

~g/mL;

Sigma Chemical Co ., St.

Louis, MO), the B-cell mitogen E. coli 1ipopolysaccharide (LPS, 20
~g/mL ;
~g/mL;

Sigma), and the T- and B-cell mitogen pokeweed mitogen (PWM , 30
Gibco).

microtiter plates.

Cells were plated in 96-well

sterile flat-bottom
Triplicate cultures containing 5xi0 5 viable (i.e .,

trypan blue-excluding) cells per well

in 0.1 5 mL of medium with or

without mitogen were prepared for splenic cells from individual treated
or control mice .

Cultures were incubated at 37°C

humidified atmosphere with 4.0%

co 2

for 48 hr in a

and harvested after a 6-hr pulse

with tritiated thymidine (3H -TdR, 0. 5 ~Ci/well; New England Nuclear,
Boston, MA) on glass fiber filters using an automatic cell harvester .
Cell-incorporated radioactivity (dpm) was quantitated with a liquid
scintillation counter (Model

2660,

Packard

Instrument Co.,

Downers

Grove, IL), and compared against background incorporation with media
alone.
Mixed Lymphocyte Culture iMbhl Responses
The responses of MLC were assessed by measurement of the
lymphoproliferation of splenocytes (responders) from toluene-treated or
control CD-1 mice after co-culture with mitomycin C-treated YAC-1 mouse
lymphoma cells (stimulators), a mouse lymphoma cell line (H -2a) of A/Sn
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origin, at responder-stimulator ratios of 1:1, 2:1 , and 4:1.
The
5
complete RPM! culture medium was su pplemented with 5x1o - M 2merc aptoethanol (2-ME).

After a 72 -hr incubation, cells were pulsed

with 3H -TdR for 6 hr and harvested and counted for the cell -i ncorporated
radio 1abe 1 as described for the mitogenesis assays above. Spontaneous
3H-TdR incorporation was quantitated in cultures incubated without YAC-1
ce 11 s.
Antibody Plague-Form i ng Cell i£££1 Responses
In a separate experiment , each mouse from control and exposed
groups wa s sensitized by ip

injection with 0. 25 ml of a 20% wa shed SRBC

sus pen si on 4 days before the end of to 1uene exposure. Numbers of lgM
plaque - forming cells (PFC) were quantitated by the methods of Cunningham
and Szenberg (1968).

Results are expressed as PFC/106 splenocytes and

as PFC/ tota 1 splenic ce 11 s.

The titer of anti- SRBC anti body in t he

serum collected from mice used in the PFC assay was analyzed by a double
s andwich enzyme - linked immun osorbent ass ay (ELISA) as previously
reported (Chapter III).
Interleukin-2

~Assays

Jnterleukin -2 production was assayed by the methods de scr ibed
elsewhere (Gillis et al., 1978; Exon et al., 1983) with minor
modifications . Briefly, aliquots of splenic lymphocytes

(5 X 105)

obtained from chemical-treated or control animals were cultured in RPM!
media with 10% FCS, 5x1o-5 M2-ME, and antibiotics with or without Con A
at the concentration of 2.5 ug/ml, to stimulate IL-2 production.

At 48

hr, the culture supernatants were collected by removing the cells with
centrifugation. Supernatants were assayed for

IL-2 content by the
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ability to enhance proliferation of an IL-2-dependent murine T-helper
cell line (HT-2) of BALB/c origin, originally established by J . Watson
(1979) . The growth of HT-2 cells was maintained in the supernatants of
Con A-stimulated rat splenic lymphocyte cultures. Serial two-fold
dilution of IL-2-containing supernatant samples (100 ~L) and 4X!0 3 HT-2
cells (50

~L)

were placed into triplicate wells of a 96 -well microtiter

plate.

Cultures were incubated at 37°C in a humidified atmosphere with
4.0% co 2 for 24 hr and harvested after a 4-hr pulse with 0.4 ~ci of 3HTdR per well. The cells were harvested onto glass fiber filters and the
amount of 3H-TdR incorporation (dpm) was determined by sci nt illation
counting.

A supernatant of Con A-stimulated rat splenic lymphocyte

culture was used as positive control.

Non -Con A-stimulated supernatants

from CO-l mouse splenic lymphocyte cultures were tested as negative
control to assess background induction of IL-2.
Statistical Analysis
All data were expressed as the means and their standard errors .
Statistical evaluation was carried out by a one-way analysis of variance
(ANOVA) and Fisher's least mean significant differences (LSD) test. A
level of p<O.OS was considered statistically significant.
RESULTS
Concentrations of toluene in the drinking water mixtures as
determined by gas chromatography decreased approximately 25-35% over a
3-day period,

when water was changed.

The actual

concentrations

(overall mean of the daily analysis) for the nominal concentrations of
0, 20, 100, and 500 mg/L were 0, 17 (± 16%), 80 (±12%), and 405 (±14%)
mg/L, respectively.

Based on toluene concentration in water during the
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exposure and the estimated water intake , doses of toluene were 0, 5, 22,
105 mgj kg/ body weight/day .
Animals exposed to toluene at the doses used did not produce
mortal i ty or exhibit overt clinical symptoms of toxicity over a 4-week
period. Overall, no significant change in food and water con sumption
between treatment and control groups was observed during the study . No
gross lesions were found at the time of sacrifice , on any of the organs
of mice in all treatment groups .
The selected organ and body we ight data for toluene -dosed mi ce are
presented in Table VI-I.

No differences were observed between group and

those of the control group . Liver weights were s ignificantly i ncrea sed ,
wh i 1e the weight of a thymus
toluene (i.e . , 105 mg/kg/day) .

was decreased, at the highest dose of
No changes were found in spleen or

kidney weights.
Table VI-2 shows the effects of toluene on spleen cellularity ,
erythrocyte and leukocyte counts and absolute differentials . Total
splenocytes did not show a significant decrea se in any treatment groups .
No

significant differences

were

observed

in

any of selected

hematological parameters, although a nonsignificant decrease i n total
circulating leukocyte counts and lymphocyte and neutrophil population s
was noted in mice receiving toluene at the 105 mg/kg/day dose.
The splenocyte lymphoproliferative response data for optimal
st imul at i ng concentrations of the T- and B-ee ll mitogen PWM, T-cell
mitogens Con A and PHA, the B-cell mitogen LPS are shown in Fig. VI-I.
Significant reductions in 3H-TdR uptake were found for spleen cells
cultured in the absence of mitogen or in the presence of PWM from the 5,
22 , and 105 mg/kg/day dosage groups .

Lymphocyte responsiveness to Con A

TABLE VI-1
ORGAN AND BODY WEIGHT OF MICE FOLLOWING 4 WEEKS OF TOLUENE EXPOSURE

Dose a
(mg/ kg/ day)

Body weight {g)b

Organ weight {g/100 g body weight)b

Day 0

Day 28

Spleen

Liver

20.62 ± 0. 13

34 .86 ± 1.18

0. 34 ± 0.03

5.67 ± 0.07

1.62 ± 0.05 0. 19 ± 0.0 2

20.56 ± 0.02

34 . 26 ± 0.64

0.31 ± 0.01

6.09 ± 0. 17

1. 72 ± 0.06 0.18 ± 0.01

22

20.16 ± 0.31

33 . 18 ± 0. 21

0.33 ± 0.01

6. 32 ± 0. 17

1.68 ± 0.03

105

20 .00 ± 0.23

35 . 12 ± 0.72

0. 28 ± 0.01

6. 73 ± 0.14*

1.68 ± 0.05 0.13 ± 0.02*

0

Kidney

Thymus

0.18 ± 0.02

a Toluene was administered continuously via drink i ng water for 4 weeks
b Value s are given as mean± SE (n=5)

* Signifi cantly different from control values at p<0.05

0
0

TABLE VI-2
EFFECTS OF FOUR WEEKS OF TOLUENE EXPOSURE ON SPLEEN CELLULARITY AND
SELECTED BLOOD PARAMETERS
Total
Dose a
splenoc7tec ErythGocy~ec Leuk~cyt~{
(10 /mm )
(10 /nm )
(mg/kg/day) (X W )

Leukocyte absolute differentialsc
Lym~hoc~te

(10 /mm )

~utrfphil

O~herb
(10 ;mm3)

(10 /mm )

7.71±0 . 27c 9.30 ± 0.26

5.96 ± 1.02

4.40 ± 0.62

1.13 ± 0.38

0. 41 ± 0.08

6.18 ± 0.52

9.87 ± 0.49

6.34 ± 0.57

4. 46 ± 0.38

1.46 ± 0. 39

0.42 ± 0.09

22

6.57 ± 0.91

8.79 ± 0.85

6.43 ± 0.57

4.50 ± 0. 78

1.42 ± 0. 48

0.50 ± 0.07

105

6.58 ± 0.47

9.38 ± 0.38

3.90 ± 0.36

2.81 ± 0.82

0.82 ± 0. 16

0. 36 ± 0.05

0

a Toluene was administered continuously via drinking water for four weeks
b Including monocyte, eosinophil and basophil
c Value s are given as mean ± SE (n=5)
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Fig. VI-1 . Effect of toluene exposure on splenocyte lymphoproliferative
responses to LPS, PWM , Con A, and PHA mitogens.
Toluene was
administered continuously to mice via drinking water for 4 weeks,
control mice received tap water without toluene. The bars (left to
right), 0 , • · IZ!, and !RBI . indicate toluene at 0 (control), 5,
22, and 105 mg/kg/day concentrations, respectively. ~ta·rs (*) denote
significantly different from control (p<O . OS) . Values represent mean±
SE of 5 animals per group.
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and PHA was suppressed significantly for mice exposed to toluene at the
two highest doses . Splenocytes from toluene -treated mice also exhibited
a decreased response to LPS at the 105 mg/kg/day dose.
Figure VI-2 illustrates the effect of toluene exposure on the mixed
lymphocyte cultures. The ability of splenic lymphocytes to proliferate
in response to a11 aanti gens (YAC-1 1ymphocyt i c ce 11 s) was unchanged by
exposure to toluene at the two low dosages, but a significant difference
was seen in the highest dosed group .
The results of primary antibody response (T-cell dependent) to SRBC
are presented in Table Vl-3. A significant reduction in PFC/10 6
splenocytes or PFC/total spleen was seen in animals that received
toluene at 105 mg/kg/day.
recovered splenocytes or

o(

However, changes in the total number of
-SRBC antibody as determined by ELISA were

not significant in any toluene-treated group.
Splenocytes taken from mice treated with 105 mg/kg/day toluene
produced significantly less IL-2 after induction by Con A in culture
(Table Vl -4) . The IL-2 activity was reduced to less than half in the
highest treatment group, compared with controls . There was no change in
IL-2 synthesis from spleen cells of mice exposed in the two low dosage
groups.
DISCUSSION
Results of evaluations of the hematotoxic potential of toluene
ingestion via drinking water for 4 weeks revealed that the chemical was
nontoxic.

There is general agreement that toluene does not have the

hematotoxi c properties of benzene ( Fishbein, 1985; U.S . En vi ronmenta 1
Protection Agency, 1980b).

Wolf et al. (1956) conducted a long-term
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STIMULATORS

Fig . VI-2.
Effect of toluene exposure via drinking water on mixed
lymphocyte culture (~C) responses . See legend of Fig. VI - I for detail s.
Responders indicate H-thymidine incorporat i on in splenic cells alone ,
whereas responders and stimulates indicate the 3 H- thymid i ne
incorporation when the splenocytes was cocultured in the presence of
mitomycin C- treated YAC-1 cells. Several stimulator: re sponder ratio s
were used , but data are pre sented only from the 1:2 ratio , whic h ga ve
optimal stimulat i on. Mean± SE of 5 an imals per qroup, each cultured in
triplicate . Stars (*) denote significantly different from contr ol
(p<O. OS).

TABLE VI-3
EFFECTS OF 4 WEEKS OF TOLUENE EXPOSURE ON ANTIBODY PLAQUE
FORMING CELLS (PFC) AND ANTIBODY TITER (oc-SRBC)a
Doseb
(mg/kg/day)

Total
splenocy7es
(x 10- )

PFC/10 6
splenocytes

PFC/spleen

o(.-SRBC

0

20.16 ± 2.75

1,184 ± 90

238,545 ± 37,429

0.44 ± 0.04

5

16.68 ± 1.19

985 ± 105

166,015 ± 30,231

0.55 ± 0.06

22

21. 7B ± 3.05

973 ± 116

217,891 ± 47,845

0.43 ± 0.05

105

13.66±1.79

631 ± 27*

a Mice were

89,936 ± 13,269*

0.32 ± 0. 03

sensitized with thymic-dependent antigen sheep erythrocyte (SRBC)

four days before the end of toluene exposure.

Splenocytes were analyzed for

antibody plaque forming cell and sera were detected for antibody titer (ocSRBC). Values are given as mean± S.D. (n=5)
b Toluene wa s administered continuously via drinking water for four weeks
* Significantly different from control values at p<O.OS

C)
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TABLE VI-4
EFFECTS OF TOLUENE EXPOSURE ON INTERLEUKIN-2 SYNTHESIS BY
CON A-STIMULATED MOUSE T-LYMPHOCYTEa
Dose
(mg/kg/day)

3H-Thymidin3 uptake
(DPM X W }

Stimulation indexb

0

12.95 ± 1.9B

15.70 ± 2.39

5

11.13 ± 2.57

13.49 ± 3.11

22

10 021 ± 1.38

12 038 ± 1.68

105

50 93 ± I. 26 *

7. 18 ± 1.53*

Positive controlc

14 . 58 ± 0.23

17.66 ± 0.27

Negative controld

1.34±0 . 76

1.62 ± 0.68

a Several serial dilutions of IL-2 sources (supernatants of
3plenocyte culture) which showed a decreasing incorporation of
H-thymidine to IL-2 dependent murine T-helper cell clone, HT -2
cell , were used. Only data obtained from a 1:2 diluted ratio
were presented. Values are given as mean ± SE (n=5)
b Stimulation index (S . I.} = dpm (culture with dilution of
supernatant}/dpm (culture with media alone)
c Rat spleen conditioned medium (supernatant of Con A-stimulated
rat splenocyte culture)
d Supernatant of non-Con A-s timulated splenocyte cultures of
untreated mice

* Significantly different from the untreated control at p<0. 05
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toxicity study in which toluene was given orally to rats, and indicated
no adverse effects on the cell counts of circulating blood and bone
marrow.

In a study of toluene-benzene interaction in mice, Andrews et
al . (1977) noted that toluene had no effect on incorporation of 59 Fe
into developing erythrocytes.
Consistent alterations in the immune parameters examined were

generally found only in mice receiving the highest dose of toluene (105
mg/ kg/day) .

The observed effects of suppressed humoral and cellular

immunity, and decreased JL-2 synthesis at this dosage were accompanied
by a decrease in thymus weight.

Thymus involution is consistent with

the impairment of T-cell function.

The suppressed proliferation

responses of lymphocytes from exposed mice to specific mitogen signa 1
was found at the lower toluene doses, but proliferation of lymphocytes
were not suppressed in response to allogeneic stimulation, and in vivo
T-dependent antibody production response was not suppressed . Other
studies have demonstrated only marginal correlation between lymphocyte
response to mitogens and alterations in host resistance or any other
immunologic function

assay

(Dean,

et al.,

1985b) . The ability of

lymphocytes to recognize and respond to foreign

histocompatibility

antigens (versus mitogens) represents a critical juncture in the
generation of an appropriate immune response . After exposure to toluene
vapor at concentrations as low as 2. 5 ppm, mice exhibited increased
susceptibility to respiratory infection with Streptococcus zooepidemicus
and decreased pulmonary bactericidal activity to Klebise71a pneumoniae
(Aranyi et al., 1985). Several reports have appeared in the literature
which 1 ink exposure of toluene to altered immunocompetence in animals
and humans (U.S. National Toxicology Program, 1987; U.S . Environmental
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Protection Agency , 1980b) .
Treatment of mice with
s i gnificantly

reduced

toluene

at

IL - 2 synthesis .

the

highest

Inhibition

dose

level

this

basic

of

immunoregulatory lymphokine may be a basic mechanism by which toluene
mediates

immunotoxic effects via oral

helper T-cell

following

allogeneic cells,

ingestion.

stimulation with

IL-2,

produced

by

either T-cell

mitogens

or

is known to augment numerous

immune responses

including proliferation and generation of cytotoxic T-cells and residual
helper-T cells ,

and to enhance

the

antibody-forming

cell

responses

(Farrar et al. , 1982; 1986; Gillis et al., 1978).
Toluene caused immunotoxicity at the 105 mg/ kg/day dose and may
al s o be linked to the induction of corticosteroid release as a result of
s timulating effects on the hypothalamic - pituitary-adrenocortical

(HPA)

ax is . This exposure regimen has been demonstrated to activate mouse HPA
status, resulting in increased concentrations of the hypothalamic
norepinephrine and its major metabolite, vanillymandelic acid, which in
turn leads to increased secretions of adrenocorticotropic hormone (ACTH)
and corticosterone from pituitary gland and adrenal gland, respect i vely
(Chapter VII). Corticosteroids , the end products of HPA axis, are known
to impair various aspects of immunocompetence and to inhibit IL - 2 as
well as IL-l synthesis (Goodwin et al., 1986; Cupps et al., 1985; Snyder
and Unanue,

1982; Gill is et al.,

1979a,b).

Increased corticosteroid

concentrations can control the clonal expansion (driven by IL - 2) of the
committed cells of the immune system (Besedovsky et al. , 1985) .

The

helper T-cell is believed to be the most susceptible lymphocyte subset
(Esterl ing and Rabin, 1987; Verbruggen et al.,
decrease

of

helper T-/suppressor T-cell

1987).

ratio

Consequently,

could

result

in
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immunosuppression.
Benzene-induced toxicity has been attributed to various reactive
intermediates (Irons, 1985).

Similarly,

it has been indicated that

formation of cresol from aromatic oxidation of toluene occurs through an
arene oxide intermediate which, in turn, is a reactive metabolite and is
responsible for the binding of toluene to biomacromolecules (Pathiratne
et al ., 1986a; Bakke and Schel ine, 1970) .
formed during the formation

Superoxide anions are also

of secondary metabolites,

such as

semiquinones and quinones, from the oxidation of cresol (Pathiratne et
al., 1986a), suggesting that covalent binding of toluene to biological
macromolecules involves more than one reactive metabolite.
covalent

binding

effects

of toluene to

However, the

biomacromolecules

were

considerably less than those of benzene, which could account for the
differences in degree of immunotoxicity of toluene and benzene
(Chapter I I I).

Further studies are needed to determine the precise

biological site of action of toluene.
induce the activities of microsomal

Toluene treatment was found to
monoxygenenase,

increasing

the

concentration of cytochrome p-450 in the 1 iver and some non-hepatic
tissues (Pathiratne et al ., 198Gb; Pyykko, 1980; 1983).

Increase of

1 iver weights in the highest dosed group of our study may support the
validity of these findings.
For the protection of human health from the toxic properties of
toluene ingested through water,

the current U.S.

Environmental

Protection Agency ( 1986a) criterion 1eve 1 for to 1uene in water is 14.3
mg/L. This permissible concentration is extrapolated from a general
toxicity evaluation of an oral dose study in rats (Wolf et al. , 1956),
which at the time was thought to be well

below any toxicity-based
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criterion .

Although at the doses

used in this study, toluene di d not

elicit any general toxicity and hematotoxicity , the effects of toluene
on immune function should be examined in more detail and in different
animal

species to more accurately assess the potential hazard to human

health of chronic low-level exposure to toluene in drinking water .
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CHAPTER VII
CHANGES IN HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL AXIS
ACTIVITY AND IMMUNE FUNCTION DURING CONTINUOUS
ORAL INGESTION OF BENZENE AND TOLUENE IN MICE

INTRODUCTION
The hypothalamic-pituitary adrenocortical (HPA) axis is a highly
sensitive index of enviromental changes and may be augmented by a broad
range of stimuli such as chemical pollultants, infections, and many
other various "stressors".

It is critically involved in the regulation

of behavioral and physiological adaptations by releasing biogenic amines
from the hypothalamus, adrenocorticotropic hormone (ACTH) from anterior
pituitary, and corticosteroids from adrenal cortex {Axelrod and Reisine,
1984; Dunn and Kramarcy, 1984). Changes in HPA activity are known to
result in marked modulation of immune functions (Lumpkin , 1987 ;
Besedovsky et al . , 1985; Ader , 1981).
Many organic solvents have been associated with a number of
neurophysiological and psychological

disturbances (Baker et al . , 1985 ;

Grasso et al . , 1984; Savo l a i nen, 1977) .
solvents
1985) .

Benzene and toluene, universal

are considered as important health hazards (Fishbein, 1984;
Previous studies have indicated that both chemicals have a

pronounced effect on metabolisms of brain neurotransmitters in rats via
inhalation exposure or the injection route {Arito et al. , 1985;
Paradowski et al., 1985; Rea et al., 1984 ; Andersson et al., 1980;
1983).

Recently we found that prolonged oral

ingestion of either

benzene or toluene significantly altered both biosyntheses and
catabolisms of regional brain biogenic amines in mice (Chapter IV, V) .
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It was therefore desirable to ascertain whether exposure to these
chemicals affected the secretion of pituitary-adrenocortical (PA)
hormones .

The specific roles of the brain monoaminergic neural system

in mediating PA hormone releases have received much attention over the
years but still remain

ill-defined (Axelrod and Reisine, 1984; Dunn and

Kramarcy, 1984; Ganong, 1980).
The purpose of this study was to investigate the changes in
hypothalamic catecholamine metabolisms and correlate them with plasma
ACTH and serum corticosterone levels in CD-1 mice during continuous oral
administration of benzene or toluene via drinking water . Since it has
been recognized, corticosteroids, the end products of HPA ax is, have
powerful effects on immune function (Besedovsky et al ., 1985; Cupps et
al ., 1985), we also examined if benzene or toluene altered the synt hetic
abilities of lymphocyte-derived interleukin-2 (IL-2) to evaluate the
hypothesis that chemicals may have an additional

adverse effect on

immune system via HPA status. IL-2 is a soluble glycoprotein that causes
lymphocyte proliferation when it binds to cells via a specific membrane
receptor, various immunoenhancing activities have been ascribed to this
cytokine (Farrar et al., 1982; 1986). Corticosteroids has been reported
to inhibit IL-2 production (Goodwin et al .,

1986; Gill is et al.,

1979a,b).
MATERIALS AND METHODS
Animals
Adult male CD-1 mice were obtained from Charles River Breeding
Laboratory Inc . (Wilmington, MA) and quarantined upon arrival for one
week prior to use.

Animals were housed in groups of 5 per cage in a
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room at a constant temperature (22-24°C) and with a 12 hour light cycle
before and during the experiment.

Commercial

rodent chow (Wayne

Products, Chicago, IL) and water were available ad libitum .
Treatments
Analytical reagent grade benzene (99.9% purity, J.T. Baker Chemical
Co., Phillipsburg, NJ) and a chromatoquality grade of toluene(99 . 7%
purity, Burdick and Jackson Labs . Inc . , Muskegon, MI) were dissolved in
normal tap water to make the desired concentrations of 40, 200 and 1000
mg/L for benzene and 20, 100 and 500 mg/ L for toluene, respectively .
The so 1ubi 1i ty of benzene in fresh water at 25°C is 1780 mg/ L (U .S.
Environmental Protection Agency, 1980a), while toluene has a solubility
535 mg/ L (U.S. Environmental Protection Agency, 1980b) . Exposures were
conducted by free-choice administration of chemical-treated solutions to
mice for 28 days via drinking water ; control animals received tap water .
Food and water consumption was monitored continuously , and an i mal s were
we i ghed once each week .

Actual benzene and toluene concentrations i n

the drinking water of mice were confirmed by gas chromatography (U . S.
Environmental Protection Agency, 1986b) .
Twenty -eight days after exposure to benzene or toluene, mice were
killed by decapitation.

The brains were removed quickly, and the

hypothalamic regions were dissected out by the procedures of Glowinski
and Iversen (1966).

The brain tissue was promptly weighed in a tared

vial containing 0.3 ml of ice-cold 0.05 M perchloric acid with 0.1%
cysteine and frozen at -80°C until analyzed.

Trunk blood was collected

into chilled EDTA tubes, and plasma samples for ACTH assay were
separated by centrifugation (within one hour) at 1500 x g for 20 min at
4°C . Serum samples for measuring corticosterone 1eve 1s were co 11 ected
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once before and at 2, 7,
venepuncture .

14, and 28 days after exposure via

Spleens were removed aseptically and the single -

splenocyte suspensions were prepared for interleukin-2 assay (des cribed
1ater) .
Neurochemical Assays
Concentrations of hypotha 1ami c NE and its metabo 1ite, VMA, were
assayed by high performance liquid chromatography

(HPLC)

with

electrochemical detection using the methods described elsewhere (Mayer
and Shoup, 1983; Sharma et al., 1986).

The homogenized brain tissues

were centrifuged (10,000 x g, 30 min) and the supernatants were filtered
through regenerated cellulose filter of

0.2~m

pore size (Bio -Analytical

System, Inc., West Lafayette, IN) prior to chromatography.

The amounts

of NE and VMA were determined by measuring the height of the individual
peaks and comparing them with the peak of various standards (Sigma
Chemical Co . , St. Louis, MO) .

The detector response provided a 1inear

correlation coefficient of >0.98 for the standard curve .

The HPLC

system consisted of a model LC - 150 electrochemical analyzer, Model LC -3A
amphoteric detector, Model LC-22A temperature controller, and a Biophase
ODS -reversed phase column

(Bio -Analytic System,

Inc.) .

A 0.15 M

monoch 1oro acetate buffer (pH 3. 0) containing sod i urn octyl sulfate as
ion-pair reagent served as mobile phase (Mayer and Shoup, 1983) .

The

instrument settings were: flow rate 1. 4 mL/min, column temperature 30°C,
detector potential +0.7V, and controller IOnA full scale.
Radioimmunoassays
Materials from commercial

radioimmunoassay kits were used for

determination of p1asma ACTH and serum corticosterone concentrations
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(Radioassay Systems laboratories, Inc . , Carson, CA).

The kit offers a

highly sensitive method of measuring ACTH and corticosterone by
monitoring the

competitive binding of radioisotope-labeled

hormones

( 125 I -ACTH and 3H -cort i costerone) and non -1 abe 1ed hormones (standards)
with their corresponding specific antibodies .

Separation of antibody -

bound 1abe 1ed antigen (hormone) from the unbound 1abe 1ed antigen was
achieved by precipitation.

The radioactivities of precipitates were

than counted and amounts of ACTH (pg/ ml) and corticosterone (ng/ ml) were
measured from the respective standard curves.
Interleukin-2

~

Ass ays

Splenic lymphocytes for Il -2 as says were prepared from chemical treated or control animals according to the procedures of Sharma and
Gehring (1979) and suspended in RPMII640 media (Gibco Laboratorie s,
Grand Island, NY) supplemented with 10% heat-inactivated fetal
seru m (Hylone Sterile Systems,

calf

UT) , 5 X I0 - 5 M 2-

Inc, Logan,

mercaptoeth anol , and 100 units penicillin and 100 .ug streptomycin per
mL.

Interleukin-2 production was assayed by the methods described

elsewhere (Gi 11 i s et al.,

1978; Exon et al. , 1983) with our minor

modifications as described in the methods section of Chapter VI .
Statistical Analyses
A11 data are expressed as means±SE. Statist i ca 1 determinations of
the neurochemical , ACTH,

and

Il - 2 data were

performed by one -way

analysis of variance (ANOVA) and follow-up Fisher 's least significant
differences (LSD) test were used to analyze the data for differences
be t ween chemical-treated and control animals .

A fixed-effect, two way

ANOVA was used for analyzing corticosterone data to evaluate the effects
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of benzene or toluene concentrations and exposure time. Differences were
considered significant at p<O.OS .
RESULTS
The average concentrations of benzene or to 1uene in the drinking
water mixtures as determined by gas chromatography are indicated in
Table VII -1. There was an approximate 30% loss of both solvents over a
3-day period, when water was changed.

Based on daily analysis the

overall means of observed concentrations were 78 (±12)%, 83 (±9)%, and
79 (±6)% of the 40 , 200, and 1000 mg/L benzene nominal concentrations,
respectively.

Likewise, actua 1 to 1uene concentrations in the drinking

water were 83 (±14)%, 80 (±10)%, and 81 (±11)% of the 20, 100, and 500
mg/L intended 1eve 1s.

The observed concentration va 1ues are used to

designate low, medium and high group dosing.
General Toxicity Evaluation
At the doses used both benzene and toluene did not elicit mortality
or any other overt clinical symptoms of toxicity in mice.

Comparison of

the body weight gains of each treated group with those of the control
groups did not suggest any consistent differences through the treatment
period.

There were also no significant changes between treatment and

control groups in food and water consumptions.
Neurochemical
The effects of benzene or toluene

exposure on the concentrations

of hypothalamic NE and its major metabolite, VMA, are presented in Table
Vll-1.

Both solvents produced marked increases

concentrations.

in hypothalamic NE

There was a dose -related response for increased NE and
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TABLE VII - I
CONCENTRATIONS OF NOREPINEPHRINE (NE) AND ITS METABOLITE
VANILLYMANDELIC ACID (VMA) IN THE HYPOTHALAMUS OF MICE
EXPOSED TO BENZENE OR TOLUENEa

Concentration in water,
Chemical

Benzene

Toluene

mg/L

Neurochemical

concentrationb

Nominal

Observed

NE

VMA

0

0

1.632 ± 0.422

0. 260 ± 0.016

40

31

2. 284 ± 0.247

0.304 ± 0.037

200

166

2. 571 ± 0. 281 *

0.367 ± 0.054

1000

790

2.637 ± 0.123 *

0.395 ± 0.033

0

0

1.307 ± 0.067

0.238 ± 0.018

20

17

1.981 ± 0. 034 *

0.422 ± 0.015

100

80

2. 125 ± 0.1 67 *

0. 393 ± 0. 046

500

405

1.762 ± 0.136*

0.596 ± 0. 210

a Chemical was administered

continuously to mice via drinking

water for 4 weeks
b In~g neurochemical/g wet tissue, Mean± SE (n=5)

* Significantly different from untreated control at p<0 . 05
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VMA with increasing levels of benzene.

Significant benzene - induced

increases of NE were found in the 166 and 790 mg/L dose groups.

The

mean concentrations of VMA were correspondingly increased by 42 and 52%
in these two treatment groups,
statistically significant .

although the findings were not

Toluene produced significant elevations of

NE at all dose levels but increases were maximal at the medium dose (80
mg/L). The three toluene doses also caused apparent accumulations of VMA
with

66-150% increases .

Plasma ACTH
Figure VII-I shows the effects of benzene or toluene exposure on
plasma concentrations of ACTH.

The results suggest that increase in

ACTH secretion was correlated with activation in hypothalamic NE
metabolisms.

Mice exposed to benzene rose ACTH by I. 6, I. 8, and 2. 5-

fold in the 31, 166, and 790 mg/L dose groups, respectively. Toluene
also caused dose-related elevation of this hormone by 2.1, 2. 6, and 3.8fold at the three dose levels.

Significant differences from untreated

control values were found in the high dose groups of both chemical
treatments.
Serum Corticosterone
The corticosterone response to benzene or toluene was assessed once
before and at 2, 7, 14, and 28 days after exposure.

Comparisons of

solvent-exposure

revealed

mice

with

same-time

controls

the

corticosterone levels were significantly higher in mice exposed to the
790 mg/L dose at 7 and 28 days and the 166 mg/L dose at the 7th day
(Fig. VII-2).

The marked increases

(1.8 fold) of corticosterone at day

7 in the 31 mg/L dose exposure were not significant due to the large
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Toluene

Fig. Vll-1. Effect of 4-- weeks benzene and toluene exposures via
drinking water on concentrations of plasma ACTH in mice
( 1ZJ ,
r®l3!l ,
control ; ~ , 31 mg/L for benzene and 17 mg/L for toluene;
166 mg/L for benzene and 80 mg/L for toluene;
• , 790 mg/L for
benzene and 405 mg/L for toluene).
Stars (*) denote a significant
effect (p<O.OS) relative to control. Values represent mean± SE (n=S) .
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Fig . VIJ-2 . Serum corticosterone concentrations in control and benzene exposed mice (
0 , control;
e , 31 mg/L ;
• , 166 mg/ L; • ,
790 mg/L). Values represent mean ± SE ( n ~ 5) . Stars (*) denote values
significantly different from same-time control values at p<0.05.
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variation.

Toluene elevated corticosterone levels at 14 and 28 days at

the highest dose (405 mg/L) only (Fig . V1I-3).

Two-way analysis of

variance showed a significant interactive effect of benzene or toluene
on plasma corticosterone over the exposure time (Table VII-2).

During a

period of 28-day benzene exposure, corticosterone increased and reached
maximal response at the 7th day, then declined to or below control l eve l
at the 14th day. However, re-elevated corticosterone concentrations were
detected in the 790 mg/L dose group at the termination of exposure. The
e1eva ted corticosterone caused by the 405 mg/L dose toluene did not
return to normal levels during the 28-day exposure.
IL -2 Synthesis
The effects of benzene or toluene ingestion on I L-2 synthesis are
illustrated in Table VII -3.

Splenocytes obtained from mice exposed to

benzene at various concentrations for four weeks and stimulated with Con
A in vitro

elicited a biphasic dose -r elated response in IL-2

productions

as determined by the proliferation of HT -2 ce 11 s. Mice

receiving 166 or 790 mg/L benzene manifested a significant suppression
of 3H -TdR incorporation into DNA of HT -2 ce 11 s.

Splenic ce 11 s taken

from mice treated with toluene produced a lesser change in IL-2
synthesis; a sig nificant depression was detected in the highest toluenedosed group (405 mg/L) only .
DISCUSSION
Oral administration of various dosages of benzene or toluene via
drinking water to CO-l mice for four weeks markedly stimulated the HPA
activity .

Hypothalamic NE activity was highly elevated by both organic

solvents,

indicated by the increased concentrations of NE,

and a
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Fig . VII -3. Serum c!'rtico st erone conce ntration s in co ntrol ar.d to lu eneexposed mice (
0 , control;
e , 17 mg/l; • _ , 80 mg/l; • ,
405 mg/l) . Values represent mean ± SE (n • 5) . Stars (*) denote value s
significantly different from same time control values at p<0.05 .
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TABLE VII -2
RESULTS OF A FIXED -EFFECT, TWO-WAY ANALYSIS OF VARIANCE
FOR SERUM CORTICOSTERONE DATA
Chemical

Source of
variance

DF

Main effects

Benzene

F ratio

35637.83

7.83*

dose

3

13957 62

3.09 *

time

4

51897 . 99

I I. 40 *

Interaction

12

8643.25

1.90*

Residual

80

4551.74

Total

99

7245 . 69

0

dose

3

43529.58

3.78 *
6. 06 *

time

4

14913 . 07

2.08

Interaction

12

19386.72

2. 70 *

Residual

80

7179.18

Total

99

10072.89

27177.28

Main effects

Toluene

MS

DF : degrees of freedom; MS: mean squares (variability)
* p<0.05
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TABLE Vll -3
EFFECTS OF BENZENE AND TOLUENE ON IL -2 PRODUCTION BY CON ASTIMULATED MOUSE T- LYMPHOCYTEa

Chemica 1

Benzene

Toluene

Solvent
Concentration
(mg/L)

3H -Thymidine uptake
(DPM X 10- 3)

0

16.63 ± 0.62

31

20.78 ± 1.36

166

9.40 ± 1.25 *

790

4.92 ± 0.79*

0

17.07 ± 1.38

17

14 . 07 ± 1.73

80

13 . 75 ± 0.86

405

10 .30 ± 1.32*

Positive controlb

18 . 92 ± 0.59

Negative controlc

1.80 ± 0. 47

a Several dilutions including
sources

(Con A-stimulated

decreasing incorporation of
murine T-helper

1:1, 1:2, 1:4, and 1:8 of IL -2
supernatants)

which

s howed

3H -thymidine to IL-2 dependent

cell clone, HT -2 cell, were used. Only data

obtained from a 1:1 diluted ratio were presented.

Values are

given as mean ± SE (n=S)
b Rat spleen conditioned medium (Con A-stimulated supernatant)
c Non -Con A- stimulated CD-I mouse lymphocyte cultural supernatant

* Significantly different from untreated control at p<O.OS

a
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parallel trend in its major metabolite, VMA, in this brain region.

At

the same time these were accompanied by increased ACTH/cort i costerone
releases

into blood.

Increases

in

NE

concentration,

metabolism or

turnover have been reported in the hypotha 1amus of rats exposed to
toluene (Arito et al., 1985; Andersson et al ., 1980; 1983) or in whole brain homogenates of rats exposed to benzene (Paradowski et al., 1985).
Significant elevations of serum corticosterone were also found in rats
following toluene exposure via inhalation (Andersson et al., 1980).
The present study provides evidence that organic so 1vent-induced
ACTH/corticosterone releases from PA axis is stimulated by the
hypothalamic noradrenergic neuronal pathway.

The specific role of NE in

the release of PA hormones has remained controversial,
reports
suggest

involving direct measurement
a

stimulatory

effect

of NE

of

NE

but several

turnover or metaboli sm
neuronal

activity

on

ACTH/corticosterone productions (Smythe et al., 1983; 1987; Johnston et
al., 1985; Hary et al., 1984; Hedge et al., 1976). These workers also
reported a highly significant correlation between NE neuronal activity
and p1asma ACTH/cort i costerone 1eve 1s after chemica 1 exposures . It was
assumed,

therefore,

hypothalamic

that AP hormone effects were mediated

noradrenergic facilitation of corticotropin

via

releasing

factor (CRF), which then acts on the pituitary gland to release ACTH
(Smythe et al ., 1987 ; Vale et al., 1981).

Lesions of the hypothalamus

were shown to block both changes in CRF content in median eminence and
plasma ACTH after a variety of stimuli

(Dallman et al.,

1987).

Corticotrophin releasing factor was thought to be the major but not the
so 1e means of re 1easing ACTH/cort i costerone from PA axis (Axe 1rod and
Reisine, 1984). It has been previously shown

that AP hormone responses
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to chemical - induced

stress were

inhibited

significantly by clonidine

( o<.radrenoreceptor agonist) and increased by yohimbine ( o<r
adrenoreceptor blocker) (Smythe et al . , 1983; 1987), both chemicals have
The o< 1 and j3 2-

greater presynaptic than postsynaptic activity.

adrenergic agonists have also been reported to stimulate ACTH releases
in vivo

by

acting on

Reisine, 1984). The

the

blockade

hypothalamic-pituita]
of postsynaptic

axis

(Axelrod

and

adrenergic receptors was

able to significantly blunt the ACTH release induced by chemical stress
(Hary

et

al.,

1984).

In

reviewing

the

roles

of

monoamine

neurotransmitters in pituitary ACTH re 1ease Ganong (1980) interpreted,
however, that NE concentrations were inhibitory to ACTH secretion. It is
noteworthy

that

his

postulation

was

mainly

based

on

either

neuropharmacological manipulation of brain NE levels or the uses of NE
agonist or antagonist drugs .

The measurement of steady- state

transmitter concentrations alone is of 1 imited value regarding the NE
neuronal activity and the relationship between NE and ACTH secretion
(Commissiong, 1985; Hedge et al., 1976).
Corticosterone secreted by adrenal

cortex is dependent on

stimulation of the hypothalamic-pituitary axis.
the

increased

NE

activity

is

due

to

a

The possibility that
positive

feedback

of

corticosterone has been excluded by the demonstrations that I)
exogenously administered corticosterone to unstressed rats had no effect
on hypothalamic NE status nor on ACTH release, and 2) corticosteronedeficient (adrenalectomized) rats exhibited enhanced hypothalamic
noradrenergic neuronal act ivity and ACTH release (Smythe et al., 1983).
The 1atter finding suggests that decreased corticosterone may exert a
negative feedback on central

NE neuronal activity which , in turn,
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increase ACTH release.

The negative feedback system on the HPA status,

however , can be overridden by a second contro 1 system with a higher
priority.

When the animal

or man is subjected

to

a variety of

environmental challenges, which are collectively referred to as "stress"
(e.g. chemical intoxication,

infection, psychologic stress, and many

other environmental stressors), noradrenergic neuronal activity and ACTH
secretion is vigorously stimulated in spite of the fact that circulating
corticosterones are much higher than those required to inhibit ACTH
production in the "unstressed" condition (Ader and Cohen, 1985).
Treatment of mice with

benzene significantly reduced

JL-2

production at the two higher doses, while toluene caused a significant
inhibition of IL-2 synthesis at the highest dose level . Benzene has been
associated with hematotoxicity and associated immunotoxic effects
( Fishbein, 1984; Chapter II I) .

Exposure of mouse T-lymphocytes to p-

benzoquinone, one of the major metabolites of benzene, was reported to
inhibit the formation of IL-2

(Post et al., 1985). Although there is

general agreement that toluene does not elicit the hematotoxic
properties of benzene, adverse effects on lymphocyte and macrophage
functions, and host resistance to infectious microorganisms have been
noted

(Suleiman,

1987;

Fishbein,

1985;

Aranyi

et al.,

1985).

We

recently found that a 4-week to 1uene ingestion resulted in suppression
of T- lymphocyte-related immune functions at the concentration of 405
mg/L (Chapter VI) .

IL-2 has been shown to augment numerous immune

responses (Farrar et al. , 1982). Inhibition of this immunoregulatory
lymphokine synthesis via HPA axis stimulation may be a possible
mechanism by which toluene mediated its immunotoxic effects via oral
ingestion. Additional studies need to be performed to determine the
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precise biological site of action of this chemical .

The reactive

metabolite(s)-mediated covalent binding of toluene to biological
macromolecules has been reported (Pathiratne et al . , 1986b).
The time-course of the corticosterone response of mice during
benzene exposure revealed that serum corticosterone was elevated during
the initial period of exposure but returned to control, or lower, values
despite the continued exposure to the solvent.

The cycling effect of

benzene on corticosterone with time may be brought about by a feedback
inhibition of ACTH release , despite the presence

of a stressor . From

the perspective of the general adaptation syndrome (GAS) response to a
variety of stressors including many pollutants (Selye, 1950), benzene
may activate the HPA axis, resulting in the process of adaptations to an
altered environment following a period of alarm.

However, re -elevated

corticosterone levels detected in the high dose group at 28 day suggest
that mice were unable to completely maintain adaptation at this dose
1eve 1 of benzene.

Likewise, mice generally adapted to to 1uene exposure

at the low and medium doses . Corticosterone remained elevated throughout
the duration of the high dose toluene exposure and suggested that
adaptation did not occur . If adaptation of GAS does not occur , the
organism may progress into producing deleterious effects

including

immunological dysfunction (Makara et al., 1980).
It is obvious from this study that organic solvents such as benzene
and toluene have, at least partially, an additive adverse effect on
immune function via activated HPA status .

Cart icosteroids, the end

products of HPA axis, are well known to impair various aspects of
immunocompetence (Besedovsky et al ., 1985; Cupps et al . , 1985) and have
been shown to inhibit IL-2 as well as IL-l productions (Snyder and
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Unanue, 1982; Gillis et al., !979a,b). Exogenous IL-2 also reverses the
inhibition of mitogen-induced T cell proliferation by corticosteroids
(Gill is et al.,

!979a,b). Increased corticosteroid concentration can

control the clonal expansion (deriven by IL-l and IL-2) of committed
cells of the

immune system that have high affinities

(Besedovsky et al.,

1985).

for antigen

Recently, Goodwin et al. , (1986) found

leukotriene B4 , the 5-lipoxygenase product in arachidonic acid
metabolism, reversed the corticosteroid-induced suppression of T cell
proliferation and IL-2 secretion, and concluded that corticosteroids, by
inhibiting leukotriene B4 production, also inhibited IL-2 synthesis,
resulting in a decreased T-cell pro lifer at ion. Lymphocyte from ACTHtreated calves which have increased plasma cortisol concentrations have
an i mpaired capacity to produce IL-2 (Blecha and Baker, 1986).
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CHAPTER VIII
EFFECTS OF REPEATED ORAL EXPOSURE TO COMBINATIONS OF
BENZENE AND TOLUENE ON IMMUNOLOGIC RESPONSES IN MICE

INTRODUCTION
Toxicity of en vi romenta 1 po 11 utants may not necessari 1y i nvo 1ve
exposure to a single

chemical

exposure, but

may reflect the combined

effects of sever a1 chemica 1s ( Lewtas, 1985). Exposures to mixtures of
chemically related substances are frequently encountered.

In such cases

the balance between different pathways of metabolism for chemicals could
be radically changed (Sipes and Gandolfi,

1986) . Alteration in

metabolism of a second compound may be beneficial

or detrimental,

depending upon the toxicity of the parent compound versus

its

metabolite(s).
Exposure to benzene has been associ ated with hematotoxi city and
immunotoxicity (Brief et al. ,

1980; Goldstein,

1983;

Chapter III).

Benzene is a carcinogen and mutagen (Aksoy, 1985; Dean, 1985; Ereson et
al ., 1985) . It has been associated with an increased incidences of
leukemia in humans (Rinsky et al.,

1987), and several

solid tumors

(Maltoni et al., 1985) and possibly leukemia/lymphoma in rodents (Snyder
et al.,

1980;

Cronkite et al.,

1984).

The embryotoxic/teratogenic

potential of this chemical in experimental animals has been noted (Green
et al., 1978; Kuna and Kupp, 1981; Ungvary and Tatrai, 1985). Although
the mechanism of these toxicities is not well elucidated, studies have
shown that benzene itself is not the primary toxicant but is converted
by

liver microsomal enzymes or bone marrow peroxidases to a reactively

oxidative metabolite(s) to exert its toxic effects (Irons, 1985;
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Sawahata et

al . ,

1985; Eastmond et al.,

Benzene is frequently employed

1987b) .
in

industry with

toluene .

Pretreatment of rats with toluene has been reported to increase the in
vitro liver microsomal metabolism of benzene (Pathiratne et al., 1986b).

However, in vivo coadministration of benzene with toluene, which
competitively inhibited benzene metabolism (Ikeda et al ., 1972; Andrews
et al ., 1977; Sato and Nakajima, 1979), prevented

benzene toxicity such

as myelotoxic {Andrews et al., 1977; Tunek et al., 1981; 1982) and
genotoxic {Tice et al., 1982; Tunek et al., 1982; Gad-El-Karim et al.,
1984; 1985a; 1986) effects.
We have recently reported that oral ingestion of benzene or toluene
possesses

immunotoxic potentials in mice (Chapter III and VI), and that

alteration of immune function in to 1uene-exposed anima 1s was generally
evident at a relatively high dose. To our knowledge, no studies have
been published on evaluation of interaction-mediated immunotoxicity
after exposure to combinations of benzene and toluene. The present study
was therefore undertaken to assess the effects of repeated expo sure to
various concentrations of benzene and to 1uene, a1one or combined, on
hematological and immunological responses in CD-I mice. Since both these
chemicals are known groundwater contaminants (U.S. Office of Technology
Assessment, 1984; U.S. Environmental Protection Agency, 1986a), oral
administration via drinking water was employed.
MATERIALS AND METHODS
Animals
Male CD-1 mice were obtained from Charles River Breeding
Laboratories (Wilmington, MA). Animals were acclimated in an AAALAC-
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accredited animal care facility with an ambient temperature of 22-24°C,
40-60% relative humidity, and a 12 - hr 1 ight/ dark cycle for one week
prior to treatment . Commercial rodent chow (Wayne Product s, Chicago, IL)
and tap water were available ad libitum.

Animals were randomly

distributed into control and treatment groups of 5 mice each.
Chemical Treatments
Analytica l reagent grade benzene (99.9% purity, J. T. Baker
Chemical Co ., Phillipsburg, NJ) and a chromatoquality grade of toluene
(99.7% purity,

Burdick and Jackson

Labs .

Inc.,

Muskegon , MI)

were

dissolved in normal tap water to make the desirable concentrations. Two
experiments were conducted . In the first experiment, the nomina 1
concentrations employed were 200 mg/ L benzene, 400 mg/L toluene, and 200
mg benzene + 400 mg to 1uene/L for the mixture.

The concentration of

toluene was reduced to 100 mg/ L in the second experiment. The solubility
of benzene in fresh water at 25°C is 1,780 mg/L (U.S. Environmental
Protection Agency, 1980a), while to 1uene has a so 1ubi 1ity of 535 mg/L
(U.S. Environmental Protection Agency, 1980b) . Treatments were achieved
by continuously administering the test material (s) in

drinking water

to mice at the intended concentrations for 28 days. Control animals
received normal tap water without test materials. The water was provided
in glass water bottles with stainless-steel sipper tubes equipped with
ball bearings. The treated solutions were changed every three days to
ensure freshness,
experiment.

and bottles were shaken frequently during the

Fluid and

food

intake was

monitored continuously,

and

anima 1s were weighed weekly. Actua 1 benzene or to 1uene concentrations
were determined daily by gas chromatography (U .S. Environmental
Protection Agency. 1986b).
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Gross Observations and Hematology
At the end of 28 days of continuous chemical exposures, mice were
killed by decapitat i on , and gross pathological examinations were
performed . Selected organs, i.e., liver, spleen, thymus, and kidney were
removed, trimmed and weighed immediately. Total blood erythrocyte and
leukocyte counts were determined on a Coulter Model ZB- I blood cell
counter (Coulter, Electronics, Inc . , Hialeah, IL). Differential counts
were determined manually by Wright ' s stained

blood

smears .

Single

splenocyte suspensions (> 95% viability by trypan blue exclusion) were
prepared asept i call y as described by Sharma and Gehring ( 1979). Cell
concentration was measured for assay of total spleen cellularity. The
splenocyte number was adjusted to the desired concentration for each
immune function assay. Unless otherwise indicated, all splenocyte
manipulations were performed in RPM! 1640 tissue culture medium
contained 5% heat-inactivated fetal
penicillin and 100

~g/ml

calf serum (FCS),

streptomycin (referred to

that

100 units/ml
as a complete

medium) .
Mitogen-Stimulated Lymphoproliferation
The proliferative responses of splenocytes to mitogens were
determined by using a microculture assay. Splenocytes from individual
animals were added in 0.1 ml (5x10 5 cell) to triplicate wells of a 96well flat-bottomed microtiter plate. The cells were incubated for 48 hr
at 37°C in a humidified
optimal

concentrations

phytohemagglutinin

(PHA,

4. 0%
of

co 2

and air mixture with or without

the
12.5

purified

~g/ml;

T-cell

mitogens

Wellcome Reagents LTD.,

Beckenham, England) or concanavalin A (Con A, 2.5

~g/ml;

Sigma Chemical

Co., St. Louis, MO), 8-cell mitogen E. coli lipopolysaccharide (LPS, 20
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JJg/mL; Sigma), and the T- and B-cell mitogen pokeweed mitogen (PWM , 30
JJg/ mL) and were harvested after a 6-hr pulse with tritiated t hym idine
( 3H-TdR, 0.5 .JJCi / well, New England Nuclear, Boston, MA) onto fiber glass
strips with a multiple sample harvester (Model M12, Biomedical Research
and Development Laboratory, Rockville, MD). Amounts of 3H-TdR
incorporation into DNA of di vi ding 1ymphocytes was quantitated with a
liquid scintillation counter (Model 2660, Packard Instrument Co . ,
Downers Grove , IL).
Mixed Lymphocyte Culture iMbhl Reaction
MLC responses were performed under s imi 1ar conditions as mitogen
as says by using

ratios of 2: 1 and 4: 1 responders ( sp 1enocyte s) to

stimulators (mitomycin C-blocked YAC -1 lymphoma cells of A/ Sn origin, H2a). The complete RPM! culture medium was supplemented with 5x1o- 5 M 2(2-ME). After 72 hr in 37°C/ 4% co 2 humidified
incubation, the cells were pulsed wi th 3H-TdR for 6 hr and ha r ve sted for

mercaptoethanol

counting the cell-incorporated radioactivity as described above.
Spontaneous 3H -TdR incorporation was determined i n cultures i ncubated
without YAC-1 cells.
Cell -Mediated

Cytolysis~

Response

Cell -mediated cytotoxicity of splenic cytotoxic T-lymphocyte s (CTL)
was generated in vitro against YAC-1 tumor cells as de scribed by
Grabstein (1980) with minor modifications (Chapter III) . The splenocytes
(responders) were co-cultured with mitomycin C-blocked YAC - 1 cells
(stimulators) in RPM! complete medium supplemented with 5x1o - 5 M 2-ME
for 5 days . These cultured splenic cells (effectors) were washed,
counted,

and

incubated with

YAC-1

cells

(targets)

previously
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radiolabeled with 51 cr-sodium chromate (New England Nuclear) at
effector: target (E:T) ratios of 100:1, 50:1; 25:1, 12:1, and 6:1. A
constant number of 51 cr-l abe led target cells (2 x 10 4) were added to
each well of a plastic 96-well microtiter plate followed by the addition
of effector cells.

After 4 hr incubation at 37°C, cells were pe ll eted

by centrifugation, and radioactivity in the supernatant of cultures was
measured with a gamma counter (Model 3320, Packard). The 51 cr labeled
target cells in the presence of culture medium or 0.5% sterilized
saponin a1one served as the spontaneous re 1ease and tot a1 re 1ease of
radioactivity, respectively. Percentage of specific cytotoxicity was
calculated as described earlier (Grabstein, 1980).
Jnterleukin-2

~

Assay

Supernatants containing IL-2 were prepared by incubating
splenocytes (5x10 5) obtained from chemical-treated or control mice with
or without Con A at the concentration of 2.5

~g/ml

in RPM! 1640 medium

supplemented with 10% FCS, 5x1o -5 M 2-ME, and antibiotics for 48 hr at
37°C/4% C0 2 . After incubation, the cell -free supernatant aliquots (100
~L) were collected by removing the cells with centrifugation at 400 x g
for 10 minutes and stored at -70°C until analysis for JL-2 activity.
A single-blind microassay, using JL-2-dependent murine T-helper
cell line (HT-2) of BALB/C origin (Watson, 1979), was used to quantitate
IL - 2 as described (Gillis et al., 1978; Exon et al., 1983) with minor
modifications as described in the methods section of Chapter VI.
Antibody Production Response
In a separate experiment, each animal from exposed and control
groups were immunized ip with 0.25 ml of a 20% suspension of saline-
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washed sheep red blood cells (SRBC) 4 days before the end of chemical
treatments. Numbers of antibody plaque - forming cells (PFC) were
quantitated by the methods of Cunningham and Szenberg ( 1968) . Results
were expressed as antibody PFC/106 splenocytes and as antibody PFC per
spleen.
The 1eve 1 of anti- SRBC anti body ( o<. -SRBC) in the serum co 11 ected
from mice utilized in PFC assay was analyzed by a double sandwich
enzyme-linked immunosorbent assay (ELISA) as previously reported
(Chapter III).
Statistical Analysis
All data were expressed as the means and their standard errors. A
one way analysis of variance and Fisher's least significant difference
(LSD) test were used to determine the statistical significance (p<0.05)
of experimental data.
RESULTS
Based on gas chromatographic analyses, the overall average of daily
observed concentrations of test materials in the drinking water of mice
was 166 (± 9. 5%) mg/L for the 200 mg/L nominal concentration of benzene,
80 (± 12%) mg/L for the toluene 100 mg/L group, and 325 (± 13.5%) mg/L
for the toluene 400 mg/L group. The benzene or toluene concentrations in
the drinking water of the mixture groups were the same as in the groups
of chemical alone.
Gross Observations
Animals exposed to various concentrations of treated water over a
4-week period did not exhibit overt clinical symptoms of toxicity. Food
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and water consumption were not affected by the test chemical(s) . There
were no apparent differences in body, spleen, kidney and liver weights
between control and treatment groups (Table VIII-I). No gross lesions
were detected at autospy in any organ from mice treated with test
chemical (s). The animals treated with benzene (166 mg/L), showed
significant reduction in thymus mass. Toluene (325 mg/L) reduced the
effect of benzene on the thymus weight . Both toluene concentrations (325
mg/L and 80 mg/L)) had no significant adverse effect on weight of
thymus.
Hematology
Table VIII -2 shows the effects of benzene and toluene, alone or
combined, on selected blood parameters . Total blood erythrocyte,
1eukocyte, and 1ymphocyte counts were depressed in mice treated with
benzene alone . Concurrent exposure of either dose of toluene (80 and 325
mg/L) with benzene (166 mg/ L) resulted in increases of erythrocyte
counts when compared to the benzene treatment alone . Toluene at 80 mg/L
did not a11 evi ate benzene - induced 1eukocytopen i a and 1ymphocytopen i a.
There were significant differences in leukocyte and lymphocyte counts
between toluene (80 mg/L) and benzene plus toluene (166 plus 80 mg/L)
treatments. No changes in hemato 1og i ca 1 responses were observed in
groups treated with toluene alone when compared to the control values.
Mitogen-Stimulated Lymphoproliferation
The lymphoproliferative response data for optimal concentrations of
the B-ee 11 mitogen LPS, T-ce 11 mitogens Con A and PHA, and the B- and Tcell mitogen PWM are summarized in Table VIII-3 . A significant decrease
in 3H-TdR uptake was observed for splenocytes from the 166 mg/L benzene

TABLE VIII-I
ORGAN AND BODY WEIGHTS OF MICE FOLLOWING 4-WEEKS OF EXPOSURE TO
BENZENE AND TOLUENE, ALONE OR COMBINEDa

Concentration
in water,mg/L

Body weight (g)
Day 0

Organ weight (g/100 g body weight)
Spleen

Day 28

Kidney

Liver

Thymus

Experiment I
Control
Benzene, 166
Toluene, 325
Benzene, 166
+Toluene,325

27.02 ± 0. 73
27.02 + 0.56
27.46 ±: 0.48
2~.78 ± 0.37

34.36 ± 0. 78
35.70 + 1.01
37.32 ±: 1.34
34.22 ± 0.39

0.31
0. 28
0.29
0.28

±
±
±
±

0.01
0.02
0.02
0.01

1.46
1.59
1.54
1.56

0.05
0.08
0.04
0.05

5.77
6.28
5.92
5.77

0. 16
0.17
0.17
0.16

0.14
0.09
0. 11
0. 11

0.01b
0.02
0. 01
0.01

Experiment II
Contro 1
Benzene, 166
Toluene, 80
Benzene, 166
+Toluene, 80

23.38
22.50
25.38
25.42

31.12
30.44
34.72
34 . 14

0.29
0.24
0.29
0.26

±
±
±
±

0.01
0.92
0.03
0.01

1. 7g
1.73
1. 74
1. 73

0.10
0.11
0.05
0.08

6.19
6.29
6.02
6.38

0.13
0.17
0. 17
0.23

0.17
0.14
0.15
0.14

0.01b
0.01
0. 01b
0.01

±
±
±
±

0. 79
0.72
0.75
0.75

±
±
±
±

1.02
0.75
1.20
1.25

a Values are given as mean ± SE (n-5)
b Significantly different from untreated controls (p<0.05)

;::;
(X)

TABLE Vlll-2
EFFECTS OF EXPOSURE TO BENZENE ANO TOLUENE, ALONE OR COMBINED , ON
SELECTED BLOOD PARAMETERS
Leukocyte absolute differentials (103/mm3)a
Concentration
(mg/L)

Experiment I
Centro l
Benzene, 166
Toluene, 325
Benzene, 166
+Toluene,325
Experiment II
Control
Benzene, 166
Toluene, 80
Benzene, 166
+Toluene, 80
a
b
c
d
e

9.73
7.09
9.78
9.45

0. 18
-+
+ 0.25 c
±0. 23d
± 0.38

9.36+0
. 18
6. 77 -± 0.35 c
10.42 ± 0.34d
9.28 ± 0. 25

6.90
4.44
6.46
5.62

±
±
±
±

1.08c
0.16
0.61
0.35

7.54 ± 0.62c
4.80 ± 0.59
7. 55 + 0.81
5.06 ± 0.60c,e

Lymphocyte

Neutrophil

5.19
2.43
4.67
3.60

1.17
I. 61
1.24
I. 57

0. 11
0. 11
0.05
0.16

0. 54
0.31
0. 55
0.44

0.09
0.04
0.08
0.07

1.36
5.66 ± o. s8c
I. 34
2.78 ± 0. 52
!.58
5.52 + 0. 76
2.93 ± 0. 54c,e I. 72

0. 22
0.26
0.17
0. Jl

0. 53
0.57
0.54
0.40

0.08
0.19
0.07
0.14

±
±
±
±

I . 03 c
0. 16
0. 54
0.31

Values are given as mean ± SE (n=S)
Including monocytes, eosinophils and basophils
Significantly different from untreated controls (p<O.OS)
Significantly different from benzene treatment alone (p<O.OS)
Significantly different from toluene treatment alone (p<O.OS)
w

"'

TABLE VIII-3
EFFECTS OF EXPOSURE TO BENZENE AND TOLUENE, ALONE OR COMBINED, ON SPLENIC
LYMPHOCYTE PROLIFERATIVE RESPONSE TO HITOGENS
Mitogenic responsesa,b
Concentration
(mg/L)

Splenocytea
(x1o- 7)
None

Experiment I
Control
Benzene, 166
Toluene, 325
Benzene, 166
+Toluene,325

8. 94 ± 1.90
7.90 + 1.67
8.61 ± 1.16
9.26 ± 0.75

Experiment II
Control
10.80 + 1.14
Benzene, 166 7.80 ± 0.05
Toluene, 80 11.38 + 1.87
Benzene, 166 10.74 ± 0.70
+Toluene, 80

2.02
1.07
1.59
3. 17

±
±
±
±

LPS

0. 48
79 .36 ± 20.14
0.29
15 . 01 ± 3. 22
32 . 14 + 5. 24
0.52d
0. 59 •e 125.41 ± 23 .93d,e

2.10 ± 0.71
0.52 + 0.23
1. 49 + 0. 28
2.05 ± 0.72

55.52 + 10 . 24
4.07 + 1.10c
27 . 43 + 9. 92
6. 02 ± 1.68c

·con A

PWH

8.99
2.53
7.72
10 . 66

±
±
±
±

0. 43c 85.45 + 39.75
13.79 + 3. 48c
0.83
2.lld 34.87 + 7. 37
1.31 174.51 ±83.59d

6. 72 ± 1.83
3.31 ± 1.32
4.49 + 0.53
3. 79 ± 1.06

PHA

103.40 + 34 . 64
14 . 18 + 2. 15c
43 .53 ± 13.55d
119 .57 ± 2.50

72 .03 + 13 .33
10 . 55 + 2. 82c
35 . 72 ± 8. 77
23.55 ± 2.82c

a Values are giv%n as mean± SE (n=5)
b dpm x 10- 3;10 splenic cells: response evaluated by incorporation of [methyl- 3H]-thymidine
splenocyte cultures for 6 hours pulsing
c Significantly different from untreated controls (p<0.05)
d Significantly different from benzene treatment alone (p<O .OS)
~Significantly different from toluene treatment alone (p<0 .05)
ND, not determined

NDf
ND
ND
ND

into

day

2

...

0
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dosage group in the presence of all mitogens tested. Toluene (80 or 325
mg/L) did not significantly suppress the proliferation of splenocytes
stimulated with mitogen , although apparent reductions (50-60%) were
observed for the mitogenesis by LPS , Con A, and PHA . Toluene at a
concentration of 325 mg/L not on 1y camp 1ete ly prevented the benzeneproduced depression in mitogenesis but enhanced the 3H-TdR uptake when
compared to the contra 1 va 1ues . No antagonistic effects on mitogen stimulated lymphoproliferation were found when benzene -exposed mice were
s imultaneously treated with toluene at the 80 mg / L dose . The
proliferation of spleen cells cultured

in the absence of mitogen

exhibited a similar mitogen -s timulated response as described above .
Mixed Lymphocyte Culture iM11l Response
The results of MLC are presented in Fig. VIII-I.

They showed that

splenocytes from control and chemical(s) -treated mice exhibit different
abilities to recognize histocompatible murine YAC-1 lymphoma cell s (H 2a), and to proliferate after recognition. A si gnificant decrease in 3HTdR incorporation into the DNA of dividing splenic lymphocytes wa s
observed for mice exposed to benzene (166 mg/L), toluene (325 mg/ L) , and
benzene (166 mg/ L) + toluene (80 mg/ L). A high toluene concentration
(325 mg/L) protected against benzene - induced suppression of MLC
responses.
Cell-Mediated

Cytolysis~

Response

Figure VIII-2 illustrates the effects of chemical exposures on CTL
generation to YAC-1 lymphoma cells. The results of 51 cr-release assay
revealed that benzene (166 mg/L) significantly impaired the capacity of
spleen cell populations to lyse tumor cells (target cells) after four
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30

A

"0
I

R:S=2:1
R:S=4:1
R ALONE
RESPONDERS(R)-TO-STIMULATORS{S) RATIO

Fig. VIII-I. Effects of benzene and toluene, alone or combined, exposure
on mixed lymphocyte culture (MLC) responses. Chemical (s) were
administered continuously to mice via drinking water for 4 weeks, while
control mice received tap water . A: the bars (left to right).
D,
ezl,
IR8l, and
• , indicate control, benzene (166 mg/L) alone,
toluene (325 mg/L) alone, and benzene (166 mg/L) + toluene (325 mg/L),
respectively. B: the bars (left to right),
CJ,
EZ!,
l88l, and
• , indicate control, benzene {166 mg/L) alone, toluene (80 mg/L),
and benzene (166 mg/L) +toluene (80 mg/L), respectively. (a) Denotes
significantly different from control (p<O.OS); (b) denotes significantly
different from benzene treatment alone (p<O.OS); (c) denotes
significantly different from toluene treatment alone (p<O.OS) . Responder
cells were the sp l enocytes of CO-l mice and stimulator cells were the
allogenic YAC-1 lymphoma cells (H-2a) of A/Sn origin. The stimulator
cells were treated with mytomycin-C before a~dition to the 3ulture. MLR
was evaluated by incorporation (dpm x 10- ) of [methyl- H)-thymidine
into day 3 MLR cultures for 6 hours pulsing. Values are given as mean ±
SE (n•S) .
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Fig. VIII-I (Continued)
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CJ CONTROL
IZ2 TOLUENE 325 mg/l
IBlll BENZENE 166 mg/l
BENZENE +TOLUENE
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E:T-=25:1
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EFFECTORS(E)-TO-TARGETS(T) RATIO

Fig . VIII - 2 . Effects of benzene and toluene alone or combined, exposure
on cytotoxic 1ymphocyte functions.
See 1egend of Fig. VI I 1-1 for
detail. Splenocyte population (e~lector cells) was generated from mixed
Cr-labeled YAC-1 lymphoma cells were
lymphocyte culture (day 5) and
used as target cells. All determinations were done in triplicate for
each E:T rat i o. Percent specific cytotoxicity was calculated as percent
of total releasable counts , corrected for spontaneous relea s e of
radiolabel. Spontaneous release was less than 8% of total releasable
counts for all assays.
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weeks of oral ingestion. Toluene (325 mg/L} itself had no noticeable
effect on the CMC response . Concomitant administration of benzene and
toluene resulted in a significant elevation of CMC activity when
compared to the control, benzene, or toluene treatment alone.
Antibody Production
The effects of chemical treatments on the capacity of T-cells, Bcells and macrophages to cooperate in the production of antibody to a Tcell-dependent antigen,

SRBC,

are presented in Table VIII -4.

Mice

exposed to benzene (166 mg/L} had significantly reduced numbers of lgM
antibody PFC per 10 6 splenocytes and per spleen, and reduced levels of
a(.

-SRBC serum

antibodies.

Toluene (325 mg/L} itself had no effect on

-SRBC anti body 1eve 1 and PFC/sp 1een, although a reduction of PFC as
expressed on specific activity (PFC/10 6 spleen cells} was noted. Toluene
ot

alleviated the adverse effects of benzene on both PFC numbers and

-SRBC

antibody levels. No significance was detected in the total of recovered
splenocyte among any of the chemical treatment groups (Table VIII-4} .
IL-2 Synthesis
Ability of the supernatants from Con A-stimulated splenocyte
cultures to promote the growth of an

IL-2-dependent T-cell line, HT-2,

are presented in Table VIII-5. The results clearly indicate that benzene
( 166 mg/L} exposure suppressed I L-2 secretions. Sp 1enocytes taken from
mice treated with 325 mg/L toluene produced less but statistically
equivalent IL-2. Spleen cells obtained from animals exposed to a mixture
of benzene (166 mg/L} and toluene (325 mg/L} and stimulated with Con A
in culture produced significantly higher levels of IL-2 than benzene or
toluene treatment alone.

TABLE VIII-4
EFFECTS OF EXPOSURE TO BENZENE AND TOLUENE, ALONE OR COMBINED, ON THE ANTIBODY
RESPONSES TO T-DEPENDENT ANTIGEN SHEEP ERYTHROCYTE (SRBC)a
Total
Concentration
(mg/L)

(x W)

PFC/10 6
splenocytes

PFC/spljen
(x 10 - )

o<. -SRBC
antibody titer

22 .01 ± 2. 29b

1485 ± 66

splenoc~te s

337 .36 ± 44 .82

0. 78 ± 0.07

17.81 ± 1.18

833 ± 89b

151.41 ± 21.53b

o.47 ± o. o5b

Toluene, 325

19 .02 ± 1.03

1190 ± 109b

229.51 ± 32.30

0.67 ± 0.03

Benzene, 166
+Toluene,325

22 .96 ± 1.61

1972 ± 159b,c,d

454 . 90 ± 42 . 48c,d

1. 24 ± 0. 1ob,c,d

Control, 0
Benzene, 166

a Mice were sensitized with SRBC 4 days before the end of exposure . Splenic cells were
analyzed for antibody forming cells (plaque-forming cell,
detected for antibody titer

(~ - SRBC) .

PFC)

and sera were

Values are given as mean± SE (n=S)

b Significantly different from untreated controls (p<0. 05)
c Significantly different from benzene treatment alone (p<0.05)
d Significantly different from toluene treatment alone (p<0.05)
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TABLE VIII-5
EFFECTS OF SIMULTANEOUS EXPOSURE TO BENZENE AND TOLUENE ON
INTERLEUKIN-2 SYNTHESIS BY CON A-STIMULATED MOUSE T-LYMPHOCYTEa
Concentration
in Water, mg/L

3H-Thymidine ~ptake
(DPMx10- )

Stimulationb
index

Experiment
11.07 ± 1.09

Control

13.42 ± 1.32

Benzene, 166

6.31 ± 0. 36c

7.65 ± 0.43c

Toluene, 325

8.09 ± 1.26
12 .65 ± 1. 40d' e

9.81 ± 1. 53
15 . 21 ± 1. 77 d,e

12.20 ± 2.41

14 . 79 ± 2.93

Benzene, 166
tToluene,325
Experiment II
Control
Benzene, 166
Toluene,

80

Benzene, 166
+Toluene, 80

4.22 ± 0.59c
10.07 ± 0.63
6. 19 ± o. soc,e

5. 13 ± 0.7oc
11.71 ± 0.77
7. 51 ± 0.6lc , e

a Several doubling dilutions of IL-2 sources (Con A-stimula~ed
supernatants) which showed a decreasing incorporation of Hthymidine to IL-2 dependent murine T-helper cell clone, HT -2
cell, were used. Only data <P,tained from 1:1 diluted ratio
are
presented. Uptakes of H-thymidine by HT-2 cells in
presence of positive control IL-2 source (supernatants of Con
A-stimulated rat splenocyte cultures) and negative control IL-2
source (supernatants of non-Con A-stim ulated splenocyte
cultures of untreated CO-l mice) were 18.92 ± 0. 59 and 1.62 ±
0.60, respectively. Values are given as mean ± SE (n=S)
b Stimulation index (S.l . ) = dpm (culture with dilution of
supernatant/dpm (culture with media alone)
c Significantly different from the untreated control at p<O.OS
d Significantly different from the benzene treatment alone at
p<O.OS
e Significantly different from the toluene treatment alone at
p<O.OS
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DISCUSSION
The present study reports on the development of an animal model for
simultaneous subchronic exposure of benzene and toluene via oral
ingestion in which the immunotoxic interactions between the agents were
evaluated. The results demonstrate that the combination of ingested
benzene and sufficient amounts of toluene is less hematotoxic and
immunotoxic than ingested benzene alone.

Compared to treatment with

benzene alone, the combined exposure (166 mg benzene + 325 mg toluene/L)
produced a markedly protective effect on benzene-induced depressions of
tot a 1 blood erythrocyte, 1eukocyte,

and 1ymphocyte counts,

abnormalities of immune-associated parameters,

and

including humoral and

cellular immunity.
Alterations in immunocompetence following a four-week oral
ingestion of benzene alone was evidenced by a significant involution of
thymus and a loss of circulating lymphocytes, both as

useful indicators

of immune function. The sensitivity of lymphocytes to benzene revea 1ed
the immunotoxic potential of this agent. Evidence from several recent
studies implicated the immune system as a target organ for benzene .
Administration of benzene by inhalation or injection to experimental
animals has been shown to suppress the mitogenic response of B- and Tlymphocyte proliferations (Rozen and Snyder, 1985;

Rozen et al., 1984;

Wierda et al ., 1981), humoral antibody response as measured by plaqueforming cells to sheep erythrocytes (Aoyama, 1986; Wierda et al ., 1981),
and host resistance to the
monocytogenes

(Rosenthal and Snyder, 1985) and Klebsiella pneumonfae

(Aranyi et al., 1986).
exposure to

pathogenic microorganisms, such as Listeria

Recently, it has also been

reported that

100 ppm benzene (5 days/week x 4 weeks) via inhalation in
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mice depressed the mixed lymphocyte culture (MLC) response and tumor
lytic

ability

of cytotoxic

T lymphocytes,

and

ruled

out

the

possibilities that dep ressions in immune function are due to an
induction of suppressor cell activity (Rosenthal and Snyder, 1987).

As

MLC responsiveness is generally thought to represent the initial phases
in the induction of cytotoxic T cells ( CTL), the

benzene-induced 1oss

of CTL lytic ability to tumor cells might be explained by an impaired
ability of T cells to recognize foreign tissue or tumor-associated
anti gens during T-he 1per-ce ll-medi ated induction of CTL cells. 1n the
present study benzene ingestion significantly reduced the production of
IL - 2,

a known important immunoregulatory lymphokine and a necessary

component in MLC response and CTL generation (Farrar et al., 1982).
Toluene,

a widely

used

organic

s olvent,

is

an

agent

of

environmental and occupational significance (U.S. National Academy of
Sciences,

1982).

This agent

is

known to possess the potential

to

significantly alter the metabolism and resulting bioactivity of certain
other chemicals, thereby influencing their toxicities (Hayden et al.,
1977; Fishbein, 1985). In animal models toluene exposure is associated
with the induction of microsomal cytochrome P-450 dependent enzymes and
conjugation enzymes (Pyykko, 1980; Toftgard et al., 1982; Pathiratne et
al.,

1986a), and depletion of liver glutathione (van Doorn et al.,

1980) . Time-course of effects of toluene on several micro so mal
monoxygenases in 1 iver or some non-hepatic tissues of r ats exposed to
toluene has been reported (Pyykko, 1983).
The reasonab 1e exp 1an at ion for reduced benzene immunotoxi city is
that toluene decreases the levels of toxic benzene metabolites.
Metabolism of benzene is required for its toxicity (Irons, 1985; Snyder
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et al . , 1983) . Benzene metabolites have been shown to produce a variety
of alterations i n immune function . The ab i lity of phenol , hydroqu i none ,
and catechol

to suppress lymphocyte growth and function

in vitro

correlates with their capacity to undergo oxidation and with their
concentration in the bone marrow or lymphoid organs (Irons et al., 1981;
Pfeifer and Irons, 1981; 1982; 1983) .
product, p-benzoquinone, inhibit

Hydroquinone and its oxidation

proliferation and differentiation in

lectin - stimulated lymphocytes in culture at concentrations that are not
cytotoxic, while phenol

or catechol

suppress lymphocyte growth or

function and only at concentrat i ons that result in cell death .
Suppression of lymphocyte blastogenesis by hydroquinone is probably
mediated by the

interaction of

p-benzoquinone

with sulfhydryl (SH)

groups on tubulin (Irons et al., 1981; 1984; Pfeifer and Irons , 1983).
Post et al. (1985) demonstrated that exposure to p-benzoquinone in mice
completely i nhibits the proliferation and production of the T-cell
lymphokine,

interleukin-2 , by concanavalin A (Con A) -stimulated T-

lymphocytes. Hydroqu i none and catecho 1 have been shown to reduce the
frequency of spleen and bone marrow progenitor B-lymphocytes and to
inhibit polyclonal plaque-forming cells (Wierda and Irons, 1982) .
Toluene is a substrate for cytochrome P-450 and has been shown to
competitively inhibit benzene biotransformation in vitro or in vivo . The
conversion of benzene to pheno 1s in rats , mice or in vitro has been
reported to be suppressed when benzene was given in combination with
toluene

(Ikeda et al., 1972; Andrews et al . , 1977; Sato and Nakajima,

1979; Gilmour et al., 1986) .

Andrews

et al.

(1977) coadministered

benzene and toluene to mice or rabbits and observed a marked reduction
in levels of benzene metabolites in bone marrow, coupled with a
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compensatory increase in pulmonary excretion of unmetabol ized benzene.
It was also demonstrated using liver microsomes in vitro that toluene is
a competitive inhibitor of benzene metabolism.

When benzene and toluene

were administered in combination to rats i ntraperitoneally , their
disappearance rates from b1ood and the rates of uri nary excretion of
their metabolites were delayed compared with those observed when they
were given separately.

Their metabolic interaction was found to be

dose-dependent (Sato and Nakajima, 1979) .

Several

studies have

indicated that to 1uene can significantly influence the myelotoxic and
genotoxic effects of benzene . It was demonstrated that toluene protects
against benzene-induced depression of red cell
marrow of mice (Andrews et al., 1977).

59 Fe uptake in bone

Toluene not only alleviates the

benzene-induced leukopenia but the benzene-induced increase in leukocyte
alkaline phosphatase activity (Li et al., 1986).

Toluene significantly

decreased the adverse effects of benzene on granulopoietic stem cells
(CFU per tibia) and on tibial bone marrow cellularity in mice
al., 1981 ; 1982).

(Tunek et

When benzene-exposed mice were simultaneously given

an ip injection of toluene, the sister chromatid exchange (SCE)
incidence was reduced by up to 90% compared with ani rna 1s exposed to
benzene alone (Tice et al., 1982).

Gad-El-Karim et al. (1984; 1985a;

1986) found that toluene antagonized benzene's mye 1ocl astogeni city and
metabolism when mixtures of both chemicals were administered orally to
CD-1 mice. On the other hand, toluene-induced protection against benzene
toxicities might be related to the enhancement of detoxication
reactions, i.e., conjugation reactions . Pretreatment of rats with
toluene has

been found to

increase the

in vitro liver microsomal

metabolism of benzene (Pathiratne et al., 1986b).
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Toluene treatment alone (at doses used) did not show the dramatic
immunosuppresive effects of benzene . A previous study has indicated that
alteration in immune functions of mice ingesting toluene is generally
evident at relatively high doses (Chapter VI) . Alterations in host
resistance to infectious microorganisms, lymphocyte and macrophage
functions has also been noted (Aranyi et al . , 1985; Fishbein, 1985 ;
Suleiman, 1987). Similar to the metabolite(s)-mediated mechanism of
benzene to xi city, it has been reported that formation of cresol from
aromatic oxidation of toluene occurs through an arene oxide intermediate
which, in turn, is a reactive metabolite and is responsible for the
binding of toluene to biomacromolecules (Pathiratne et al., 1986a; Bakke
and Scheline, 1970). Superoxide anions are also formed during the
formation of secondary metabolites, such as semiquinones and qui nones,
from the oxidation of cresol (Pathiratne et al., 1986a). This suggests
that covalent binding of toluene to biological macromolecules involves
more than one reactive metabolite. However, the covalent binding effect
of toluene to biomacromolecules is considerably less than that of
benzene. This could account for the differences

in the degree of

immunotoxicity of toluene and benzene in this study.
Enhancements of immune responses in the combined exposure (166 mg
benzene + 325 mg toluene/L) group, when compared to the untreated
control, might involve the
toluene decreases

benzene

fact that concurrent administration of
metabolism and

results in low

amounts of

reactive oxidative metabolites of benzene. Several studies have
indicated that low concentrations of benzene or its metabolite(s)
possess promotive effects on the immune and hemopoietic systems (Chapter
III; Gaido and Wierda, 1985; Garnett et al., 1983; Harigaya et al .,
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1981).

In conclusion,

the present study demonstrates that oral ingestion

of toluene in combination with benzene over a four-week period causes
antagonistic effects on benzene immunotoxicity, while toluene itself
shows no strong immunosuppressions . Since time of exposure to toluene
relative to the time of exposure to a second chemical

is quite

important, further studies involved in the time-course of effects of
toluene on benzene metabolism or toxicity seem to be warranted in order
to better assess their interaction mechanisms.
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CHAPTER IX
EFFECTS

OF

REPEATED

ORAL

EXPOSURE

TO

COMBINATIONS

OF

BENZENE AND TOLUENE ON REGIONAL BRAIN MONOAMINE
METABOLISM IN MICE

INTRODUCTION
Exposure to chemicals in combinations has received much attention .
The possible modes by which chemicals

modify the toxicity of other

compounds include an interaction at the target site, an interaction with
drug-metabolizing enzymes, a modification of the absorption site
changing the body burden, or alterat i on of the chemical or physical
characteristics of the compounds leading to an alteration in biological
action (Mitchell, 1976; Sipes and Gandolfi, 1986).

Such interactions

may be very critic al in environmental situations and the investigations
of synergism and antagonism are important area s.
Benzene and toluene, the major aromatic hydrocarbons, are known to
produce numerous to xi co 1ogi ca 1 effects on a variety of organ systems
(Fishbein, 1984; 1985). Both compounds are extensively coemployed in
industry, chemistry, and used as important components in gasoline. The
potential for human exposure to one or both of these agents is great
(U .S. National Academy of Sciences, 1982). Several in vitro or in vivo
studies have indicated that toluene is a competitive inhibitor of the
biotransformations of benzene (Ikeda et al . , 1972 ; Andrews et al ., 1977;
Sato and Nakajima, 1979; Gilmour et al . , 1986), and can significantly
alter the hematotoxic and genotoxic effects of benzene (Andrews et al.,
1977; Tunek et al., 1981; 1982; Tice et al., 1982; Gad-El-Karim et al.,
1984; 1985a; 1986). We have recently reported that toluene has an
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antagonistic effect on benzene immunotoxicity (Chapter VIII). However,
none of these studies involved evaluation of interaction-induced
neurotoxicity after simultaneous exposure to the mixtures of these two
compou nd s. Neuro l ogi cal effects produced by either benzene or toluene
alone have been characterized (Brief et al., 1980; Evans et al., 1981;
Benignus, 198Ja,b; Dempster et al ., 1984). Changes in regional brain
catechol amine and indoleamine metabolisms in mice following benzene or
toluene ingestion have also been noticed {Chapters IV and V).
The present study was designed to assess the effects of continuous
exposure to various levels of benzene and toluene, alone or combined, on
concentration of regional brain monoamines and their major metabolites
in CO-l mice. The results of this investigation should help our
understanding of the possible mechanisms of solvent action on the
central nervous system.
MATERIALS AND METHODS
Animals
Male CO-l mice
MA) and

obtained from Charles River Lab. Inc. (Wilmington,

6 weeks old on arrival were used. After 1-week acclimatization

in a AAALAC-accredited animal care facility with an ambient temperature
of 21 ± J°C, a relative humidity of 50 ± 10%, and a 12 -h light-dark
cycle (7 a.m. - 7 p.m.), animals were randomized into control and test
groups of 5 mice each. A standard commercial rodent chow (Wayne
Products, Chicago, IL) and water were available ad libitum throughout
the entire experimental period.
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Chemical Exposures
Benzene (analytical

reagent grade,

99 .9% purity ; J.

T. Baker

Chemical Co ., Philipsburg, NJ) and toluene (chromatoquality grade, 99 . 7%
purity; Burdick and Jackson Labs. Inc., Muskegon, MI) were dissolved in
normal tap water to make the desirable concentrations. Two experiments
were conducted . The first experiment was designed primarily to study a
combination exposure of 200 mg benzene plus 400 mg toluene/ L. The
results of this experiment were compared to single exposures of benzene
(200 mg/L) and toluene (400 mg/ L) that were conducted

sim~ltaneously .

The concentration of toluene was reduced to 100 mg/L in the second
experiment. Benzene and toluene have a solubility of 1,7BO and 535 mg/L,
respectively, in fresh water at 25°C (U .S. Environmental Protection
Agency, 19BO a,b) . Exposures were achieved by continuously administering
chemical (s)-treated solutions to mice for 2B days.

Water and food

consumption was monitored continuously , and animals were weighed weekly.
Actual concentrations of benzene and toluene were confirmed daily by gas
chromatography (U.S . Environmental Protection Agency, 19B6b) .
Proces s ing of Brain Tissues
Twenty-eight days after continuous exposure to test material (s) ,
mice were decapitated and brains were microdissected immediately, on an
ice-cold plate, into six discrete regions: hypothalamus, medulla
oblongata , cerebellum, corpus stria tum , cerebral cortex and the
remainder of the brain,

midbrain,

according to the procedures of

Glowinski and Iversen (1966). The midbrain includes the hippocampus,
thalamus and subthalamus (Coulombe and Sharma, 19B6). Each dissected
brain region was promptly weighed in tared vials containing several
volumes (in relation to tissue weight) of ice-cold 0. 05 M perchloric
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aci d with 0. 1% cysteine . To overcome possible diurnal alternation s in
regional brain neurochem ic als (Matsumoto et al. , 1981). All an imals of
eac h experiment were samp 1ed between 9:30 and 11 :30 a .m.

on the same

day . Ti ss ue samples

prepared

for

chromatographic

analysis

were

as

described in the methods section of Chapter IV.
Assay of Neurochemical s
Brain

regional

concentrations of the

major

catecholamines

norepinephrine (NE), dopamine (DA) , and their principal metabolites, 3methoxy - 4- hydroxymandelic acid (vanillymandelic acid, VMA) , 3,4dihydroxyphenylacetic acid (DOPAC) , and homovanillic acid (HVA); the
indo 1eami ne serotonin ( 5-HT) and its met abo 1 ite 5-hydroxyi ndo 1eacet i c
acid (5-HIAA) in perchloric acid extracts were simultaneou sly determ i ned
by high performance 1 iquid chromatography with eletrochemical detection
( HPLC - ECD) using the method s described e 1sewhere
1983). The HPLC system consisted of a Model
analyzer,

Model

LC-3A amphoter ic detector,

(Mayer and So up ,

LC-150 electrochemical

Model

LC-22A temperature

controller, and a 250 x 4. 6 nvn ODS -- 5 )Jm-- reversed phase column (BioAnalytic Systems Inc . ). A 0. 15 M monochloroacetate buffer (PH 3.0)
containing sodium octyl

sulfate as ion-pair reagent served as mobile

phase . The instrument settings were : flow rate

1. 4 ml/ min,

column

temperature 30°C, detector potentia 1 +0. 7 V, contro 11 er 10 nA full
scale, and sample volume 20 JJL . The amounts of neurochemicals were
determined by measuring the height of the individual peaks and comparing
them with the peak of various reference compounds (Sigma Chemical Co. ,
St. Louis , MO). The detector response provided a 1 inear correlation
coefficient of >0.98 for the standard curves. Data were collected with a
Hewlett - Parkard (Avondale, PA) 3390A integrator.
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Statistical Analysis
The concentrations of monoami nes and their met abo 1i tes obtai ned
from brain regions were expressed as JJg/g wet tissue. All data were
given as mean ± SE. Analysis of variance (ANOVA) and followed-up
Fisher's least significant differences (LSD) test were used to determine
the statistical differences (p<0.05) of experimental data .
RESULTS
Concentrations of test material(s) in the drinking water mixtures
of mice as determined by gas chromatography decreased approximately 30%
over a three-day period, when the water was changed.

Overall means of

the daily analyses for the nominal concentrations of 200 mg/L benzene,
100 mg/L toluene, and 400 mg/L toluene were 166 (± 9.5%), 80 (± 12%),
and 325 (± 13.5%) mg/L,

respectively.

The benzene or toluene

concentrations in the drinking water of the mixture groups were the same
as the group treated with benzene or toluene alone.
Repeated exposure to benzene and toluene, alone or combined, over a
four -week period did not adversely affect growth, body weights, water
and food consumption, nor did it elicit mortality and any other overt
clinical

symptoms of toxicity

and gross treatment-related behavioral

alterations in test animals .
At the doses used, both benzene and toluene treatments (alone or
combined) induced significant increases in concentrations of biogenic
monoamines (NE, DA, 5-HT) and their major metabolites (VMA, DOPAC, HVA,
5-HIAA) in several of the brain regions studied . Furthermore, in several
instances, the increased metabolite concentrati ons were greater in the
combined treatment than when either chemical was used alone .

Fig. IX-1

!59
and

Table

IX-I

show the

effects

of chemical(s)

exposures

on

concentrations of selected neurotransmitters and their metabolites in
the hypotha 1amus. When compared to the untreated contro 1, s igni fi cant
increases of NE in the hypothalamus, the region containing the highest
1eve 1 of this amine, were found in the benzene ( 166 mg/L), to 1uene ( 80
and 325 mg/L), and benzene plus toluene (166 plus 325 mg/L) mixture
groups (Fig. IX-lA). Dopamine concentrations increased significantly in
the hypothalamus of animals treated with 166 mg/L benzene, 80 mg/L
toluene, or 166 mg benzene + 325 mg toluene/L

(Fig. IX-18). Elevated

levels of 5-HT also appeared in this region of mice exposed to benzene
(166 mg/L) and toluene (325 mg/L), alone or in combination

(Fig. IX-

JC) . Increases of various monoamine metabolites in the hypothalamus were
noticed and statistical

differences were detected in

the

166 mg/L

benzene (HVA, 5-HIAA), 325 mg/L toluene (5-HIAA), and their combination
groups (VMA, HVA, 5-HIAA) (Table IX - I) .
Concentrations of monoamines and their major metabolites in the
corpus striatum are

illustrated

in

Fig.

IX-2

and

Table

IX-2,

respectively. Benzene (166 mg/L) had no obvious effects on the stri atal
NE , while toluene increased NE at a concentration of 80 mg/L.
Coadministration of benzene with toluene

(80 mg/L)

increase of this neurochemical when compared to control

resulted

in

an

(Fig. IX-2A).

Increases of DA in the corpus striatum, a brain area especially rich in
DA, were seen in animals exposed to benzene alone or its combination
with

either dose

of toluene

(80 and 325 mg/L)

(Fig.

IX-28).

Concentrations of striatal 5-HT in animals receiving benzene and toluene
(325 mg/L), alone or together, were significantly higher than those in
the untreated control (Fig. IX-2C). Increases of amine metabolites in
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Fig . IX - !. Effects of benzene and toluene, alone or combined , exposure
on monoamine concentrations in the hypothalamus of CD-I mice.
A:
effects of chemical treatments on norepinephrine; B: effects of chemical
treatments on dopamine; C: effects of chemical treatments on serotonin;
BTH: exposure to 166 mg/L benzene, 325 mg/L toluene, and combination of
benzene (166 mg/L) and toluene (325 mg/L); BTL : exposure to 166 mg/L
benzene, 80 mg/L toluene, and combination of benzene (166 mg/L) and
toluene (80 mg/L) .
The bars (left to right),
O ,
IZI , !ZD, and
111, indicate treatment groups of control, benzene, toluene, and
benzene + toluene mixture, respectively . Values are given as mean± SE
(n•S). Stars (*) denote significant differences from control values at
p<0 . 05 .

161

DA
1.2

8

BTH

Fig. IX-1 (Continued)

BTL

162

5-HT
1.5

c

BTH

Fig. IX-1 (Continued)

BTL

TABLE IX-1
CONCENTRATIONS OF MONOAMINE METABOLITES IN HYPOTHALAMUS OF MICE TREATED
WITH BENZENE AND TOLUENE, ALONE OR COMBINEDa
Neurochemical concentrationb
Concentration
in water, mg/l
VMA

DO PAC

HVA

0. 224 + 0.038
0.368 :;: 0.074
0.351 :;: 0.054
0.424 :± 0.048

0.156 + 0.016
0.260 :;: 0.026c
0.243 :;: 0.025
0.288 :± 0.03lc

0. 316 + 0.066
0.686 :;: 0.037c
0.677 :;: 0.046c
0.756 :± 0.057c

0.206 +
0.338:;:
0. 273 :;:
0.263 :±

0.156 +
0. 435:;:
0.259 :;:
0.259 :±

0.601 + 0.058
l.l80+0 . J83c
0.836 :± 0. 175d
0. 708 ± 0.076

5-HIAA

Experiment
Control
Benzene, 166
Toluene, 325
Benzene, 166
+Toluene,325

0.202 +
0.275 :;:
0.266:;:
0.383 :±

0.031
0.054
0.037
0.045c

Experiment II
Control
Benzene, 166
Toluene, 80
Benzene, 166
+Toluene, 80

0.219 + 0.042
0.270 :;: 0.030
0. 266 :± 0.038
0.261 ± 0.032

0.030
0.050
0.014
0.022

0.020
0.140
0.040
0.032

a Chemical(s) was (were) administered continuously to mice via drinking water for
b 4 weeks. Abbreviations for various chemicals have been described in text
In~g neurochemical/g wet brain tissue , mean± SE (n=5)
c Significantly different from untreated control at p<O .OS
d Significantly different from benzene treatment alone at p<O.OS
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Fig . IX -2. Effects of benzene and toluene, alone or combined, exposure
on monoamine concentrations in the corpus striatum. A: effects of
chemical treatments on norepinephrine; B: effects of chemical treatments
on dopamine; C: effects of chemical treatments on serotonin. The bars
(left to right) indicate treatment groups of control, benzene, toluene,
and o~nzene + toluene mixture, respectively. Values are given as mean ±
SE (nKS). Stars (*) denote significant differonces from control value s
at Q<0 .05. BTH : exposure to 166 mg/L benzene, 325 mg/L toluene, and
combination of benzene {166 mg/L) and toluene (325 mg/L); BTL :exposure
to 166 mg/L benzene, 80 mh/1 toluene, and combination of benzene (166
mg/L) and toluene (80 mg/L).
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this brain region were detected in the 166 mg/L benzene (VMA, HVA), 80
mg/L toluene (VMA, HVA), and both combination groups (DOPAC, HVA) . There
were significantly higher concentrations of striatal DOPAC and HVA in
the benzene (166 mg/L) plus toluene (325 mg/L) and benzene (166 mg/L)
plus toluene (80 mg/L) groups, respectively, than in the single chemical
treatment groups (Table IX-2).
Figure IX -3 showed the effects of benzene and toluene, alone or
combined, on major ami nes in the cerebral cortex, midbrain, medulla
oblongata, and cerebellum. Benzene caused increases of NE in the cortex,
midbrain, and medulla oblongata. Toluene significantly increased NE in
the medulla oblongata. Concurrent exposures of toluene (325 mg/L) with
benzene (166 mg/L) reduced the benzene-induced effects on this
neurotransmitter in the cortex and midbrain (Fig. IX-3A) . Significant
higher concentrations of DA were also observed in the cerebral cortex of
animals receiving both toluene doses, i.e., 80 and 325 mg/L (Fig. IX3B). Amounts of DA in the cerebellum, a region containing relatively low
levels of this catecholamine, were not determined. Benzene (166 mg/L)
increased 5-HT concentrations in the cortex,
oblongata, while

midbrain and medulla

toluene-induced increases of this indo l eami ne were

detected in the cortex and midbrain of mice treated with 325 mg/L
toluene (Fig. IX-3C).
Concentrations of the major metabolites of biogenic amines in the
brain regions of cortex, midbrain, medulla oblongata, and cerebellum are
given in Table IX-3 - IX-6. The results shown in Table IX-3 indicate
that significant increases of the NE metabolite, VMA, were observed in
the midbrain and medulla oblongata of mice coadministered with benzene
(166 mg/L) and toluene (325 mg/L)

as compared to the untreated control

TABLE JX-2
CONCENTRATIONS OF MONOAMINE METABOLITES IN CORPUS STRIATUM OF MICE TREATED
WITH BENZENE AND TOLUENE, ALONE OR COMBINEDa
Neurochemical concentrationb
Concentration
in water, mg/L

VMA

DO PAC

HVA

5-HIAA

Experiment
Control
Benzene, 166
Toluene, 325
Benzene, 166
+Toluene, 325.

0.122 ± 0.017
0.162 + 0.010
0.138 0.010
0.109 ± 0.012

1.206 + 0.038
0.930 + 0. 068
1.281 ±. 0. 088c
1.425 0.074
1.458 0.054
1. 088 + 0. 053
1.920 0.158c,d,e 1.272 0.054c

0.547 + 0.069
0.671 0.059
0.582 0.047
0.722 0.036

0.156 + 0.014
0.249 0.022c
0.199 0.041c
0.223 ± 0.037

0.822 ± 0.076
1.068 + 0.054
1.161 0.058
1. 249 o. 098c

0.408 + 0.036
0.491 0.056
0.537 0.053
0.564 ±0.078

±

+
+
±

±

+
+
±

Experiment II
Control
Benzene, 166
Toluene, 80
Benzene, 166
+Toluene, 80

+
±

+
±

0.886 + 0.107
1.209 0.045c
1.280 0.044c
1. 510 0.066c,d,e

+
+
±

+
+

a Chemical (s) was (were) administered continuously to mice via drinking water for 4
weeks
b In ~g neurochemical/g wet brain tissue, mean ± SE (n=5)
c Significantly different from untreated control at p<0.05
d Significantly different from benzene treatment alone at p<0.05
e Significantly different from toluene treatment alone at p<0.05
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Fig. IX-3 . Effects of benzene and toluene, alone or combined, exposure
on monoamine concentrations in cerebral cortex, midbrain, medulla
oblongata, and cerebellum. A: effects of chemical treatments on
norepinephrine; B: effects of chemical treatments on dopamine; C:
effects of chemical treatments on serotonin. Stars (*) and (~) denote
significant (p<0.05) differences from untreated control and benzene
treatment alone, respectively . Values are given as mean± SE (n• 5) .
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TABLE IX-3
CONCENTRATIONS OF VANILLYMANDELIC ACID (VMA) IN CEREBRAL CORTEX, MIDBRAIN,
MEDULLA OBLONGATA AND CEREBELLUM OF MICE TREATED WITH BENZENE
AND TOLUENE, ALONE OR COMBINEDa
Neurochemical concentrationb
Concentration
in water, mg/L
Cortex

Midbrain

Medulla
oblongata

Cerebell urn

Experiment
Control
Benzene, 166
Toluene, 325
Benzene, 166
+Toluene,325

0.106 + 0.020
0. 147 0.01B
0. 131 0.006
0. 132 0. 009

0.085 + 0.020
0.107
0.078 0.004
0.120
0.101 0.005 d 0.168
0.133 0.012c,
0.208

0.220 + 0.033
0. 251 ±0.015
0.21 B + 0.029
0.224 ±0.030

0.166 ± 0.033
0. 198 + 0. 041
0.164 0. 032
0. 167 ± 0.025

+
+
±

+
+
±

± 0.007
-+ 0.003 c
± 0.025 d
± 0.012c,

0.117
0.099
0.143
0.152

± 0.015
-+ 0.017
± 0.045
± 0.030

Experiment II
Control
Benzene, 166
Toluene, BO
Benzene, 166
+Toluene, BO

±

0.150 ± 0.011
0.178 + 0.024
0. 212 0.020
0.235 ± 0.036

±

0.121 ± 0.033
0.132 + 0. 015
0.164 0.041
0.137 ± 0. 018

±

a Chemical(s) was (were) administered continuously to mice via drinking water for
4 weeks
b In ~9 neurochemical/g wet brain tissue, mean ± SE (n=5)
c Significantly different from untreated control at p<0.05
d Significantly different from benzene treatment alone at p<0 . 05
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or benzene treatment alone . Toluene (325 mg/ L)-treated animals al so
showed higher concentrations of VMA

in the medulla oblongata than

control group. Occasional increases of DOPAC and HVA , the main acid
metabolites of DA, were detected in the cortex and medulla oblongata
(Table IX-4 and IX-5).

The effects of solvent exposures,

alone or

combined, on the concentration of the 5-HT metabolite, 5-HIAA , in these
brain areas are illustrated in Table IX-6 . Benzene (166 mg/L) cau sed
elevations of 5-HIAA in midbrain. Mice exposed to toluene (80 mg/ L) had
higher 5- HIAA concentrations in the cortex, midbrain and medulla
oblongata than control group . Simultaneous exposure of benzene and
toluene raised this neurochemical

in the midbrain and cortex when

compared to the untreated control.

Concentrations of 5-HIAA in the

cortex of mice treated with benzene plu s toluene (166 plu s 80 mg/ L) were
s ignificantly different from benzene treatment alone .
DISCUSSION
Benzene and toluene are known neurotoxicants . Alteration of
neurotoxicity has been previously shown to occur between different
neurotoxicants (Savolainen, 1977;

Abou - Donia et al., 1985a,b) . This

study was undertaken to i nvestigate the possible interaction effects
between benzene and toluene,

on the catecholamine and

indoleamine

metabolism. The neurochemicals selected for evaluation are known to play
an important role in physiology and behavior (Rogawski and Baker, 1985 ;
Poirier and Bedard,

1984).

Changes

in concentrations of their

metabolites provide an appropr iate indication of neural activity
(Commissiong, 1985). Assays in various brain regions are essential to
detect potential perturbation s of a specific neurotran smitter(s).
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TABLE IX-4
CONCENTRATIONS OF 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC) IN
CEREBRAL CORTEX, MIDBRAIN, AND MEDULLA OBLONGATA OF MICE
TREATED WITH BENZENE AND TOLUENE, ALONE OR COMBINEDa
Neurochemical concentrationb
Concentration
in water, mg/L
Cortex

Midbrain

Medulla oblongata

Experiment
Control

0.205 ± 0. 009

0.212 ± 0.031

0.062 ± 0.018

Benzene, 166

0.232 + 0. 028

O.I75 ± 0.006

0.066 ± 0.013

Toluene, 325

0.273 + 0.034

0.2 I6 ± 0.040

0.040 ± 0.005

Benzene, 166
tToluene,325

0.283 ± 0. 033

0.183 ± 0. 011

0. 066 ± 0.011

0.137±0.005

0.127 ± O.OI4

0.030 ± 0.002

Benzene, 166

0. 175 ± 0.008

0.134 ± 0.007

0.047 ± 0.005

Toluene,

80

0. 200 ± 0.020c

0. 117 ± 0.016

0.040 ± 0.004

Benzene, I66
+Toluene, 80

0.193 ± O.OI9c

0.169 ± 0.031

0.056 ± 0.007c

Experiment II
Control

a Chemical (s)

was (were) administered continuously to mice via

drinking water for 4 weeks
b In ~g neurochemical/g wet brain tissue, mean ± SE (n=5)
c Significantly different from untreated control at p<0 . 05
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TABLE IX-5
CONCENTRAT IONS OF HOMOVANILLIC ACID (HVA) IN CEREBRAL CORTEX ,
MIDBRAIN, AND MEDULLA OBLONGATA OF MICE TREATED
WITH BENZENE AND TOLUENE , ALONE OR COMBINEDa
Neurochemical concentrationb

Concentration
in water, mg/L
Cortex

Midbrain

Medulla oblongata

Control

0. 155 ± 0.014

0. 129 ± 0.010

0.050 ± 0.007

Benzene, 166

0. 218 ± 0.047

0. 193 ± 0. 068c

0.064 ± 0.007

Toluene, 325

0.234 ± 0. 044

0. 178 ± 0.024

0. 054 ± 0. 008

Benzene , 166
+Toluene,325

0.211 ± 0.018

0. 157 ± 0. 012

0.057 ± 0.006

Experiment

Experiment II
Control

0. 165 ± 0.010

0. 163 ± 0. 019

0.030 ± 0.005

Benzene , 166

0.220 ± O. Oll c

0. 194 ± 0.014

0.047 ± 0. 007 c

Tol uene ,

80

0. 260 ± 0.02 1c

0. 154 ± 0. 009

0. 040 ± 0.004c

Benzene, 166
+Toluene, 80

0.256 ± 0. 019c

0. 220 ± 0.026

0.056 ± 0.004c

a Chemical (s) was (were) administered

continuously to mi ce vi a

drinking water for 4 weeks
b In~g neurochemical/g wet brain tissue, mean± SE (n=5)
c Significantly different from untreated control at p<0.05

TABLE JX-6
CONCENTRATIONS OF 5-HYDROXYINDOLEACETIC ACID (5-HIAA) IN CEREBRAL CORTEX,
MIDBRAIN, MEDULLA OBLONGATA, AND CEREBELLUM OF MICE TREATED
WITH BENZENE AND TOLUENE , ALONE OR COMBINEDa
Neurochemical concentrationb
Concentration
in water, mg/L
Cortex

Midbrain

Medulla
oblongata

Cere be 11 urn

0.371 + 0. 036
0.456 :± 0.033
0. 432 + 0.031
0.489 :± 0.030

0. 167 + 0.009
0.165 0.003
0.162 0.017
0. 178 :± 0.008

0.390 + 0. 034
0. 480 :;: 0.020
0. 513 0.035c
0.449 0.010

0.135 ± 0.016
0.142 + 0.011
0.163 0.010
0. 151 0.003

Experiment
Control
Benzene, 166
Toluene, 325
Benzene, 166
tToluene,325

0.283 + 0.023
0.361 0.019
0. 336 0.017
0.344 :± 0.021

+
+

0. 550 t O.Oll
0.705 :± 0.036c
0.628 + 0.030
0. 708 :± 0.025c

+
+

Experiment II
Control
Benzene, 166
Toluene, 80
Benzene, 166
+Toluene, 80
a Chemical(s) was
4 weeks
b In ~g neurochem
c Significantly d
d Significantly d

0.245 + 0.010
0.491 + 0.020
0.657 0.044c
0.263 - 0.010 c
0.318 + 0.020 d 0.670 0.075c
0.305 :± o.oo9c,
0.669 0.043c

+

+
+
±

+
±

+
±

(were) admin istered continuously to mice via drinking water for
cal/g wet brain ti ss ue, mean± SE (n=5)
fferent from unt reated control at p<0.05
fferent from benzene treatment alone at p<0. 05
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Recently,

several

studies have indicated that chemical-induced

neurotoxicity might be related to the alterations of certain
neurochemical (s) in certain minute brain region(s) of mice or rats
(Coulombe and Sharma, 1985; 1986; Sharma et al . , 1986).
Significant increases in concentrations of various biogenic amines
and their respective metabolites in several brain regions caused by
benzene treatment alone would be sufficient to suggest benzene-induced
alterations in brain monoamine metabolisms. In rats a four-week
prolonged sc administration of benzene has been shown to increase the
contents of NE and DA in brain and other internal organs such as spleen,
liver, and kidney (Paradowski et al., 1985), and also produced
accumulations of both 5-HT and its metabolite,
hypothalamus

and

corpus

striatum

(Paradowski

5-HIAA,

in the

et

1984).

al,

Intraperitoneal administration of benzene to mice caused

increased

striatal levels of 5-HT and 5-HIAA (Juorio and Yu, 1985a). The mechanism
for benzene-induced changes in levels of monoamines and their
metabolites is not yet known. Benzene produced an induction of aromaticL-amino acid decarboxylase (AADC) but showed no effect on monoamine
oxidase (Juorio and Yu, 1985a) .

However, due to its high enzymatic

activity, the induction of AADC may not result in significant changes of
endogenous

monoamine

levels

(Cooper

et

al.,

1986).

Further

investigations are needed to determine whether benzene alters the
kinetics of the rate-limiting enzyme,

tyrosine hydroxylase and

tryptophan hydroxylase, in the catecho 1amine and indo l eami ne metabolic
pathways, respectively.
Toluene ingestion also caused dramatic effects on brain monoamine
metabolisms.

Several studies have indicated that concentrations of
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various brain biogenic amines are affected by acute or subchronic
adm i nistration of toluene via inhalation or ip injection to rats . Mo st
reports

sho~:ed

that brain NE increased wh i 1e DA increased or remained

unaltered after toluene treatment (Rea et al., 1984; Andersson et al .,
1980; 1983; Arito et al., 1984; 1985). Significant alterations in brain
concentrations of 5-HT were a1so reported (Rea et a1 . , 1984; Arito et
al., 1984; 1985). We have recently demonstrated that toluene - induced
increases in CNS neurotransmitter metabolisms exhibited a biphasic dose effect in mice (Chapter V), and that toluene,

by significantly

increasing concentrations of hypothalamic NE and a parallel trend in i ts
major metabolite VMA, markedly stimulated the hypothalamic -pituitary adrenocorticol (HPA) axis, resulting in an elevated serum corticosterone
and a decreased immune function (Chapter VII) .
Increases in the region a1 concentrations of brain neurochemi ca 1s
produced by the combined exposures , compared to the untreated control,
indicate the absence of protective effect on
neurotoxicity between

benzene

and toluene ,

at

monoamine - related
least

at the do ses

administered in this study. Toluene has been shown to alleviate benzeneinduced hematotoxicity (Andrews et al ., 1977 ; Tunek et al . , 1981; 1982 ;
Li et al . , 1986), genotoxicity (Tice et al . , 1982, Gad-El-Karim et al .,
1984; 1985a; 1986), and immunotoxicity (Chapter VIII).

Contrarily,

the

fact that concurrent administration of two compounds raised the
concentrations of biogenic amine metabolites in

few instances when

compared to either chemica 1 treatment a1one suggests that there are
marginal additive effects of the combined treatment.
One possible explanation

for

these phenomena

is

that

toluene

competitively inhibits the biotransformation of benzene (Ikeda et al.,
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1972; Andrews et al., 1977; Sato and Nakajima, 1979; Gilmour et al. ,
1986). When benzene and toluene were administered in combination to rats
intraperitoneally,

th~ir

disappearance rates from blood and the rates of

urinary excretion of their metabolites were delayed compared with those
observed when they were given separately (Sato and Nakajima, 1979). The
prolonged half-life of both benzene and toluene,

which have been

reported to be readily taken up by the CNS and possess high ability to
modify membrane environments (Baker et al., 1985), may render CNS cell
more susceptible to the toxic effects of these organic solvents. The
effects of two or more solvents in combination may be potentiating
rather than additive (Savolainen, 1977).
However, the possible role of oxidative metabolism and tissue
binding in the CNS has been suggested as a factor for benzene and
toluene in particular (Savolainen, 1977;

Baker et al., 1985). The

decreased concentrations of regional brain monoamines and their
metabolites produced by phenol, a major metabolite of benzene, following
a four-week repeated exposure in mice (Hsieh et al., 1988) together with
the reported delayed

excretion of this benzene

metabolite caused by a

sufficient amount of toluene (Sato and Nakajima, 1979) support the
findings

in the present study. Additional

research on in vivo

neurobehavioral assays, pharmacokinetics, and nervous system molecular
events may provide relevant information to realistically evaluate
neurotoxic mechanisms of benzene-toluene interaction.
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SUMMARY AND CONCLUSION

Benzene and toluene are major aromatic hydrocarbon compounds with
enviromental and occupational significance. The basic immunotoxic and
neurotoxic mechanIsms of these chemicals and the! r InteractIons were
evaluated in this study by utilizing various immunological and neuro endocrinobiochemical parameters in CO-l mice continuously exposed to 0,
31, 166, and 790 mg/L benzene and 0, 17, 80, and 405 mg/L toluene,
respectively , in drinking water for four weeks .
Benzene exposure caused a dose-dependent reduct I on In numbers of
peripheral blood leukocytes, lymphocytes, erythrocytes and resulted in a
severe macrocytic anemia .

Splenic lymphocyte proliferation to both B

cell and T cell mitogens (lipopolysaccharide, pokeweed mitogen ,
concanavalin A, and phytohemagglutinin) was followed by a dose -related
biphasic responsiveness, enhanced at the lowest dose

(31 mg/L)

and

depressed in the higher dosage groups (166 and 790 mg/ L) . Cell-mediated
immunity as measured by mixed-lymphocyte culture response to allogeneic
cells and cytotoxic lymphocyte activity to YAC-1 tumor cells exhibited a
si milar biphasic phenomenon .

Antibody production as assessed by

enumeration of sheep red blood cell
cells

(PFC)

(SRBC)-specific plaque - forming

indicated a significant suppression of PFC

exposed to 166 and 790 mg/L benzene.

in animals

A decrease In ant I -SRBC ant I body

titer corresponded to the numbers of PFC.

The findings indicate that

oral ingestion of benzene produced a biologically significant alteration
in both humoral and cellular immune responses.
Benzene also Induced both synthesIs and catabolIsm of reg! on al
brain monoamine neurotransmitters . In the hypothalamus, the brain region
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richest in NE, concentrations of NE increased by 40, 58 and 61% when
mice

received doses of 31, 166 and 790 mg/L

benzene, respectively .

Significant increases of NE were also observed in the medulla oblongata
and cerebellum. Dopamine concentrations increased

significantly in the

hypothalamus and corpus striatum. Increases of catecholamine metabolites
were seen in a number of brain regions: midbrain (DOPAC),

corpus

striatum (VMA, DOPAC, HVA), cerebral cortex (VMA) and cerebellum (VMA) .
Benzene treatment significantly increased 5-HT concentr ations in the
hypothalamus, corpus stria tum, midbrain, cerebral cortex and medulla
oblongata . Concomitant with increases of 5-HT, 5-HIAA increased in
hypothalamus , corpus striatum,

midbra i n, cerebral cortex and medulla

oblongata .
Toluene is not as strong an immunotoxicant as its analogue benzene .
No effects on hemato logical parameters , including erythrocytes,
leukocytes

and

their

differentials

were

noticed .

Splenocyte

lymphopro l i ferat ion to all oant igens decreased at the 405 mg/ L toluene
dose only .

Numbers of SRBC - specific PFC decreased in the 405 mg/ L dosed

animals,

however,

antibody

level .

no significant change was observed in

anti -SRBC

Toluene (405 mg/L) also adversely affected IL -2

synthesis . It appeared that suppresion of immune functions of mice
ingesting toluene was

generally evident at relatively high do ses ,

except for splenic lymphocyte responses to selected mitogens.
The maximum toluene - induced increases in brain biogenic amines and
their metabolites occurred at a toluene concentration of BO mg/L . In the
hypothalamus , the concentrations of NE significantly increased by 51 ,
63, and 34% in groups dosed with 17, 80,

and 405 mg/L toluene,

respectively . Increases of NE were also observed in the medulla
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oblongata and midbrain. Correspondingly, concentrations of VMA increased
in various brain regions .

Concentrations of DA were higher in the

corpus striatum and hypothalamus.

Alterations

in levels of the DA

metabolites, DOPAC and HVA, were marginal. Toluene increased 5-HT in all
dissected brain regions except cerebellum, and 5-HIAA levels in the
hypotha 1amus, corpus stria tum and cerebra 1 cortex. Noradrenerg i c and
serotonergic neurons appeared to be highly vulnerable to toluene while
dopaminergic neurons were rather resistant.
The concentrarions of hypothalamic NE and VMA, plasma ACTH and
serum corticosterone were increased following both chemical exposures.
Comparisons of benzene-treated mice with appropriate - time - controls
revealed that corticosterone levels were significantly higher in mice
after 7 days ( 166 and 790 mg/L benzene) and at 28 days ( 790 mg/L of
benzene). Toluene elevated corticosterone levels at 14 and 28 days at
the 405 mg/L exposure.

IL-2 production was suppressed in the two higher

benzene - treated groups, while toluene decreased IL-2 synthesis at the
405 mg/L concentration only.

Results indicated that both benzene and

toluene ingestion stimulated the hypothalamic-pituitary-adrenocortical
(HPA) axis, resulting in elevation of corticosterone which has been
reported to inhibit IL-2 production and impair immunocompetence.
Toxicity of environmental pollutants may be expressed as combined
effects of the chemicals. Benzene frequently occurs in a cocontaminated
enviroment

of

the

biotransformation of benzene. When coadministered with benzene

(166

mg/L),

with

toluene

toluene,

(325 mg/L)

a

competitive

completely

inhibitor

inhibited

benzene-induced

immunotoxicity, i.e., involution of thymic mass and suppressions of both
B- and T-cell mitogeneses, mixed lymphocyte culture response to
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alloantigens, the ability of cytotoxic lymphocytes to lyse tumor cells,
antibody production response to SRBC, and IL-2 secretion by Con Astimulated mouse T-cells. However, the low dose of toluene (80 mg/L) did
not protect against benzene-induced depressions of immune function. The
results demonstrate that toluene, in sufficient amounts, has an
antagonistic effect on benzene immunotoxicity. When compared to the
untreated controls, mice given the combined treatments of benzene and
toluene exhibited elevated regional concentrations of brain amines and
their metabolites in several brain regions. Increased concentrations of
biogenic amine metabolites in a few brain regions were greater in the
combined exposures of benzene and toluene than when either chemical was
used alone; there was a

marginal additive effect between these two

types of neurotoxicants.
The present study demonstrates that both benzene and toluene
possess the potential for inducing immunotoxic and neurotoxic effects in
CO-l mice following

four weeks of continuous exposure via drinking

water. Of particular importance was the fact that the neurotoxic effects
were evident at the lowest dose of benzene or toluene treatment, and a
no-effect level could not be established. Further studies involving
lower levels of exposure are necessary to fully assertain the safety of
these compounds in drinking water. The results of combination studies
suggest that benzene i mmunotoxi city is mainly due to action of the
reactive metabolites, whereas benzene neurotoxicity results from benzene
itself. In addition, both benzene and toluene have, at least partially,
an additive negative effect on immune function via the activated HPA
axis.
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